PATH: Form 990, tax year 2023
View the entire original 990 at ProPublica ↗
- Organization
- PATH (EIN 91-1157127)
- Tax period
- 2023-01-01 to 2023-12-31
- Filed
- 2024-09-11
- IRS object ID
- 202442559349300319
- Schema version
- 2023v5.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2024-09-11T08:25:10-05:00 | ReturnTs |
| Tax Period End | 2023-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 521392008 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | GELMAN ROSENBERG & FREEDMAN | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 4550 MONTGOMERY AVE SUITE 800N | AddressLine1Txt |
| City | BETHESDA | CityNm |
| State Abbreviation | MD | StateAbbreviationCd |
| ZIP | 208142930 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2023-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 911157127 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PATH | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | PATH | BusinessNameControlTxt |
| Phone | 2062853500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2201 WESTLAKE AVENUE 200 | AddressLine1Txt |
| City | SEATTLE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98121 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | KELLY PRIESTLEY | PersonNm |
| Person Title | CONTROLLER & PRIN. FIN. OFFICER | PersonTitleTxt |
| Phone | 2062853500 | PhoneNum |
| Signature | 2024-09-11 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | 0 | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | RICHARD J LOCASTRO CPA | PreparerPersonNm |
| PTIN | P00288314 | PTIN |
| Phone | 3019519090 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2023 | TaxYr |
| Build TS | 2024-08-08 14:25:15Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | KELLY PRIESTLEY | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2201 WESTLAKE AVENUE 200 | AddressLine1Txt |
| City | SEATTLE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98121 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $379,356,376 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.PATH.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1981 | FormationYr |
| Legal Domicile State | WA | LegalDomicileStateCd |
| Activity Or Mission | SEE PART III, LINE 1. | ActivityOrMissionDesc |
| Voting Members Governing Body | 13 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 13 | VotingMembersIndependentCnt |
| Total Employee | 634 | TotalEmployeeCnt |
| Total Volunteers | 0 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $347,720,581 | PYContributionsGrantsAmt |
| CY Contributions Grants | $327,947,500 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $4,226,978 | PYInvestmentIncomeAmt |
| CY Investment Income | $4,822,459 | CYInvestmentIncomeAmt |
| PY Other Revenue | $869,980 | PYOtherRevenueAmt |
| CY Other Revenue | $1,344,719 | CYOtherRevenueAmt |
| PY Total Revenue | $352,817,539 | PYTotalRevenueAmt |
| CY Total Revenue | $334,114,678 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $90,575,790 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $73,720,867 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $138,417,115 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $136,439,630 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,497,048 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $117,640,612 | PYOtherExpensesAmt |
| CY Other Expenses | $128,413,756 | CYOtherExpensesAmt |
| PY Total Expenses | $346,633,517 | PYTotalExpensesAmt |
| CY Total Expenses | $338,574,253 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $6,184,022 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$4,459,575 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $335,091,155 | TotalAssetsBOYAmt |
| Total Assets EOY | $346,497,870 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $282,616,412 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $292,900,954 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $52,474,743 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $53,596,916 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | PATH'S MISSION IS TO ADVANCE HEALTH EQUITY THROUGH INNOVATION AND PARTNERSHIPS. (CONTINUED ON SCHEDULE O) | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $136,566,533 | ExpenseAmt |
| Grant | $37,041,293 | GrantAmt |
| Desc | THE PROGRAMS & INNOVATION DIVISION BRINGS DEEP TECHNICAL EXPERTISE AND A ROBUST, COLLABORATIVE, AND INTERDISCIPLINARY APPROACH TO SUPPORT PATH COUNTRY PROGRAMS AND PARTNERS IN ADVANCING HEALTH EQUITY. WE FOCUS ON GENERATING ANALYTICAL INSIGHTS, TRANSLATING THEM INTO ADVOCACY AND ACTION, ADVANCING INCLUSIVE AND SUSTAINABLE INNOVATION, AND STRENGTHENING WORKFORCE SKILLS AND RESOURCES THAT SUPPORT INTEGRATED AND RESILIENT HEALTH SYSTEMS. OUR WORK COVERS DIGITAL TRANSFORMATION AND DATA USE, PRIMARY HEALTH CARE, DIAGNOSTICS, PRODUCT DEVELOPMENT, MARKET SHAPING, EPIDEMIC PREPAREDNESS AND RESPONSE, MALARIA AND NEGLECTED TROPICAL DISEASES, AND MORE.(CONTINUED ON SCHEDULE O)CENTER OF DIGITAL AND DATA EXCELLENCEPATH USES DIGITAL TECHNOLOGIES AND DATA-DRIVEN STRATEGIES TO ADVANCE HEALTH EQUITY. IN 2023, PATH'S CENTER OF DIGITAL AND DATA EXCELLENCE CATALYZED COUNTRY-LED DIGITAL HEALTH TRANSFORMATION IN NUMEROUS WAYS.WORK CONCLUDED ON THE DATA USE PARTNERSHIP (DUP) AND THE DIGITAL HEALTH ECOSYSTEM (DHE) PROJECTS. DUP, A PROJECT FUNDED BY THE BILL & MELINDA GATES FOUNDATION, WAS TRANSITIONED TO THE GOVERNMENT OF TANZANIA TO CONTINUE ENHANCING THEIR HEALTH INFORMATION SYSTEMS AND USE OF DATA. THE PROJECT CULMINATED WITH ESTABLISHING THE CENTER FOR DIGITAL HEALTH, WHICH WILL SERVE AS A CENTRAL COORDINATION POINT FOCUSED ON GOVERNANCE, TECHNOLOGY, WORKFORCE CAPACITY, RESEARCH, AND CHANGE MANAGEMENT, ENSURING THAT TANZANIA REMAINS AT THE FOREFRONT OF DIGITAL HEALTH INNOVATION.THE DHE PROJECT, FUNDED BY THE BAYER FOUNDATION, WRAPPED UP WORK TO SUPPORT SUSTAINABILITY AND EXPANSION OF DIGITAL TOOLS FOR HEALTH BY HELPING LOCAL AFRICAN ENTREPRENEURS MORE EASILY ACCESS FINANCING, TECHNICAL RESOURCES, AND OPPORTUNITIES FOR SCALE.DIGITAL SQUARE, A PATH-LED INITIATIVE BACKED BY A UNITED STATES AGENCY FOR INTERNATIONAL DEVELOPMENT (USAID) INVESTMENT OF UP TO $170 MILLION THROUGH 2026, CONTINUED TO BRING DONORS AND PARTNERS TOGETHER TO IMPROVE HOW THE GLOBAL COMMUNITY DESIGNS, USES, AND PAYS FOR DIGITAL HEALTH TOOLS AND APPROACHES WITH AN EMPHASIS ON COUNTRY-DRIVEN PRIORITIES. HIGHLIGHTS FROM 2023 INCLUDED WELCOMING A NEW EXECUTIVE DIRECTOR, DR. BILAL MATEEN; PRODUCING A DIGITAL VERSION OF THE DIGITAL SQUARE GLOBAL GOODS GUIDEBOOK; LAUNCHING THE ENTERPRISE ARCHITECTURE FOR DIGITAL TRANSFORMATION IN BURKINA FASO, THE DEMOCRATIC REPUBLIC OF CONGO (DRC), AND SENEGAL; CONCLUDING THE PILOT DIGITAL HEALTH APPLIED LEADERSHIP PROGRAM; AND CONTINUING TO PARTNER WITH OTHER IMPLEMENTERS AND ORGANIZATIONS TO SUPPORT OPEN-SOURCE DIGITAL TOOLS.IN 2023, THE DIGITAL RESULTS IMPROVED VACCINE EQUITY AND DEMAND (DRIVE DEMAND) PROJECT, FUNDED BY THE ROCKEFELLER FOUNDATION, CONTINUED TO UNDERSTAND, TRACK, AND INFLUENCE DEMAND FOR IMMUNIZATIONS IN FIVE COUNTRIES.THE DIGITAL INNOVATION IN PANDEMIC CONTROL (DIPC) PROJECT, FUNDED BY DEUTSCHE GESELLSCHAFT FUR INTERNATIONALE ZUSAMMENARBEIT (GIZ), CONTINUED PARTNERING WITH MINISTRIES IN GHANA, MALAWI, AND TANZANIA TO SELECT AND ADAPT ROBUST DIGITAL TOOLS TO STRENGTHEN IMMUNIZATION SYSTEMS.PATH, WITH US CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FUNDING, IS LEADING OVERALL HEALTH INFORMATION SYSTEM (HIS) SUPPORT ACTIVITIES AS PART OF THE US PRESIDENT'S EMERGENCY PLAN FOR AIDS RELIEF (PEPFAR) TECHNICAL ASSISTANCE PLATFORM (TAP), WHICH PARTNERS WITH COUNTRIES TO BUILD LASTING DIGITAL HEALTH CAPACITY. IN 2023, THE TEAM BEGAN IMPLEMENTING THE FOURTH YEAR OF THE PROJECT, WITH A FOCUS ON NATIONAL HEALTH DATA POLICIES AND GOVERNANCE, HEALTH INFORMATION SYSTEM STANDARDS, AND HEALTH INFORMATION SYSTEM WORKFORCE STRENGTHENING. THROUGH TAP, PATH WORKED TO STRENGTHEN HEALTH SYSTEMS FOR HIV AND/OR COVID-19 IN BOTSWANA, CTE D'IVOIRE, DRC, ETHIOPIA, HAITI, KENYA, NAMIBIA, NIGERIA, RWANDA, UGANDA, VIETNAM, AND ZAMBIA.PATH CONTINUED TO PARTICIPATE IN HIGH-LEVEL GLOBAL COALITIONS, INCLUDING TRANSFORM HEALTH; THE HEALTH WORKING GROUP FOR RECOMMENDATIONS FOR G20 LEADERS; THE WORLD HEALTH ORGANIZATION'S (WHO) GLOBAL INITIATIVE FOR DIGITAL HEALTH; THE DIGITAL CONNECTED CARE COALITION; THE DIGITAL PUBLIC GOODS ALLIANCE; AND THE DIGITAL PUBLIC GOODS CHARTER CAMPAIGN.DIAGNOSTICSPATH'S DIAGNOSTICS PROGRAM AIMS TO ADVANCE AND INCREASE ACCESS TO HIGH-QUALITY AND APPROPRIATE DIAGNOSTICS THAT IMPROVE THE HEALTH OUTCOMES OF PEOPLE AND COMMUNITIES IN LOW-RESOURCE SETTINGS.IN 2023 PATH SUPPORTED THE ADVANCEMENT OF AFFORDABLE AND RELIABLE DIAGNOSTICS, PROTEINS, ANTIBODIES, AND TOOLS BY AIDING THE DEVELOPMENT, COMMERCIALIZATION, AND PROCUREMENT OF NEW TECHNOLOGIES; CONDUCTED PERFORMANCE EVALUATIONS AND CLINICAL STUDIES TO INFORM PATIENT CARE; FACILITATED A G6PD (GLUCOSE-6-PHOSPHATE DEHYDROGENASE) OPERATIONAL RESEARCH COMMUNITY OF PRACTICE; AND PUBLISHED NINE PEER-REVIEWED ARTICLES. WE CONTINUED TO CONTRIBUTE TO THE AVAILABILITY OF COST-EFFECTIVE AND DEPENDABLE DIAGNOSTIC SOLUTIONS IN LOW-RESOURCE SETTINGS, ENSURING THAT COMMUNITIES IN NEED HAVE ACCESS TO TOOLS FOR AN ACCURATE AND TIMELY DIAGNOSIS.ABBOTT DIAGNOSTICS IS DEVELOPING A NEXT-GENERATION TB LAM ASSAY. PATH IS SUPPORTING ABBOTT'S RESEARCH AND DEVELOPMENT EFFORTS BY QUALIFYING URINE SAMPLES USING OUR IN-HOUSE REFERENCE ASSAY FOR TB LAM MEASUREMENT. ONCE THE NEW ASSAY IS READY, THE UNIVERSITY OF WASHINGTON WILL CONDUCT CLINICAL STUDIES OF IT. PATH WILL RECEIVE THE URINE SAMPLES TESTED BY THE ABBOTT ASSAY AND QUALIFY THE TEST RESULT FOR TB LAM USING THE IN-HOUSE REFERENCE ASSAY.THE EQUALS PROJECT SUCCESSFULLY DEFINED THE CONTENT OF INTERNAL QUALITY CONTROLS REQUIRED TO QUALIFY TEST RESULTS DERIVED FROM WASTEWATER SURVEILLANCE. THIS WAS ACHIEVED THROUGH CONSULTATION WITH THE TECHNICAL ADVISORY GROUP. HOWEVER, CONSENSUS ON THE DESIGN OF EXTERNAL QUALITY CONTROLS HAS NOT BEEN REACHED, SO DISCUSSIONS ARE ONGOING WITH STAKEHOLDERS TO IDENTIFY THEIR COMPOSITION.WITH POLIOVIRUS SURVEILLANCE, WE HAVE SUCCESSFULLY SCALED UP TESTING IN PAKISTAN TO 40 SITES ACROSS THE COUNTRY. AFGHANISTAN IS STILL ON HOLD AS WE WAIT FOR GUIDANCE FROM THE GATES FOUNDATION. SUPPORT FROM THE WHO REGIONAL OFFICE FOR THE EASTERN MEDITERRANEAN (EMRO) IN YEMEN IS ONGOING, AND THEY HAVE EXPANDED COLLECTION TO FOUR SITES FROM THE ORIGINAL THREE.WE HAVE COMPLETED RESEARCH AND DEVELOPMENT (R&D) OF THE SEROTYPE-SPECIFIC URINARY ANTIGEN DETECTION ASSAY FOR PNEUMOCOCCAL SURVEILLANCE. QUANSYS HAS COMPLETED THEIR PHASE II EFFORT, AND IN 2024, WE WILL PROCEED WITH A PRODUCT LOCK AND QUALIFY THE ASSAY FOR PRODUCTION. THE CDC HAS AGREED TO SUPPORT A CLINICAL EVALUATION OF A CLINICAL PANEL THAT THEY HAVE.FOR POINT-OF-CARE (POC) MOLECULAR DIAGNOSTICS, WE SELECTED 14 DIFFERENT MANUFACTURERS OF POC COVID-19 MOLECULAR ASSAYS AND ASSESSED THEM USING A TEST PANEL TO DETERMINE THE BEST IN CLASS, A SECOND SERIES OF PERFORMANCE ASSESSMENT AT PATH. WE ALSO EVALUATED THEIR USABILITY, PROVIDING FEEDBACK TO THE DEVELOPERS ON THE DESIGN FEATURES AND INSTRUCTIONS FOR USE. THROUGH THIS PROCESS, WE SUCCESSFULLY IDENTIFIED SEVERAL TESTS THAT WERE BEST IN CLASS.THE REMAINING FUNDS FOR THE DEMONSTRATION SAMPLE REPOSITORY AND DIAGNOSTIC DEVICE EVALUATOR PROJECT WERE ROLLED INTO THE APOLLO PROJECT TO PROVIDE FURTHER RESOURCES FOR TESTING.TO ENHANCE THE SECURITY OF LOCAL DIAGNOSTIC SUPPLY CHAINS IN LOW- AND MIDDLE-INCOME COUNTRIES (LMICS), PATH CONDUCTED A COMPREHENSIVE LANDSCAPE ANALYSIS TO DETERMINE KEY MARKET FAILURES AND IDENTIFY MARKET-SHAPING INTERVENTIONS NEEDED TO EXPAND ACCESS TO HIGH-QUALITY DIAGNOSTICS. THIS INCLUDED DEVELOPING AN INTERACTIVE DASHBOARD THAT CONSOLIDATED PUBLICLY AVAILABLE DATA ON DIAGNOSTIC COMPANIES WITH A MANUFACTURING PRESENCE IN AFRICA, LATIN AMERICA, AND SOUTHEAST ASIA. THE DASHBOARD INCREASED THE VISIBILITY AND AWARENESS OF THESE COMPANIES WITHIN EACH REGION WHILE PROVIDING AN OVERVIEW OF THEIR PRODUCT PORTFOLIOS AND QUALITY SYSTEMS.PATH CONTINUED ITS SUPPORT OF DIAGNOSTIC TOOLS FOR MALARIA CASE DETECTION AND CASE MANAGEMENT. SPECIFICALLY, PATH COMPLETED CLINICAL STUDIES TO ADVANCE NEXT-GENERATION RAPID DIAGNOSTIC TESTS FOR MALARIA AND SUPPORTED THE CHARACTERIZATION OF SPECIMENS FROM THESE STUDIES IN ETHIOPIA AND SENEGAL. PATH ALSO EVALUATED RAPID DIAGNOSTIC TESTS AND REAGENTS, SUCH AS ANTIBODIES, FROM A SERIES OF MANUFACTURERS IN ITS LABORATORY. TO INCREASE ACCESS TO G6PD TESTING, WHICH IS ESSENTIAL FOR TREATING PLASMODIUM (P.) VIVAX MALARIA PATIENTS, PATH CONTINUED WITH THE SUPPORT OF ONE MANUFACTURER IN ITS RESPONSES TO WHO PREQUALIFICATION, AND ADVANCED THE DEVELOPMENT EFFORTS OF A SECOND MANUFACTURER TOWARD CLINICAL STUDIES. THE PERFORMANCE OF THE SECOND PRODUCT WAS EVALUATED IN A PRECLINICAL STUDY, IN ANTICIPATION OF REGULATORY STUDIES FOR 2024. PATH HAS ALSO CONTINUED TO PLAN IMPLEMENTATION STUDIES IN ETHIOPIA AND VIETNAM FOR BOTH THE G6PD TEST AND NEW TREATMENTS FOR P. VIVAX, WHICH WE ANTICIPATE WILL BEGIN IN 2024. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $88,671,858 | ExpenseAmt |
| Grant | $26,898,550 | GrantAmt |
| Desc | ESSENTIAL MEDICINES:PATH'S ESSENTIAL MEDICINES DIVISION DEVELOPS AND DELIVERS LIFESAVING VACCINES AND DRUGS FOR COMMUNITIES AROUND THE GLOBE--ESPECIALLY WOMEN AND CHILDREN.(CONTINUED ON SCHEDULE O)CENTER FOR VACCINE INNOVATION AND ACCESSPATH'S CENTER FOR VACCINE INNOVATION AND ACCESS ALIGNS EXPERTISE ACROSS EVERY STAGE OF VACCINE RESEARCH, DEVELOPMENT, AND INTRODUCTION TO MAKE VACCINES AVAILABLE TO MORE COMMUNITIES, PARTICULARLY IN LOW- AND MIDDLE-INCOME COUNTRIES (LMICS). OUR PORTFOLIO INCLUDES MORE THAN TWO DOZEN VACCINE PRODUCTS IN DEVELOPMENT OR ALREADY IN USE, WITH AN EMPHASIS ON THE LEADING INFECTIOUS CAUSES OF CHILD DEATH AND DISEASE WORLDWIDE.IN 2023, PATH CONTINUED TO SUPPORT COVID-19 PREVENTION AND EMERGENCY RESPONSE PREPAREDNESS BY COORDINATING GRANTS TO RESEARCH GROUPS CONDUCTING TRIALS OF COVID-19 VACCINES AT FRACTIONAL DOSES IN LOW-RESOURCE SETTINGS. WE SUPPORTED THE MRNA VACCINE TECHNOLOGY HUB IN SOUTH AFRICA AND PROVIDED COORDINATION AND TECHNICAL ASSISTANCE FOR A CONSORTIUM DEVELOPING AN EGG-BASED COVID-19 VACCINE FOR PRODUCTION IN BRAZIL, THAILAND, VIETNAM, AND OTHER LMICS. PATH, IN COLLABORATION WITH THE WORLD HEALTH ORGANIZATION (WHO), CONTINUED TO CURATE THE COVID-19 MATERNAL IMMUNIZATION RESOURCE LIBRARYA ONE-STOP ONLINE HUB FOR PUBLIC HEALTH INFORMATION ABOUT COVID-19 VACCINES AND PREGNANCY.IN ONGOING EFFORTS TO FACILITATE LOCAL VACCINE PRODUCTION, PATH SUPPORTED LMIC VACCINE MANUFACTURERS TO READY LOCALLY MADE VACCINES FOR THE GLOBAL MARKET, THEREBY INCREASING AVAILABLE INTERVENTIONS AND POTENTIALLY MAKING VACCINES MORE ACCESSIBLE FOR LMICS. WE PROVIDED TECHNICAL ASSISTANCE TO SEVERAL MANUFACTURERS PREPARING FOR WHO PREQUALIFICATION SUBMISSION OR INSPECTION, SUPPORTED MANUFACTURERS IN CLINICAL TRIAL DESIGN AND REGULATORY FILINGS, MAPPED THE CURRENT VACCINE MANUFACTURING CAPACITY IN AFRICA, AND SUPPORTED CLINICAL ASSAY DEVELOPMENT AND TECHNOLOGY TRANSFERS, AMONG OTHER ACTIVITIES.PATH CONTINUED TO PROVIDE TECHNICAL SUPPORT TO POLIO VACCINE MANUFACTURERS AND ADVANCE RESEARCH ON NEW INACTIVATED POLIO VACCINE AND ORAL POLIO VACCINE CANDIDATES. IN 2023, NOVEL TYPE-2 ORAL POLIO VACCINE RECEIVED WHO PREQUALIFICATION, AND A NOVEL TYPE-1 ORAL POLIO VACCINE CANDIDATE ADVANCED TO PHASE 2 STUDY.THROUGHOUT THE YEAR, PATH AND OUR PARTNERS EXPANDED COVERAGE OF JAPANESE ENCEPHALITIS (JE) VACCINATION AND FINALIZED AND DISSEMINATED EVIDENCE TO SUPPORT JE VACCINE DECISION-MAKING. PATH CONCLUDED STUDIES ON THE COST OF ILLNESS FOR JE AND ITS LONG-TERM CONSEQUENCES IN BANGLADESH, LAOS, AND VIETNAM. PATH HELD A BI-REGIONAL MEETING IN VIENTIANE, LAOS, IN OCTOBER 2023 TO BRING STAKEHOLDERS TOGETHER TO DISCUSS LESSONS LEARNED, IDENTIFY OPPORTUNITIES FOR FURTHER JE VACCINE INTRODUCTION AND SCALE-UP, AND CONTINUE THE MOMENTUM FOR JE CONTROL. PATH'S JE PROJECTS CONCLUDED IN DECEMBER 2023.ALSO IN 2023, MENFIVE, THE POLYVALENT MENINGOCOCCAL MENINGITIS CONJUGATE VACCINE (MMCV) THAT PATH SUPPORTED IN DEVELOPMENT, CLINICAL STUDIES, AND REGULATORY SUBMISSION, RECEIVED WHO PREQUALIFICATION. PREQUALIFICATION CONFIRMS THE VACCINE MEETS STRICT INTERNATIONAL QUALITY STANDARDS AND CAN BE MADE AVAILABLE ON THE GLOBAL MARKET. DEVELOPED BY SERUM INSTITUTE OF INDIA PVT. LTD., MENFIVE BUILDS ON THE SUCCESS OF MENAFRIVAC, A GROUNDBREAKING VACCINE AGAINST SEROGROUP-A MENINGOCOCCAL MENINGITIS THAT WAS DEVELOPED THROUGH AN EARLIER PATH PARTNERSHIP. THE POLYVALENT VACCINE TARGETS SEROGROUPS A, C, W, X, AND Y. AS THE FIRST VACCINE TO TARGET SEROGROUP X, THE VACCINE HAS THE POTENTIAL TO ELIMINATE MENINGOCOCCAL MENINGITIS EPIDEMICS FROM AFRICA'S "MENINGITIS BELT" REGION. WE ALSO CONTINUED TO CONTRIBUTE TECHNICAL AND STRATEGIC EXPERTISE TO THE GLOBAL DEFEATING MENINGITIS BY 2030 INITIATIVE. AND, WE SERVED AS A COORDINATOR BETWEEN WHO, GAVI (THE VACCINE ALLIANCE), AND GLOBAL PARTNERS TO IDENTIFY PATHWAYS TO ACCELERATE MMCV INTRODUCTION ONCE THE VACCINE IS MADE AVAILABLE, WHICH LED TO A RECOMMENDATION BY WHO'S STRATEGIC ADVISORY GROUP OF EXPERTS ON IMMUNIZATION THAT MENFIVE BE INTRODUCED VIA VACCINATION CAMPAIGNS AND ROUTINE ADMINISTRATION IN THE MENINGITIS BELT.PATH ALSO ACCELERATED THE INTRODUCTION OF MALARIA IMMUNIZATION IN 2023. WE CONTINUED TO WORK WITH WHO; THE MINISTRIES OF HEALTH IN GHANA, KENYA, AND MALAWI; AND OTHER PARTNERS TO INTRODUCE AND SHARE INFORMATION ABOUT THE MALARIA VACCINE. WE CONTINUE TO ADVANCE RESEARCH INTO DOSE SCHEDULE, UPTAKE, AND EFFICIENT DELIVERY OF BOTH AVAILABLE MALARIA VACCINATIONS THAT ARE PRE-QUALIFIED AND RECOMMENDED BY THE WHO: RTS,S AND R21. IN AUGUST 2023, WE ANNOUNCED THE RESULTS FROM A LANDMARK STUDY THAT CONFIRMED THE BENEFITS OF COMBINING THE VACCINE WITH SEASONAL MALARIA CHEMOPREVENTION TO AVERT MALARIA IN HIGHLY SEASONAL SETTINGS. IN ADDITION, WE ARE SPONSORING A FIRST-IN-HUMAN PHASE 1/2 TRIAL THAT STARTED IN 2023 AND IS EVALUATING THE SAFETY AND IMMUNOGENICITY OF THE MALARIA VACCINE CANDIDATE RH4.2-VIRUS-LIKE PARTICLE IN MATRIX-M ADJUVANT. THE DEFEAT DIARRHEAL DISEASE INITIATIVE CONTINUED ITS ROLE AS A DIGITAL HUB FOR INFORMATION ON PREVENTING AND TREATING CHILDHOOD DIARRHEAL DISEASE, WHICH IS THE SECOND-LEADING CAUSE OF DEATH AMONG CHILDREN IN LMICS. A MAJOR FOCUS IN 2023 WAS THE OPPORTUNITY FOR ROTAVIRUS VACCINE IMPACT IN SOUTHEAST ASIA AND THE ROLE OF CLIMATE CHANGE IN INCREASING THE INCIDENCE OF DIARRHEAL DISEASES, ESPECIALLY CHOLERA. TO REDUCE THE BURDEN OF ROTAVIRUS, A MAJOR CAUSE OF SEVERE DIARRHEA, PATH COMPLETED A PHASE 3 EFFICACY STUDY OF AN INJECTABLE NONREPLICATING ROTAVIRUS VACCINE CANDIDATE AT THREE CLINICAL SITES IN AFRICA. PATH ALSO COMPLETED A PHASE 2 STUDY WITH THIS CANDIDATE IN SOUTH AFRICA TO EXAMINE IMMUNE RESPONSES TO DIFFERENT COMBINATIONS OF ORAL AND INJECTED ROTAVIRUS VACCINES. PATH BEGAN AN OBSERVATIONAL, FOLLOW-ON STUDY TO GATHER MORE INFORMATION ON ROTAVIRUS DISEASE IN THE SECOND YEAR OF LIFE IN GHANA AND MALAWI. IN ADDITION, IN DECEMBER 2023, PATH COMPLETED A CASE-CONTROL STUDY IN INDIA THAT EVALUATED THE EFFECTIVENESS OF SERUM INSTITUTE OF INDIA PVT. LTD.'S LICENSED ROTAVIRUS VACCINE, ROTASIIL. PATH CONTINUED TO SUPPORT RESEARCH RELATED TO VACCINE CANDIDATES THAT MAY PROVIDE PROTECTION AGAINST SHIGELLA, ONE OF THE LEADING BACTERIAL CAUSES OF DIARRHEAL ILLNESS, FOR WHICH THERE IS CURRENTLY NO LICENSED VACCINE. IN 2023, WE CONTINUED PRECLINICAL RESEARCH ON THE NOVEL, ORALLY ADMINISTERED, INACTIVATED WHOLE-CELL SHIGELLA TRUNCATED MUTANT VACCINE CANDIDATE. WE ALSO CONCLUDED A CLINICAL TRIAL TO TEST TWO EXPERIMENTAL CHALLENGE STRAINS OF SHIGELLA. THE RESULTS OF THIS TRIAL WILL HELP GUIDE FUTURE DEVELOPMENT OF SHIGELLA VACCINES.PATH CONTINUED TO ADVANCE PRECLINICAL DEVELOPMENT OF A VACCINE AGAINST GROUP B STREPTOCOCCUS, A LEADING CAUSE OF BACTERIAL SEPSIS AND MENINGITIS IN YOUNG INFANTS WORLDWIDE, AND AGAINST PNEUMOCOCCAL DISEASE, A TOP CAUSE OF DEADLY CHILDHOOD PNEUMONIA. WE SUPPORTED INVENTPRISE AS IT WORKS TO DEVELOP MULTIVALENT CONJUGATE VACCINES FOR BOTH DISEASES THAT WILL BE AFFORDABLE FOR LMICS. WE ALSO INITIATED WORK ON A PROJECT TO EVALUATE TWO DIFFERENT MEASLES AND RUBELLA MICROARRAY PATCHES. CLINICAL STUDY PREPARATIONS WERE UNDERWAY THROUGHOUT 2023. AS PART OF THE TYPHOID VACCINE ACCELERATION CONSORTIUM, PATH WORKED TO ADVANCE TYPHOID CONJUGATE VACCINE (TCV) INTRODUCTION IN GAVI-ELIGIBLE COUNTRIES. WE PROVIDED SUPPORT TO THE GOVERNMENT OF MALAWI TO INTRODUCE TCV IN MAY 2023 AND MAKE THE TRANSITION TO INCLUDE TCV IN ROUTINE IMMUNIZATION. WE ALSO CONTINUED TO SUPPORT THE GOVERNMENT OF KENYA TO PLAN FOR TCV INTRODUCTION. ADDITIONALLY, PATH WORKED WITH NATIONAL DECISION-MAKERS TO ADVANCE APPLICATIONS FOR TCV INTRODUCTION. BURKINA FASO COMPLETED AND SUBMITTED AN APPLICATION FOR TCV INTRODUCTION IN 2023. IN OTHER COUNTRIES, WE INITIATED AND/OR CONTINUED DISCUSSIONS TO SUPPORT DECISION-MAKING. WE CONTINUED TO SHARE NEW DATA AND SERVE AS A HUB FOR INFORMATION ON TYPHOID, RAISING AWARENESS ABOUT THE DISEASE AND ITS PREVENTION THROUGH AN INTEGRATED APPROACH THAT INCLUDES VACCINES.TO PREVENT CERVICAL CANCER, PATH CONTINUED TO COORDINATE A CONSORTIUM OF NINE INDEPENDENT RESEARCH INSTITUTIONS TO COLLATE, ANALYZE, AND DISSEMINATE EVIDENCE ON SINGLE-DOSE HUMAN PAPILLOMAVIRUS (HPV) VACCINATION TO WHO AND OTHER STAKEHOLDERS. WE INITIATED AND COORDINATED A GROUP OF COMMUNICATORS ENGAGING ON HPV VACCINATION WITH REGULAR MEETINGS AND SHARED CALENDAR RESOURCES. IN ADDITION, WE COMPLETED AND DISSEMINATED FINDINGS OF AN HPV COST-OF-DELIVERY STUDY IN SIX COUNTRIES. ALSO, WE CONTINUED TO PARTNER WITH SEVERAL LMICS ON THE PLANNING, IMPLEMENTATION, AND ONGOING MONITORING OF NATIONAL HPV VACCINATION PROGRAMS. FINALLY, WE CONTINUED TO SUPPORT A PHASE 3 CLINICAL STUDY OF CECOLIN, A BIVALENT HPV VACCINE THAT RECEIVED WHO PREQUALIFICATION IN 2021, TO GENERATE EVIDENCE ON EXTENDED AND ALTERNATIVE DOSING SCHEDULES. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $41,839,288 | ExpenseAmt |
| Grant | $5,381,556 | GrantAmt |
| Desc | ASIA, MIDDLE EAST, AND EUROPE REGION: PATH'S LEADERSHIP IN THE ASIA, MIDDLE EAST, AND EUROPE (AMEE) REGION LEVERAGES OUR GLOBAL EXPERTISE ACROSS MULTIPLE HEALTH DISCIPLINES TO CHAMPION EQUITY IN ACCESS TO CARE, INTRODUCE NEW TECHNOLOGIES AND APPROACHES, AND PARTNER ACROSS SECTORS TO PROVIDE HUMAN-CENTERED CARE AND SUPPORT. PATH COORDINATES OUR WORK IN THIS REGION FROM OFFICES IN NINE COUNTRIES, INCLUDING OFFICES IN CHINA, INDIA, UKRAINE, VIETNAM, AND SWITZERLAND THAT SERVE AS REGIONAL HUBS FOR TECHNICAL AND SCIENTIFIC INNOVATION AND PROGRAM DELIVERY. (CONTINUED ON SCHEDULE O)HIGHLIGHTS INCLUDE:IN 2023, PATH INTENSIFIED ITS EFFORTS IN LOCAL AND REGIONAL COLLABORATIONS, PARTICULARLY IN BANGLADESH, INDONESIA, LAOS, AND NEPAL, AND EXPLORED NEW COLLABORATIONS IN THE MIDDLE EAST. THIS EXPANSION WAS FUELED BY AN INCREASED DEMAND FOR OUR SERVICES, NECESSITATING SUBSTANTIAL GROWTH IN OUR WORKFORCE WITHIN THE REGION.PATH PREPARED FOR AND RESPONDED TO EMERGING HEALTH THREATS IN THE REGION BY PROVIDING TECHNICAL SUPPORT, ENHANCING LABORATORY CAPACITY, AND SCALING UP INNOVATIONS. PATH'S PROACTIVE RESPONSE TO EMERGING HEALTH THREATS INCLUDED MENTAL HEALTH SUPPORT IN MYANMAR, CLIMATE-HEALTH INITIATIVES IN INDIA, TACKLING ANTIMICROBIAL RESISTANCE IN VIETNAM, AND ENHANCING LABORATORY AND TB TREATMENT CAPACITIES IN UKRAINE.THANKS TO OUR CONTINUOUS WORK IN IMPROVING LIVES THROUGH SCIENCE AND TECHNOLOGY, WE HAVE ACHIEVED SIGNIFICANT ADVANCEMENTS IN VARIOUS AREAS, SUCH AS HEALTH CARE WASTE MANAGEMENT IN MYANMAR, RICE FORTIFICATION IN INDIA, NONCOMMUNICABLE DISEASES PREVENTION AMONG VIETNAMESE ADOLESCENTS, AND REVOLUTIONIZING HEPATITIS SELF-TESTING. OUR EFFORTS IN VACCINE DEVELOPMENT AND MANUFACTURING, PARTICULARLY IN CHINA, HAVE ENHANCED GLOBAL ACCESS TO VACCINES AGAINST DISEASES LIKE INFLUENZA, HPV, AND JAPANESE ENCEPHALITIS.THROUGHOUT THE YEAR, OUR AMEE PROGRAMS FOCUSED ON ENHANCING PRIMARY HEALTH SYSTEM SERVICES AND RESILIENCE USING A COMMUNITY-BASED APPROACH THAT BRINGS AWARENESS, AVAILABILITY, AND ACCESSIBILITY OF HEALTH SERVICES TO THE PEOPLE WHO NEED THEM. SOME OF THE INITIATIVES INCLUDED LAUNCHING NATIONAL HPV VACCINATION AND STRENGTHENING IMMUNIZATION IN BANGLADESH, DIGITALIZING HEALTH RECORDS IN INDIA, STRENGTHENING NEWBORN NUTRITION IN NEPAL, AND BOLSTERING THE PRIMARY HEALTH CARE SYSTEM IN UKRAINE.PATH ELEVATED ITS PRESENCE AT MAJOR INTERNATIONAL FORUMS, INCLUDING THE G20 MEETINGS IN INDIA, FOCUSING ON PRIORITIZING DIGITAL HEALTH INVESTMENTS AND FOSTERING A GLOBAL VACCINE RESEARCH COLLABORATION. ADDITIONALLY, OUR COLLABORATION WITH THE COMMONWEALTH SECRETARIAT TO LAUNCH THE ACCELERATOR FOR RESILIENCE IN CLIMATE AND HEALTH MARKS A SIGNIFICANT STRIDE IN SOURCING, DEPLOYING, AND SCALING INNOVATIONS FOR BETTER CLIMATE-HEALTH OUTCOMES ACROSS THE GLOBE.IN 2023, WE NOT ONLY CONTINUED OUR COLLABORATION WITH LONGSTANDING DONORS BUT ALSO ESTABLISHED NEW STRATEGIC ALLIANCES WITH MAJOR INSTITUTIONS LIKE THE ASIAN INFRASTRUCTURE INVESTMENT BANK, KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY, ASIAN DEVELOPMENT BANK, DEUTSCHE GESELLSCHAFT FR INTERNATIONALE ZUSAMMENARBEIT (GIZ), KFW BANKENGRUPPE, CHILDREN'S INVESTMENT FUND FOUNDATION (CIFF), AND NOVARTIS TO TACKLE KEY CHALLENGES IN CLIMATE CHANGE, DIGITAL INNOVATION, AND HEALTHY LIVING TO BRING HEALTH AND WELL-BEING TO ALL. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $38,727,611 | ExpenseAmt |
| Grant | $4,399,468 | GrantAmt |
| Desc | AFRICA REGIONPATH'S WORK IN AFRICA INTERSECTS VIRTUALLY EVERY PATH GLOBAL PROGRAM, FROM ADVOCACY AND PUBLIC POLICY TO SEXUAL AND REPRODUCTIVE HEALTH. WE HAVE COUNTRY OFFICES IN SEVEN NATIONS SPANNING CENTRAL, EASTERN, SOUTHERN, AND WESTERN AFRICA (DRC, ETHIOPIA, KENYA, SENEGAL, TANZANIA, UGANDA, AND ZAMBIA) WITH PROJECT OFFICES IN FIVE MORE. HIGHLIGHTS FROM OUR OFFICES INCLUDE:DEMOCRATIC REPUBLIC OF THE CONGO(1) USAID-FUNDED MOMENTUMROUTINE IMMUNIZATION TRANSFORMATION AND EQUITY (M-RITE) PROJECT: THE M-RITE/PATH PROJECT SIGNIFICANTLY ADVANCED COVID-19 IMMUNIZATION EFFORTS BY TRAINING HEALTH ZONE MANAGEMENT TEAMS ON THE DHIS2 AGGREGATE FORM ACROSS EIGHT ZONES, ACHIEVING A 17% INCREASE IN COVERAGE. FURTHERMORE, THE M-RITE/PATH PROJECT SUPPORTED INTEGRATION OF VACCINE SERVICES INTO 72 PRIVATE HEALTH STRUCTURES IN TEN ZONES IN HAUT-KATANGA AND KASAI ORIENTAL, REDUCING GEOGRAPHICAL BARRIERS AND VACCINATING 33,481 CHILDREN, INCLUDING 4,348 WITH NO PRIOR DOSES. ADDITIONALLY, THE OFFICIAL LAUNCH OF COMMUNITY POLIO SURVEILLANCE ACTIVITIES IN THESE PROVINCES INVOLVED OVER 400 PARTICIPANTS AND EXTENSIVE MEDIA COVERAGE. A CASCADE TRAINING COURSE WAS CONDUCTED FOR 318 HEALTH AGENTS, COMMUNITY RELAYS, AND HEALTH ZONE STAFF ON COMMUNITY-BASED SURVEILLANCE.(2) DRC ZERO-DOSE CHILDREN TECHNICAL ASSISTANCETECHNICAL SUPPORT WAS PROVIDED FOR THE NATIONAL WORKSHOP TO CONTEXTUALIZE INTERVENTIONS IN THE ZERO-DOSE AND UNDER-VACCINATED CHILDREN REDUCTION PLAN 20232025. THIS INCLUDED REVISING TOOLS FOR THE CATCH-UP PLAN FOR CHILDREN AGED 12 TO 59 MONTHS MISSED DURING THE COVID-19 PANDEMIC (20192022) AND INITIAL PLANNING OF THE ZERO-DOSE AND UNDER-VACCINATED REDUCTION PLAN.(3) NATIONAL POLIO SURVEILLANCEPATH SUPPORTED THE EXPANDED PROGRAM ON IMMUNIZATION (EPI)-DRC IN DEVELOPING THE "STRATEGIC PLAN TO STOP THE CIRCULATION OF POLIOVIRUS DERIVED FROM THE TYPE 1 AND TYPE 2 VACCINE STRAIN IN DRC" FOR PROVINCES INCLUDING MANIEMA, TANGANYIKA, AND HAUT-LOMAMI. EIGHT VACCINATION CAMPAIGNS WERE IMPLEMENTED TO COMBAT VARIANT POLIOVIRUS TYPES 1 AND 2, REDUCING LAB-DETECTED CASES FROM 539 IN 2022 TO 281 IN 2023. ADDITIONAL EFFORTS INCLUDED DRAFTING PLANS TO INTERRUPT THE CIRCULATION OF CVDPV1, CVDPV2, AND VDPV3 IN THE DRC FOR EARLY 2024 AND INITIATING THE RIVER STRATEGY PROJECT IN HAUT-LOMAMI, FUNDED BY THE GATES FOUNDATION. TRAINING WAS PROVIDED FOR 10 HEALTH ZONE MANAGERS, 68 HEAD NURSES, AND 170 COMMUNITY RELAYS ON COMMUNITY-BASED SURVEILLANCE AND VACCINATION REFERRALS IN HAUT-KATANGA AND KASAI ORIENTAL.(4) DIGITAL SQUARE PROJECTPATH SUPPORTED THE DRC MINISTRY OF PUBLIC HEALTH, HYGIENE, AND PREVENTION IN ITS DIGITAL TRANSFORMATION THROUGH THE DIGITAL SQUARE INITIATIVE. IN 2023, PATH FACILITATED THE LAUNCH OF THE ENTERPRISE ARCHITECTURE APPROACH FOR DIGITAL HEALTH, INVOLVING KEY STAKEHOLDERS AND DEVELOPING A GOVERNANCE FRAMEWORK. ANICNS, DRC'S DIGITAL HEALTH AGENCY, PARTICIPATED IN THE GLOBAL DIGITAL HEALTH FORUM, SHARING THE DRC'S EXPERIENCES WITH INTERNATIONAL EXPERTS.(5) CDC TAP-HIV DATA SYSTEMS FOR UHCTHE CDC TAP PROJECT ESTABLISHED A TECHNICAL WORKING GROUP FOCUSED ON HIV RESPONSE AND DIGITAL HEALTH, CHAIRED BY ANICNS AND CO-CHAIRED BY PNLS (DRC'S NATIONAL HIV/AIDS AND SEXUALLY TRANSMITTED INFECTION CONTROL PROGRAM). AN ASSESSMENT OF THE HEALTH INFORMATION SYSTEM WAS CONDUCTED, LEADING TO THE DEVELOPMENT AND DISSEMINATION OF A ROADMAP ADDRESSING IDENTIFIED WEAKNESSES. THIS ROADMAP FACILITATED THE LAUNCH OF MULTIPLE PROJECTS AIMED AT SYSTEM IMPROVEMENTS.(6) THE MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) PROJECTTHE DRC MACEPA 4 PROJECT SUPPORTED THE DRAFTING OF A CONCEPT NOTE FOR THE GLOBAL FUND'S GRANT CYCLE 7, INVOLVING KEY PARTNERS IN MALARIA CONTROL. THE PROJECT DEVELOPED A MALARIA RESEARCH, DEVELOPMENT, AND QUALITY ASSURANCE GUIDE, CONDUCTED DATA QUALITY ASSESSMENTS, AND CONTRIBUTED TO STRATEGIC PLANNING DOCUMENTS SUCH AS THE NATIONAL PROGRAM TO COMBAT MALARIA (PNLP) STRATEGIC PLAN 20242028 AND THE ANNUAL OPERATIONAL PLAN FOR 2023 AND 2024. EFFORTS ALSO INCLUDED UPDATING COMMUNITY HEALTH POLICIES AND SUPPORTING THE DEVELOPMENT OF THE "GUIDE DE MISE EN OEUVRE DES SITES DE SOINS COMMUNAUTAIRES," THE IMCI STRATEGIC PLAN 20242030, THE ANNUAL OPERATIONAL PLAN 2024 OF THE PNCHOL-MD, AND THE ROADMAP FOR STRENGTHENING COMMUNITY HEALTH OF THE COMMUNITY HEALTH SUB-COMMISSION.(7) PERENNIAL MALARIA CHEMOPREVENTION--GIVEWELLTHE PMC-GIVEWELL PROJECT ESTABLISHED A FRAMEWORK FOR COLLABORATION, LAUNCHING THE PERENNIAL MALARIA CHEMOPREVENTION (PMC) MODEL IN FOUR HEALTH ZONES IN NOVEMBER 2023. TRAINING WAS PROVIDED FOR 687 STAKEHOLDERS, INCLUDING 11 PROVINCIAL MANAGERS, 82 MEMBERS OF MANAGEMENT OF HEALTH ZONE TEAMS, 24 FIELD AGENTS, 137 NURSES, 359 PROVIDERS, 74 PRSICODESA, 370 COMMUNITY RELAYS, AND 54 RECOSITES. BY DECEMBER 2023, 2,309 DOSES OF SULFADOXINE-PYRIMETHAMINE (SP) WERE ADMINISTERED TO CHILDREN UNDER TWO. (8) SOURCE PROJECTTHE SOURCE PROJECT IN 2023 INCLUDED A BIOMEDICAL EQUIPMENT SURVEY ACROSS 26 PROVINCES, A QUALITATIVE SURVEY ON OXYGEN AVAILABILITY, AND DEVELOPMENT OF AN ADVOCACY PLAN FOR PNEUMONIA TREATMENT FOCUSED ON OXYGEN AND AMOXICILLIN. A WORK PLAN FOR CIVIL SOCIETY ORGANIZATIONS AIMED AT INCREASING THE OXYGEN BUDGET WAS ALSO DEVELOPED.(9) ACCELERATING MEASURABLE PROGRESS AND LEVERAGING INVESTMENTS FOR PPH IMPACT (AMPLI-PPHI)IN 2023, THE AMPLI-PPHI PROJECT CONDUCTED A SUPPLY CHAIN ASSESSMENT AND A PRICING AND AVAILABILITY SURVEY FOR POSTPARTUM HEMORRHAGE (PPH) MEDICINES, LIKE OXYTOCIN, TRANEXAMIC ACID, AND MISPOROSTOL. TECHNICAL SUPPORT WAS PROVIDED FOR QUANTIFYING PPH COMMODITIES AND DEVELOPING SCALE-UP AND BUSINESS CASE DEVELOPMENT PLANS FOR HEAT-STABLE CARBETOCINE AND TRANEXAMIC ACID.(10) ADVOCACY AND PUBLIC POLICYIN SUPPORT OF THE IMMUNIZATION PROGRAM, THE THIRD NATIONAL FORUM ON VACCINATION AND POLIO ERADICATION, LED BY THE PRESIDENT OF THE DRC ON JUNE 2728, 2023, HIGHLIGHTED THE COUNTRY'S HIGH-LEVEL COMMITMENT TO IMMUNIZATION. THIS EVENT MARKED A SIGNIFICANT PARTNERSHIP EFFORT IN THE HEALTH SECTOR. ADDITIONALLY, TWO WORKING SESSIONS WITH THE NATIONAL REPACAV FOCUSED ON THE IMMUNIZATION PERFORMANCE OF THE EPI IN KISANTU AND KINSHASA IN APRIL 2023. WORKSHOPS WERE HELD IN KINSHASA, TANGANYIKA, AND HAUT-LOMAMI TO RAISE AWARENESS OF PROVINCIAL IMMUNIZATION COMMITMENTS.POLITICAL APPROVAL OF PNC 2023-2027 WAS ACHIEVED WITH THE INVOLVEMENT OF GTFCC/CSP, UNICEF, WHO, AND OTHER PARTNERS, WITH PATH PLAYING A KEY ROLE IN ORGANIZING THE WORKSHOP BY THE PNC STEERING COMMITTEE (COPIL). FOLLOWING THIS, PATH COLLABORATED WITH GTFCC/CSP, UNICEF, AND WHO TO ORGANIZE A RESOURCE MOBILIZATION ROUNDTABLE WITH PRIVATE DONORS.FOR THE POLIO RESPONSE PROGRAM, REGULAR MEDIA BRIEFINGS IN KINSHASA AND THE PROVINCES RESULTED IN 17 NATIONAL MEDIA OUTLETS PUBLISHING 27 ARTICLES AND INTERVIEWS ABOUT ROUTINE VACCINATION AND CAMPAIGNS, HIGHLIGHTING THE EFFORTS OF THE EPI AND ITS PARTNERS. ONLINE COMMUNICATION EFFORTS ALSO STRENGTHENED, REACHING 4,000 FOLLOWERS ON TWITTERA 30.7% INCREASE FROM 2022WITH DAILY POSTS ON ROUTINE VACCINATION AND POLIO ON TWITTER, FACEBOOK, INSTAGRAM, AND LINKEDIN.HUMAN AFRICAN TRYPANOSOMIASIS (HAT) TECHNICAL ASSISTANCE TO CSOS:TECHNICAL SUPPORT WAS PROVIDED TO CIVIL SOCIETY ORGANIZATIONS FOR THE 4TH NATIONAL DAY AGAINST SLEEPING SICKNESS, WITH PARTICIPATION FROM LOCAL AND INTERNATIONAL PARTNERS. TRAINING WAS CONDUCTED FOR CNRSC STAFF ON THE GATES FOUNDATION'S LOBBYING POLICY, AND POLITICAL AUTHORITIES WERE ENGAGED IN THE HAT ELIMINATION AGENDA IN THE DRC. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $38,727,611 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $4,399,468 | TotalOtherProgSrvcGrantAmt |
| Total Program Service Expenses | $305,805,290 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (1) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | Yes (1) | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | Yes (1) | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (1) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (1) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| Info In Schedule O Part V | Yes (X) | InfoInScheduleOPartVInd |
| IRP Document | 187 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 634 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (1) | ForeignFinancialAccountInd |
| Foreign Country | BE | ForeignCountryCd |
| Foreign Country | CH | ForeignCountryCd |
| Foreign Country | ET | ForeignCountryCd |
| Foreign Country | GH | ForeignCountryCd |
| Foreign Country | IN | ForeignCountryCd |
| Foreign Country | KE | ForeignCountryCd |
| Foreign Country | MZ | ForeignCountryCd |
| Foreign Country | PE | ForeignCountryCd |
| Foreign Country | SG | ForeignCountryCd |
| Foreign Country | SZ | ForeignCountryCd |
| Foreign Country | TZ | ForeignCountryCd |
| Foreign Country | UG | ForeignCountryCd |
| Foreign Country | UK | ForeignCountryCd |
| Foreign Country | VM | ForeignCountryCd |
| Foreign Country | ZA | ForeignCountryCd |
| Foreign Country | CG | ForeignCountryCd |
| Foreign Country | MI | ForeignCountryCd |
| Foreign Country | BM | ForeignCountryCd |
| Foreign Country | SF | ForeignCountryCd |
| Foreign Country | UP | ForeignCountryCd |
| Foreign Country | NP | ForeignCountryCd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 13 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 13 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KELLY PRIESTLEY CONTROLLER & PRINCIPAL FINANCIAL OFFICER | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 2062853500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2201 WESTLAKE AVE SUITE 200 | AddressLine1Txt |
| City | SEATTLE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98121 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (30 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| BETH GALETTI MBA | |||||||||
| CHAIR | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| FREDERICK WERE MD MMED PHD | |||||||||
| VICE CHAIR | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| SANFORD MELZER MD MBA | |||||||||
| SECRETARY | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| BRUCE MCNAMER JD MBA | |||||||||
| TREASURER | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| YEHONG ZHANG PHD MBA | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| CAROLE FAIG | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| JOHN-ARNE ROTTINGEN MD PHD | |||||||||
| MSC, MPA--DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| JOEL HOLSINGER | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| HELENA WAYTH MSC | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| ABAYOMI SULE MBBS MBA | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| LISA ANDERSON PMP | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| RACHEL SIBANDE MSC | |||||||||
| DIRECTOR (RESIGNED 6/22/23) | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| SYLVANA SINHA ESQ | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| LUTZ HEGEMANN MD PHD | |||||||||
| DIRECTOR | 2.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| NIKOLAJ JESTED GILBERT MSC | |||||||||
| PRESIDENT AND CEO | 39.00 | 1.00 | Yes (X) | $636,343 | $0 | $67,062 | |||
| BEN ALIWA MBA | |||||||||
| CHIEF OF BUSINESS & FINANCE OFFICER | 39.00 | 1.00 | Yes (X) | $0 | $239,285 | $22,048 | |||
| PHILIPPE GUINOT MBA | |||||||||
| CHIEF, BUS/FIN/OPS (UNTIL 1/6/23) | 39.00 | 1.00 | Yes (X) | $0 | $14,305 | $10 | |||
| JESSICA MILMAN MPH | |||||||||
| GBL. HEAD, CENTER FOR VAX INNOV. & ACCESS | 40.00 | 0.00 | $363,861 | $0 | $49,749 | Yes (X) | |||
| KAMMERLE SCHNEIDER EBERLE MIA | |||||||||
| CHIEF PROGRAMS & INNOVATION OFFICER | 40.00 | 0.00 | $334,777 | $0 | $54,601 | Yes (X) | |||
| MEISSA DIAW | |||||||||
| CHIEF PEOPLE & DIVERSITY OFFICER | 40.00 | 0.00 | $293,361 | $0 | $291 | Yes (X) | |||
| HEATHER RAE IGNATIUS | |||||||||
| CHIEF OF EXTERNAL AFFAIRS | 40.00 | 0.00 | $263,263 | $0 | $48,702 | Yes (X) | |||
| SABRINA L POWERS JD | |||||||||
| CHIEF OF LEGAL & RESEARCH AFFAIRS/GC | 40.00 | 0.00 | $300,789 | $0 | $49,847 | Yes (X) | |||
| NANTHALILE C MUGALA MD MMED | |||||||||
| CHIEF OF AFRICA REGION | 40.00 | 0.00 | $319,230 | $0 | $0 | Yes (X) | |||
| NABEEL A GOHEER PHD | |||||||||
| CHIEF OF AFRICA | 40.00 | 0.00 | $286,531 | $0 | $2,190 | Yes (X) | |||
| LAURIE WERNER MPA | |||||||||
| DIR., CENTER OF DIG. & DATA EXCELLENCE | 40.00 | 0.00 | $250,649 | $0 | $41,939 | Yes (X) | |||
| TRAD M HATTON MA MHS | |||||||||
| DIR., CEN. AFRICA HUB & DRC COUNTRY PRO. | 40.00 | 0.00 | $341,251 | $0 | $57,509 | Yes (X) | |||
| ASHLEY J BIRKETT PHD | |||||||||
| GLOBAL HEAD, MALARIA VACCINES | 40.00 | 0.00 | $354,453 | $0 | $66,489 | Yes (X) | |||
| BRUCE LAMONT INNIS MD FIDSA | |||||||||
| GLOBAL HEAD, RESPIRATORY INFECTIONS | 40.00 | 0.00 | $364,985 | $0 | $33,732 | Yes (X) | |||
| KATYA SPIELBERG | |||||||||
| GBL. HEAD, INTEG. PORT. & FIN. MGMT. | 40.00 | 0.00 | $325,066 | $0 | $74,187 | Yes (X) | |||
| KIMBERLY GREEN PHD | |||||||||
| DIRECTOR, PRIMARY HEALTH CARE | 40.00 | 0.00 | $546,693 | $0 | $88,813 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $4,981,252 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $253,590 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $657,169 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 385 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | CountryContractorAddress/ForeignAddress/CountryCd | Foreign PostalContractorAddress/ForeignAddress/ForeignPostalCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd |
|---|---|---|---|---|---|---|---|---|---|
| RANDSTAD INDIA PVT LTD | |||||||||
| SUITE NO 001 002 COPIA | NEW DELHI | IN | 110025 | STAFFING SERVICES | $2,596,739 | ||||
| GLOBALIZATION PARTNERS INC | |||||||||
| STAFFING SERVICES | $1,293,002 | 175 FEDERAL ST 17TH FL | BOSTON | MA | 02110 | ||||
| WMBE PAYROLLING INC DBA TCWGLOBAL | |||||||||
| GENERAL CONTRACTOR | $675,655 | 9475 CHESAPEAKE DRIVE | SAN DIEGO | CA | 92123 | ||||
| AVAAP USA LLC | |||||||||
| CONSULTING | $581,845 | 1400 GOODALE BLVD SUITE 100 | COLUMBUS | OH | 43212 | ||||
| CWT INDIA PRIVATE LIMITED | |||||||||
| HIMALAYA HOUSE FIRST FLOOR J-1 | NEW DELHI | IN | 110001 | TRAVEL SERVICES | $538,268 | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 72 | CntrctRcvdGreaterThan100KCnt |
| Related Organizations | $2,356,451 | RelatedOrganizationsAmt |
| Government Grants | $120,654,880 | GovernmentGrantsAmt |
| All Other Contributions | $204,936,169 | AllOtherContributionsAmt |
| Noncash Contributions | $355,699 | NoncashContributionsAmt |
| Total Contributions | $327,947,500 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $4,793,349 | TotalRevenueColumnAmt |
| Exclusion | $4,793,349 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $45,231,711 | SecuritiesAmt |
| Other | $39,097 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $45,229,237 | SecuritiesAmt |
| Other | $12,461 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $2,474 | SecuritiesAmt |
| Other | $26,636 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $29,110 | TotalRevenueColumnAmt |
| Exclusion | $29,110 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| OTHER | 900099 | $1,079,737 | $1,079,737 |
| REIMBURSEMENTS | 900099 | $264,982 | $264,982 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $1,344,719 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $334,114,678 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $6,167,178 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $21,998,905 | TotalAmt |
| Program Services | $21,998,905 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $51,721,962 | TotalAmt |
| Program Services | $51,721,962 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,363,184 | TotalAmt |
| Program Services | $1,732,913 | ProgramServicesAmt |
| Management And General | $1,625,805 | ManagementAndGeneralAmt |
| Fundraising | $4,466 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $99,006,683 | TotalAmt |
| Program Services | $85,970,588 | ProgramServicesAmt |
| Management And General | $12,322,179 | ManagementAndGeneralAmt |
| Fundraising | $713,916 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,016,092 | TotalAmt |
| Program Services | $10,330,010 | ProgramServicesAmt |
| Management And General | $1,603,066 | ManagementAndGeneralAmt |
| Fundraising | $83,016 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $17,544,969 | TotalAmt |
| Program Services | $15,818,501 | ProgramServicesAmt |
| Management And General | $1,641,463 | ManagementAndGeneralAmt |
| Fundraising | $85,005 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,508,702 | TotalAmt |
| Program Services | $3,874,880 | ProgramServicesAmt |
| Management And General | $602,615 | ManagementAndGeneralAmt |
| Fundraising | $31,207 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,121,101 | TotalAmt |
| Program Services | $464,631 | ProgramServicesAmt |
| Management And General | $656,470 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,044,928 | TotalAmt |
| Program Services | $275,886 | ProgramServicesAmt |
| Management And General | $769,042 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $129,573 | TotalAmt |
| Program Services | $129,573 | ProgramServicesAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $290,011 | TotalAmt |
| Management And General | $290,011 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $16,445,699 | TotalAmt |
| Program Services | $14,469,676 | ProgramServicesAmt |
| Management And General | $1,776,546 | ManagementAndGeneralAmt |
| Fundraising | $199,477 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $61,395 | TotalAmt |
| Program Services | $44,550 | ProgramServicesAmt |
| Management And General | $9,153 | ManagementAndGeneralAmt |
| Fundraising | $7,692 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,342,183 | TotalAmt |
| Program Services | $3,942,408 | ProgramServicesAmt |
| Management And General | $336,616 | ManagementAndGeneralAmt |
| Fundraising | $63,159 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,013,565 | TotalAmt |
| Program Services | $5,818,579 | ProgramServicesAmt |
| Management And General | $1,135,996 | ManagementAndGeneralAmt |
| Fundraising | $58,990 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $259,972 | TotalAmt |
| Program Services | $259,972 | ProgramServicesAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,120,309 | TotalAmt |
| Program Services | $44,773 | ProgramServicesAmt |
| Management And General | $12,076,416 | ManagementAndGeneralAmt |
| Fundraising | -$880 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $17,140,641 | TotalAmt |
| Program Services | $15,591,109 | ProgramServicesAmt |
| Management And General | $1,545,404 | ManagementAndGeneralAmt |
| Fundraising | $4,128 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $12,695,480 | TotalAmt |
| Program Services | $12,100,544 | ProgramServicesAmt |
| Management And General | $584,837 | ManagementAndGeneralAmt |
| Fundraising | $10,099 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $371 | TotalAmt |
| Program Services | $371 | ProgramServicesAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,893,077 | TotalAmt |
| Management And General | $1,893,077 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $804,383 | TotalAmt |
| Program Services | $186,690 | ProgramServicesAmt |
| Management And General | $617,693 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| SUBCONTRACTORS | $30,599,028 | $30,599,028 | ||
| PROF. SERVICES ALLOC | $13,701,112 | $11,031,502 | $2,555,449 | $114,161 |
| EQUIP RENT & MAINT | $3,889,109 | $3,891,148 | -$2,039 | |
| DIRECT AID TO BENEF. | $2,045,902 | $2,045,902 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,815,917 | TotalAmt |
| Program Services | $13,461,189 | ProgramServicesAmt |
| Management And General | -$10,767,884 | ManagementAndGeneralAmt |
| Fundraising | $122,612 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $338,574,253 | TotalAmt |
| Program Services | $305,805,290 | ProgramServicesAmt |
| Management And General | $31,271,915 | ManagementAndGeneralAmt |
| Fundraising | $1,497,048 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,287,583 | BOYAmt |
| EOY | $12,802,633 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $39,962,314 | BOYAmt |
| EOY | $69,288,147 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $37,140,905 | BOYAmt |
| EOY | $34,122,933 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $303,620 | BOYAmt |
| EOY | $117,402 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,299,862 | BOYAmt |
| EOY | $6,488,268 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $38,942,823 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $32,090,954 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $6,572,733 | BOYAmt |
| EOY | $6,851,869 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $198,170,250 | BOYAmt |
| EOY | $188,619,248 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $33,353,888 | BOYAmt |
| EOY | $28,207,370 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $335,091,155 | BOYAmt |
| EOY | $346,497,870 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $240,270,829 | BOYAmt |
| EOY | $257,648,624 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $42,345,583 | BOYAmt |
| EOY | $35,252,330 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $282,616,412 | BOYAmt |
| EOY | $292,900,954 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $23,389,854 | BOYAmt |
| EOY | $26,624,779 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $29,084,889 | BOYAmt |
| EOY | $26,972,137 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $52,474,743 | BOYAmt |
| EOY | $53,596,916 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $335,091,155 | BOYAmt |
| EOY | $346,497,870 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | -$4,459,575 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $5,581,748 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $0 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $286,808,545 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $287,454,383 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $333,068,959 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $347,720,581 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $327,947,500 | CurrentTaxYearAmt |
| Total | $1,582,999,968 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $286,808,545 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $287,454,383 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $333,068,959 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $347,720,581 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $327,947,500 | CurrentTaxYearAmt |
| Total | $1,582,999,968 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $692,576,411 | SubstantialContributorsTotAmt |
| Public Support Total170 | $890,423,557 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $6,310,221 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $12,207,084 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $8,920,472 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $4,050,778 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $4,793,349 | CurrentTaxYearAmt |
| Total | $36,281,904 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $836,870 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,030,112 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $843,270 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $869,980 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,344,719 | CurrentTaxYearAmt |
| Total | $4,924,951 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $1,624,206,823 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $2,038 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.54820 | PublicSupportCY170Pct |
| Public Support PY170 | 0.53610 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
Total Grassroots Lobbying TotalGrassrootsLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $1,184 | FilingOrganizationsTotalAmt |
Total Direct Lobbying TotalDirectLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $128,389 | FilingOrganizationsTotalAmt |
Total Lobbying Expend TotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $129,573 | FilingOrganizationsTotalAmt |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $338,154,669 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $338,284,242 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $1,000,000 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $250,000 | FilingOrganizationsTotalAmt |
Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $1,000,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $1,000,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $1,000,000 | CurrentYearMinus1Amt |
| Current Year | $1,000,000 | CurrentYearAmt |
| Total | $4,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $6,000,000 | LobbyingCeilingAmt |
Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $135,193 | CurrentYearMinus3Amt |
| Current Year Minus2 | $207,166 | CurrentYearMinus2Amt |
| Current Year Minus1 | $198,070 | CurrentYearMinus1Amt |
| Current Year | $129,573 | CurrentYearAmt |
| Total | $670,002 | TotalAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $250,000 | CurrentYearMinus3Amt |
| Current Year Minus2 | $250,000 | CurrentYearMinus2Amt |
| Current Year Minus1 | $250,000 | CurrentYearMinus1Amt |
| Current Year | $250,000 | CurrentYearAmt |
| Total | $1,000,000 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,500,000 | GrassrootsCeilingAmt |
Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $405 | CurrentYearMinus3Amt |
| Current Year Minus2 | $29,340 | CurrentYearMinus2Amt |
| Current Year | $1,184 | CurrentYearAmt |
| Total | $30,929 | TotalAmt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $9,433,480 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $1,692,138 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $587,131 | OtherExpendituresAmt |
| End Year Balance | $10,538,487 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $11,742,214 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | -$1,762,177 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $546,557 | OtherExpendituresAmt |
| End Year Balance | $9,433,480 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $10,930,723 | BeginningYearBalanceAmt |
| Contributions | $2,500 | ContributionsAmt |
| Investment Earnings Or Losses | $1,323,367 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $514,376 | OtherExpendituresAmt |
| End Year Balance | $11,742,214 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $10,287,113 | BeginningYearBalanceAmt |
| Contributions | $2,745 | ContributionsAmt |
| Investment Earnings Or Losses | $1,095,576 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $454,711 | OtherExpendituresAmt |
| End Year Balance | $10,930,723 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $9,095,917 | BeginningYearBalanceAmt |
| Contributions | $2,100 | ContributionsAmt |
| Investment Earnings Or Losses | $1,691,617 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $502,521 | OtherExpendituresAmt |
| End Year Balance | $10,287,113 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.36000 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.32000 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.32000 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | 0 | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | 0 | EndowmentsHeldRelatedOrgInd |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $22,631,131 | OtherCostOrOtherBasisAmt |
| Depreciation | $19,443,868 | DepreciationAmt |
| Book Value | $3,187,263 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $8,096,983 | OtherCostOrOtherBasisAmt |
| Depreciation | $7,242,269 | DepreciationAmt |
| Book Value | $854,714 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $8,214,709 | OtherCostOrOtherBasisAmt |
| Depreciation | $5,404,817 | DepreciationAmt |
| Book Value | $2,809,892 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $6,851,869 | TotalBookValueLandBuildingsAmt |
Other Assets Org OtherAssetsOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | RIGHT-OF-USE ASSET | Desc |
| Book Value | $28,207,370 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Other Assets | $28,207,370 | TotalBookValueOtherAssetsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | LEASE LIABILITY | Desc |
| Amt | $35,252,330 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $35,252,330 | TotalLiabilityAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART V, LINE 4: | FormAndLineReferenceDesc |
| Explanation | PATH UTILIZES THE INVESTED INTEREST EARNINGS FROM THE ENDOWMENT AS AN IMPORTANT FUNDING SOURCE TO FUND NEW OPPORTUNITIES TO EXPAND ITS REACH AND IMPACT AS AN ORGANIZATION IN THE FIELD OF GLOBAL HEALTH, IN ACCORDANCE WITH PATH'S ENDOWMENT SPENDING POLICY. | ExplanationTxt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (57 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | PROGRAM SERVICES | PROGRAM INNOVATION | $98,550 |
| CENTRAL AMERICA AND THE CARIBBEAN | 0 | 0 | GRANTMAKING | $859,867 | |
| EAST ASIA AND THE PACIFIC | 6 | 133 | PROGRAM SERVICES | AFRICA | $8,131 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | AMEE | $7,903,461 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | BID & PROPOSAL | BID & PROPOSAL | $67,181 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | ESSENTIAL MEDICINE | $598,610 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | FUNDRAISING | FUNDRAISING | $5,000 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | $2,509,930 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | OTHER | $1,219 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | PROGRAM SERVICES | PROGRAM INNOVATION | $1,631,142 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTMAKING | $6,671,868 | |
| EUROPE | 3 | 47 | PROGRAM SERVICES | AFRICA | $730 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | AMEE | $542,525 |
| EUROPE | 0 | 0 | BID & PROPOSAL | BID & PROPOSAL | $31,118 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | ESSENTIAL MEDICINE | $7,168,522 |
| EUROPE | 0 | 0 | FUNDRAISING | FUNDRAISING | $106,394 |
| EUROPE | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | $1,657,002 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | OTHER | $12,610 |
| EUROPE | 0 | 0 | PROGRAM SERVICES | PROGRAM INNOVATION | $3,888,832 |
| EUROPE | 0 | 0 | GRANTMAKING | $19,073,215 | |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | PROGRAM SERVICES | AFRICA | $6,000 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | $38,527 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | PROGRAM SERVICES | PROGRAM INNOVATION | $38,040 |
| MIDDLE EAST AND NORTH AFRICA | 0 | 0 | GRANTMAKING | $219,998 | |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | AMEE | $1,830 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | ESSENTIAL MEDICINE | $480,155 |
| NORTH AMERICA | 0 | 0 | FUNDRAISING | FUNDRAISING | $14,376 |
| NORTH AMERICA | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | $82,463 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | OTHER | $1,017 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | PROGRAM INNOVATION | $211,921 |
| NORTH AMERICA | 0 | 0 | GRANTMAKING | $1,027,792 | |
| RUSSIA AND NEIGHBORING STATES | 1 | 39 | PROGRAM SERVICES | AMEE | $6,562,743 |
| RUSSIA AND NEIGHBORING STATES | 0 | 0 | BID & PROPOSAL | BID & PROPOSAL | $2,470 |
| RUSSIA AND NEIGHBORING STATES | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | $1,108,659 |
| RUSSIA AND NEIGHBORING STATES | 0 | 0 | PROGRAM SERVICES | PROGRAM INNOVATION | $97,356 |
| RUSSIA AND NEIGHBORING STATES | 0 | 0 | GRANTMAKING | $1,339,333 | |
| SOUTH AMERICA | 1 | 5 | PROGRAM SERVICES | ESSENTIAL MEDICINE | $500 |
| SOUTH AMERICA | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | $147,662 |
| SOUTH AMERICA | 0 | 0 | PROGRAM SERVICES | PROGRAM INNOVATION | $791,046 |
| SOUTH AMERICA | 0 | 0 | GRANTMAKING | $253,146 | |
| SOUTH ASIA | 5 | 251 | PROGRAM SERVICES | AFRICA | $20,314 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | AMEE | $11,983,467 |
| SOUTH ASIA | 0 | 0 | BID & PROPOSAL | BID & PROPOSAL | $237,995 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | ESSENTIAL MEDICINE | $2,085,503 |
| SOUTH ASIA | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | $4,178,583 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | OTHER | $6,650 |
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | PROGRAM INNOVATION | $1,390,375 |
| SOUTH ASIA | 0 | 0 | GRANTMAKING | $3,252,977 | |
| SUB-SAHARAN AFRICA | 42 | 906 | PROGRAM SERVICES | AFRICA | $21,428,896 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | AMEE | $31,017 |
| SUB-SAHARAN AFRICA | 0 | 0 | BID & PROPOSAL | BID & PROPOSAL | $239,601 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | ESSENTIAL MEDICINE | $4,167,999 |
| SUB-SAHARAN AFRICA | 0 | 0 | FUNDRAISING | FUNDRAISING | $1,411 |
| SUB-SAHARAN AFRICA | 0 | 0 | MANAGEMENT & GENERAL | MANAGEMENT & GENERAL | $11,252,035 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | OTHER | $1,096,629 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | PROGRAM INNOVATION | $22,645,091 |
| SUB-SAHARAN AFRICA | 0 | 0 | GRANTMAKING | $19,023,766 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 6 | SubtotalOfficesCnt |
| Subtotal Employees | 133 | SubtotalEmployeesCnt |
| Continuation Total Office | 52 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 1248 | ContinuationTotalEmployeeCnt |
| Total Office | 58 | TotalOfficeCnt |
| Total Employee | 1381 | TotalEmployeeCnt |
| Subtotal Spent | $12,050,730 | SubtotalSpentAmt |
| Continuation Spent | $156,252,520 | ContinuationSpentAmt |
| Total Spent | $168,303,250 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (214 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Non Cash AssistanceNonCashAssistanceAmt |
|---|---|---|---|---|
| CENTRAL AMERICA AND THE CARIBBEAN | ESSENTIAL MEDICINE | $326,087 | CHECK/WIRE | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | PROGRAM INNOVATION | $50,000 | CHECK/WIRE | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | PROGRAM INNOVATION | $269,700 | CHECK/WIRE | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | PROGRAM INNOVATION | $130,000 | CHECK/WIRE | $0 |
| CENTRAL AMERICA AND THE CARIBBEAN | ESSENTIAL MEDICINE | $84,080 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION | $430,000 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $35,373 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION | $10,000 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $10,373 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $62,628 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $11,271 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION | $95,238 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION | $84,379 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $27,029 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $53,853 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $34,385 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | ESSENTIAL MEDICINE | $79,780 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | ESSENTIAL MEDICINE | $495,592 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $14,972 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $14,937 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | ESSENTIAL MEDICINE | $30,000 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION | $54,327 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | ESSENTIAL MEDICINE | $2,591,324 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $86,658 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $29,426 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $21,117 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION & ESSENTIAL MEDICINE | $1,607,811 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION | $93,558 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $30,648 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION | $50,000 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $79,610 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION | $298,650 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | PROGRAM INNOVATION | $7,330 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | ESSENTIAL MEDICINE | $22,955 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $97,254 | CHECK/WIRE | $0 |
| EAST ASIA AND THE PACIFIC | AMEE | $105,271 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $68,759 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $845,355 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $191,831 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $62,766 | CHECK/WIRE | $0 |
| EUROPE | ESSENTIAL MEDICINE | $797,750 | CHECK/WIRE | $0 |
| EUROPE | AFRICA | $64,753 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $74,862 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION & ESSENTIAL MEDICINE | $4,088,621 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $22,800 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $152,152 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $171,295 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $317,141 | CHECK/WIRE | $0 |
| EUROPE | ESSENTIAL MEDICINE | $14,900 | CHECK/WIRE | $0 |
| EUROPE | ESSENTIAL MEDICINE | $488,235 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $606,717 | CHECK/WIRE | $0 |
| EUROPE | ESSENTIAL MEDICINE | $75,000 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $1,370,673 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $110,012 | CHECK/WIRE | $0 |
| EUROPE | AMEE | $144,000 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $52,016 | CHECK/WIRE | $0 |
| EUROPE | ESSENTIAL MEDICINE | $870,000 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $1,375,740 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION & ESSENTIAL MEDICINE | $17,114 | CHECK/WIRE | $0 |
| EUROPE | ESSENTIAL MEDICINE | $628,666 | CHECK/WIRE | $0 |
| EUROPE | ESSENTIAL MEDICINE | $306,218 | CHECK/WIRE | $0 |
| EUROPE | AMEE | $227,866 | CHECK/WIRE | $0 |
| EUROPE | AFRICA | $17,614 | CHECK/WIRE | $0 |
| EUROPE | PROGRAM INNOVATION | $41,000 | CHECK/WIRE | $0 |
| EUROPE | AFRICA, AMEE, ESSENTIAL MEDICINE, OTHER, & PROGRAM INNOVATION | $5,869,356 | CHECK/WIRE | $0 |
| MIDDLE EAST & NORTH AFRICA | ESSENTIAL MEDICINE | $100,050 | CHECK/WIRE | $0 |
| MIDDLE EAST & NORTH AFRICA | ESSENTIAL MEDICINE | $119,948 | CHECK/WIRE | $0 |
| NORTH AMERICA | ESSENTIAL MEDICINE | $22,361 | CHECK/WIRE | $0 |
| NORTH AMERICA | ESSENTIAL MEDICINE | $133,333 | CHECK/WIRE | $0 |
| NORTH AMERICA | ESSENTIAL MEDICINE | $432,643 | CHECK/WIRE | $0 |
| NORTH AMERICA | ESSENTIAL MEDICINE | $294,295 | CHECK/WIRE | $0 |
| NORTH AMERICA | PROGRAM INNOVATION | $10,000 | CHECK/WIRE | $0 |
| NORTH AMERICA | PROGRAM INNOVATION | $27,210 | CHECK/WIRE | $0 |
| NORTH AMERICA | ESSENTIAL MEDICINE | $107,950 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $8,241 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $140,647 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $93,766 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $9,397 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $15,736 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $28,419 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $12,790 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $433,083 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $55,110 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $39,238 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $18,982 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | PROGRAM INNOVATION | $53,000 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $53,208 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $104,399 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $127,381 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $54,060 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $45,437 | CHECK/WIRE | $0 |
| RUSSIA AND NEIGHBORING STATES | AMEE | $46,438 | CHECK/WIRE | $0 |
| SOUTH AMERICA | PROGRAM INNOVATION | $78,130 | CHECK/WIRE | $0 |
| SOUTH AMERICA | ESSENTIAL MEDICINE | $37,143 | CHECK/WIRE | $0 |
| SOUTH AMERICA | PROGRAM INNOVATION | $8,447 | CHECK/WIRE | $0 |
| SOUTH AMERICA | PROGRAM INNOVATION | $35,000 | CHECK/WIRE | $0 |
| SOUTH AMERICA | ESSENTIAL MEDICINE | $49,103 | CHECK/WIRE | $0 |
| SOUTH AMERICA | PROGRAM INNOVATION | $20,000 | CHECK/WIRE | $0 |
| SOUTH AMERICA | PROGRAM INNOVATION | $23,142 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE & PROGRAM INNOVATION | $175,570 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE, ESSENTIAL MEDICINE, & PROGRAM INNOVATION | $32,728 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $138,491 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $194,140 | CHECK/WIRE | $0 |
| SOUTH ASIA | PROGRAM INNOVATION | $60,000 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $100,016 | CHECK/WIRE | $0 |
| SOUTH ASIA | PROGRAM INNOVATION | $6,088 | CHECK/WIRE | $0 |
| SOUTH ASIA | ESSENTIAL MEDICINE | $1,275,497 | CHECK/WIRE | $0 |
| SOUTH ASIA | PROGRAM INNOVATION | $213,677 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $105,566 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $59,543 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $490,486 | CHECK/WIRE | $0 |
| SOUTH ASIA | PROGRAM INNOVATION | $53,960 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $70,051 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $54,272 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $8,862 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $203,970 | CHECK/WIRE | $0 |
| SOUTH ASIA | AMEE | $7,209 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | OTHER | $19,044 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $171,641 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $33,654 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $18,108 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $10,000 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $30,484 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $68,778 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $25,889 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $30,426 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $49,814 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $14,064 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $100,524 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $55,650 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $48,224 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $28,717 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | ESSENTIAL MEDICINE | $218,452 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $132,758 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $478,477 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $268,922 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $10,464 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $15,174 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $12,198 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $245,855 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $44,735 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | OTHER | $18,481 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $35,954 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $42,754 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA & PROGRAM INNOVATION | $76,010 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $5,185 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $7,065 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $6,998 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $48,347 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $72,499 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $51,469 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA & PROGRAM INNOVATION | $208,588 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $91,934 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $121,540 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $47,940 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $46,727 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA & PROGRAM INNOVATION | $65,658 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | OTHER | $59,972 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | ESSENTIAL MEDICINE | $35,791 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | ESSENTIAL MEDICINE & PROGRAM INNOVATION | $8,789 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $28,235 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $68,164 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $26,103 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | OTHER | $22,849 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $25,850 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $82,068 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $833,623 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $62,547 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | ESSENTIAL MEDICINE | $1,145,308 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $214,889 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $331,737 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $112,240 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $118,146 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $21,468 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $9,251 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $146,354 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $500,000 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $9,261 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $9,860 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $152,117 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $40,471 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | ESSENTIAL MEDICINE | $978,697 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | OTHER | $14,396 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $14,073 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $23,020 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $170,884 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $30,985 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | ESSENTIAL MEDICINE | $360,000 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $35,151 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $45,801 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $11,476 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $30,978 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $49,044 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $50,681 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $26,795 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $27,219 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $49,279 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $20,233 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | ESSENTIAL MEDICINE | $25,000 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $5,468 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $235,717 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $46,865 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $13,364 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $84,193 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | ESSENTIAL MEDICINE | $15,342 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $296,976 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $63,062 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | PROGRAM INNOVATION | $116,851 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $6,723 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | ESSENTIAL MEDICINE & PROGRAM INNOVATION | $263,177 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $30,454 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $29,961 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA | $141,227 | CHECK/WIRE | $0 |
| SUB-SAHARAN AFRICA | AFRICA, AMEE, ESSENTIAL MEDICINE, OTHER, & PROGRAM INNOVATION | $8,495,931 | CHECK/WIRE | $0 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 163 | Total501c3OrgCnt |
| Total Other Org | 52 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | Yes (1) | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | PATH HAS ROBUST POLICIES, PROCEDURES, AND GUIDELINES, INCLUDING SUBRECIPIENT POLICY AND PROCEDURES, IN PLACE TO GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING (FINANCIAL AND TECHNICAL), SITE VISITS, REGULAR CONTACT, ANNUAL AUDITS, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS/DONORS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS, AND THAT THE SUBRECIPIENT ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL. THESE ARE COMBINED WITH AN INTERNAL AUDIT FUNCTION THROUGH WHICH PATH CONDUCTS AUDITS ON GRANT-FUNDED PROGRAMS TO ENSURE COMPLIANCE WITH REGULATORY AND DONOR REQUIREMENTS. THE AUDIT IS CONDUCTED FOR THE COUNTRY PROGRAMS AND IS EXTENDED TO THE SUBRECIPIENTS. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (54 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|
| ABH PARTNERS LLC | |||||||||
| 1015 15TH ST NW SUITE 543K | WASHINGTON | DC | 20005 | 852460113 | OTHER | $45,320 | $0 | AFRICA | |
| AKROS INC | |||||||||
| PO BOX 457 | LARAMIE | WY | 82073 | 263668995 | OTHER | $126,125 | $0 | PROGRAM INNOVATION | |
| BUILD HEALTH INTERNATIONAL INC | |||||||||
| 100 CUMMINGS CENTER SUITE 120 B | BEVERLY | MA | 01915 | 464300024 | 501(C)(3) | $13,528 | $0 | PROGRAM INNOVATION | |
| CASE WESTERN RESERVE UNIVERSITY | |||||||||
| 10900 EUCLID AVE | CLEVELAND | OH | 441067037 | 341018992 | 501(C)(3) | $24,210 | $0 | PROGRAM INNOVATION | |
| CINCINNATI CHILDREN'S HOSPITAL | |||||||||
| MEDICAL CENTER 3333 BURNET AVE ML | CINCINNATI | OH | 452293039 | 310833936 | 501(C)(3) | $253,324 | $0 | ESSENTIAL MEDICINES | 6014 |
| CLINTON HEALTH ACCESS INITIATIVE | |||||||||
| 383 DORCHESTER AVE SUITE 400 | BOSTON | MA | 02127 | 271414646 | 501(C)(3) | $768,014 | $0 | PROGRAM INNOVATION | |
| COOPERSMITH | |||||||||
| 5302 VALBURN CIR | AUSTIN | TX | 787311145 | 472387850 | OTHER | $50,090 | $0 | PROGRAM INNOVATION | |
| DKT INTERNATIONAL INC | |||||||||
| 1001 CONNECTICUT AVE NW SUITE 800 | WASHINGTON | DC | 20036 | 581593137 | 501(C)(3) | $51,251 | $0 | PROGRAM INNOVATION | |
| FOOD AND DRUG ADMINISTRATION | |||||||||
| 5600 FISHERS LNHFA-140 RM 11-40 | ROCKVILLE | MD | 20857 | 530196965 | GOV | $165,200 | $0 | ESSENTIAL MEDICINES | |
| GEORGE WASHINGTON UNIVERSITY | |||||||||
| 45155 RESEARCH PLACE 240N | ASHBURN | VA | 201474191 | 530196584 | 501(C)(3) | $10,518 | $0 | PROGRAM INNOVATION | |
| GET ODK INC | |||||||||
| 3288 ADAMS AVE 16043 | SAN DIEGO | CA | 92176 | 851074733 | OTHER | $6,000 | $0 | PROGRAM INNOVATION | |
| GLOBAL CONNECT DEVELOPMENT GROUP LLC | |||||||||
| 56 WILLOW STREET 2 | BOSTON | MA | 02132 | 823433604 | OTHER | $258,880 | $0 | PROGRAM INNOVATION | |
| GLOBAL HEALTH CORPS | |||||||||
| 318 WEST 39TH STREET ROOM 9L | NEW YORK | NY | 10018 | 800512336 | 501(C)(3) | $10,500 | $0 | PROGRAM INNOVATION | |
| GLOBAL HEALTH STRATEGIES LLC | |||||||||
| 27 WEST 24TH STREET SUITE 900 | NEW YORK | NY | 10010 | 272494697 | 501(C)(3) | $510,265 | $0 | PROGRAM INNOVATION | |
| GUARALDI SYSTEMS LLC | |||||||||
| 97 ALGER BROOK RD | SOUTH STAFFORD | VT | 05070 | 851148274 | OTHER | $152,811 | $0 | PROGRAM INNOVATION | |
| HARVARD UNIVERSITY | |||||||||
| 1033 MASSACHUSETTS AVE 2ND FL | BOSTON | MA | 02215 | 042103580 | 501(C)(3) | $421,441 | $0 | ESSENTIAL MEDICINE & PROGRAM INNOVATION | |
| HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE INC | |||||||||
| 6720A ROCKLEDGE DR STE 100 | BETHESDA | MD | 20817 | 521317896 | 501(C)(3) | $66,010 | $0 | ESSENTIAL MEDICINES | |
| HISP US LLC | |||||||||
| 31 ANCONA AVE | OCEAN PARK | ME | 040637308 | 850894858 | OTHER | $187,654 | $0 | PROGRAM INNOVATION | |
| ICF MACRO INC | |||||||||
| 1902 RESTON METRO PLAZA | RESTON | VA | 21090 | 520955232 | OTHER | $3,057,961 | $0 | PROGRAM INNOVATION | |
| INDIANA UNIVERSITY | |||||||||
| 107 S INDIANA AVE | BLOOMINGTON | IN | 474057000 | 356001673 | GOV | $207,441 | $0 | PROGRAM INNOVATION | |
| INTRAHEALTH INTERNATIONAL INC | |||||||||
| 6340 QUADRANGLE DRIVE SUITE 200 | CHAPEL HILL | NC | 27517 | 550825466 | 501(C)(3) | $217,336 | $0 | PROGRAM INNOVATION | |
| IPAS | |||||||||
| PO BOX 9990 | CHAPEL HILL | NC | 27515 | 561071085 | 501(C)(3) | $100,000 | $0 | PROGRAM INNOVATION | |
| JHPIEGO | |||||||||
| 1615 THAMES STREET SUITE 200 | BALTIMORE | MD | 212313447 | 237424444 | 501(C)(3) | $1,006,648 | $0 | AFRICA, AMEE, & PROGRAM INNOVATION | |
| JSI RESEARCH AND TRAINING INSTITUTE INC | |||||||||
| 44 FARNSWORTH STREET | BOSTON | MA | 02210 | 042679824 | 501(C)(3) | $740,338 | $0 | PROGRAM INNOVATION | |
| LINKSBRIDGE SPC | |||||||||
| 101 TAYLOR AVE N 105 | SEATTLE | WA | 98109 | 263067893 | 501(C)(3) | $48,277 | $0 | ESSENTIAL MEDICINES | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| DEPT OF EM MED ZERO EMERSON PL 104 | BOSTON | MA | 02114 | 041564655 | 501(C)(3) | $89,449 | $0 | ESSENTIAL MEDICINES | |
| MEDIC MOBILE INC | |||||||||
| 3254 19TH STREET FLOOR 2 | SAN FRANCISCO | CA | 94110 | 275104203 | 501(C)(3) | $643,346 | $0 | PROGRAM INNOVATION | |
| MICRON BIOMEDICAL INC | |||||||||
| 311 FERST DRIVE NW SUITE L1309 | ATLANTA | GA | 303320390 | 471692844 | OTHER | $95,080 | $0 | PROGRAM INNOVATION | |
| NATIONAL FOUNDATION FOR THE CDC | |||||||||
| 600 PEACHTREE ST NE SUITE 1000 | ATLANTA | GA | 30308 | 582106707 | 501(C)(3) | $151,025 | $0 | ESSENTIAL MEDICINES | |
| ONA SYSTEMS INC | |||||||||
| 126 E 12TH ST SUITE 4A | NEW YORK | NY | 100035320 | 383940780 | OTHER | $294,600 | $0 | PROGRAM INNOVATION | |
| OPEN DEVELOPMENT LLC | |||||||||
| 400 G ST NE | WASHINGTON | DC | 20002 | 472659640 | OTHER | $134,748 | $0 | AFRICA | |
| OPEN FUNCTION GROUP INC | |||||||||
| 66 EUCLID AVE | HASTINGS ON HUDSON | NY | 10706 | 923992725 | OTHER | $10,000 | $0 | PROGRAM INNOVATION | |
| OPENMRS INC | |||||||||
| 10425 COMMERCE DR STE 110 | CARMEL | IN | 460327643 | 455316647 | 501(C)(3) | $730,135 | $0 | PROGRAM INNOVATION | |
| PHARMARON CPC INC | |||||||||
| 800 W BALTIMORE STREET 5TH FLOOR | BALTIMORE | MD | 21201 | 432065612 | OTHER | $14,626 | $0 | ESSENTIAL MEDICINES | |
| POPULATION SERVICES INTERNATIONAL INC | |||||||||
| 1120 19TH ST NW STE 600 | WASHINGTON | DC | 20036 | 560942853 | 501(C)(3) | $1,174,593 | $0 | PROGRAM INNOVATION | |
| PROMINEX INC | |||||||||
| 6181 CORNERSTONE COURT E STE 106 | SAN DIEGO | CA | 92121 | 823746153 | OTHER | $15,000 | $0 | PROGRAM INNOVATION | |
| REGENSTRIEF INSTITUTE INC | |||||||||
| 1101 WEST TENTH STREET | INDIANAPOLIS | IN | 46202 | 300007730 | 501(C)(3) | $1,293,753 | $0 | PROGRAM INNOVATION | |
| SOCIAL AND ENVIRONMENTAL ENTREPRENEURS INC (SEE) | |||||||||
| 23564 CALABASAS ROAD SUITE 201 | CALABASAS | CA | 91302 | 954116679 | 501(C)(3) | $51,037 | $0 | AMEE | |
| SYSTEMONE LLC | |||||||||
| 5 BRIDGE STREET | SHELBURNE FALLS | MA | 01370 | 461066795 | OTHER | $34,852 | $0 | AMEE | |
| TECHCHANGE INC | |||||||||
| 1226 9TH ST NW SUITE 200 | WASHINGTON | DC | 20006 | 273358772 | OTHER | $546,677 | $0 | PROGRAM INNOVATION | |
| THE ALBERT B SABIN VACCINE INSTITUTE INC | |||||||||
| 2175 K STREET NW SUITE 400 | WASHINGTON | DC | 20037 | 061389829 | 501(C)(3) | $2,211,718 | $0 | ESSENTIAL MEDICINES | |
| THE REGENTS OF THE UNIVERSITY OF CALIFORNIA SAN FRANCISCO | |||||||||
| 1855 FOLSOM STREET SUITE 425 | SAN FRANCISCO | CA | 941430812 | 946036493 | GOV | $205,886 | $0 | PROGRAM INNOVATION | |
| TULANE UNIVERSITY | |||||||||
| 6823 ST CHARLES AVE | NEW ORLEANS | LA | 70112 | 720423889 | 501(C)(3) | $837,089 | $0 | ESSENTIAL MEDICINE & PROGRAM INNOVATION | |
| UNITED NATIONS FOUNDATION INC | |||||||||
| 1750 PENNSYLVANIA AVE NW STE 300 | WASHINGTON | DC | 20006 | 582368165 | 501(C)(3) | $167,547 | $0 | PROGRAM INNOVATION | |
| UNIVERSITY OF CALIFORNIA LOS ANGELES (UCLA) | |||||||||
| 10889 WILSHIRE BLVD SUITE 700 | LOS ANGELES | CA | 900951406 | 956006143 | GOV | $83,958 | $0 | AFRICA | |
| UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC | |||||||||
| 310 E CAMPUS RD | ATHENS | GA | 30602 | 581353149 | 501(C)(3) | $26,215 | $0 | ESSENTIAL MEDICINES | |
| UNIVERSITY OF MASSACHUSETTS | |||||||||
| MEDICAL SCHOOL 55 LAKE AVE NORTH | WORCESTER | MA | 01655 | 043167352 | GOV | $92,662 | $0 | PROGRAM INNOVATION | |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | |||||||||
| CENTER FOR INFECTIOUS DISEASES | CHAPEL HILL | NC | 275993368 | 566001393 | GOV | $261,496 | $0 | ESSENTIAL MEDICINE & PROGRAM INNOVATION | |
| UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE | |||||||||
| 85 SO PROSPECT STREET 333 WATERMAN | BURLINGTON | VT | 05405 | 030179440 | 501(C)(3) | $171,368 | $0 | ESSENTIAL MEDICINES | BLDG |
| UNIVERSITY OF WASHINGTON (UW) | |||||||||
| GRANT CONTRACT ACCOUNTING 12455 | CHICAGO | IL | 60693 | 916001537 | GOV | $1,935,938 | $0 | ESSENTIAL MEDICINE & PROGRAM INNOVATION | COLLECTIONS DRIVE |
| VILLAGEREACH | |||||||||
| 210 S HUDSON ST SUITE 307 | SEATTLE | WA | 98134 | 912083484 | 501(C)(3) | $10,000 | $0 | PROGRAM INNOVATION | |
| VITAL WAVE INC | |||||||||
| 555 BRYANT STREET 226 | PALO ALTO | CA | 94301 | 203208079 | OTHER | $1,178,000 | $0 | PROGRAM INNOVATION | |
| VITALLIANCE CORPORATION | |||||||||
| 4055 VALLEY VIEW LANE SUITE 1000 | DALLAS | TX | 75244 | 841817390 | OTHER | $10,000 | $0 | PROGRAM INNOVATION | |
| WALTER REED ARMY INSTITUTE OF RESEARCH | |||||||||
| US TREASURY 503 ROBERT GRANT AVE | SILVER SPRING | MD | 20910 | 520664528 | GOV | $1,027,567 | $0 | ESSENTIAL MEDICINE & PROGRAM INNOVATION | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 36 | Total501c3OrgCnt |
| Total Other Org | 18 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | PATH HAS A SUBRECIPIENT POLICY AND PROCEDURES IN PLACE TO GUIDE THE WAY OUR PROJECT TEAMS MONITOR SUBRECIPIENTS. THIS INCLUDES BOTH FINANCIAL AND TECHNICAL MONITORING. PATH USES RISK ASSESSMENTS, REPORTING, SITE VISITS, REGULAR CONTACT, ANNUAL AUDITS, AND OTHER MEANS TO PROVIDE THE MONITORING REQUIRED BY FUNDERS/DONORS AND TO ENSURE GOOD PROJECT STEWARDSHIP. THESE ACTIVITIES ALSO PROVIDE RESPONSIBLE ASSURANCE THAT THE SUBRECIPIENT ADMINISTERS FUNDS IN COMPLIANCE WITH LAWS, REGULATIONS, AND PRIME AWARD TERMS, AND THAT THE SUBRECIPIENT ACHIEVES PERFORMANCE GOALS. PATH HAS ESTABLISHED COMPREHENSIVE POLICIES AND PROCEDURES TO PROMOTE BEST BUSINESS PRACTICES AND ENSURE EFFICIENT AND EFFECTIVE INTERNAL CONTROL. THESE ARE COMBINED WITH AN INTERNAL AUDIT FUNCTION THROUGH WHICH PATH CONDUCTS AUDITS ON GRANT-FUNDED PROGRAMS TO ENSURE COMPLIANCE WITH REGULATORY AND DONOR REQUIREMENTS. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Idemnification Gross Up Pmts | Yes (X) | IdemnificationGrossUpPmtsInd |
| Housing Allowance Or Residence | Yes (X) | HousingAllowanceOrResidenceInd |
| Written Policy Ref T And E Expnss | Yes (1) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | Yes (1) | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (15 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NIKOLAJ JESTED GILBERT MSC | ||||||||||||||
| PRESIDENT AND CEO | $486,278 | $0 | $149,240 | $0 | $825 | $0 | $35,800 | $0 | $31,262 | $0 | $703,405 | $0 | $0 | $0 |
| KIMBERLY GREEN PHD | ||||||||||||||
| DIRECTOR, PRIMARY HEALTH CARE | $281,314 | $0 | $0 | $0 | $265,379 | $0 | $26,101 | $0 | $62,712 | $0 | $635,506 | $0 | $0 | $0 |
| ASHLEY J BIRKETT PHD | ||||||||||||||
| GLOBAL HEAD, MALARIA VACCINES | $353,553 | $0 | $0 | $0 | $900 | $0 | $32,329 | $0 | $34,160 | $0 | $420,942 | $0 | $0 | $0 |
| JESSICA MILMAN MPH | ||||||||||||||
| GBL. HEAD, CENTER FOR VAX INNOV. & A | $350,761 | $0 | $12,500 | $0 | $600 | $0 | $30,939 | $0 | $18,810 | $0 | $413,610 | $0 | $0 | $0 |
| KATYA SPIELBERG | ||||||||||||||
| GBL. HEAD, INTEG. PORT. & FIN. MGMT. | $311,666 | $0 | $12,500 | $0 | $900 | $0 | $30,896 | $0 | $43,291 | $0 | $399,253 | $0 | $0 | $0 |
| TRAD M HATTON MA MHS | ||||||||||||||
| DIR., CEN. AFRICA HUB & DRC COUNTRY | $156,589 | $0 | $0 | $0 | $184,662 | $0 | $19,097 | $0 | $38,412 | $0 | $398,760 | $0 | $0 | $0 |
| BRUCE LAMONT INNIS MD FIDSA | ||||||||||||||
| GLOBAL HEAD, RESPIRATORY INFECTIONS | $364,385 | $0 | $0 | $0 | $600 | $0 | $33,838 | $0 | -$106 | $0 | $398,717 | $0 | $0 | $0 |
| KAMMERLE SCHNEIDER EBERLE MIA | ||||||||||||||
| CHIEF PROGRAMS & INNOVATION OFFICER | $334,102 | $0 | $0 | $0 | $675 | $0 | $35,800 | $0 | $18,801 | $0 | $389,378 | $0 | $0 | $0 |
| SABRINA L POWERS JD | ||||||||||||||
| CHIEF OF LEGAL & RESEARCH AFFAIRS/GC | $299,964 | $0 | $0 | $0 | $825 | $0 | $35,400 | $0 | $14,447 | $0 | $350,636 | $0 | $0 | $0 |
| NANTHALILE C MUGALA MD MMED | ||||||||||||||
| CHIEF OF AFRICA REGION | $251,888 | $0 | $0 | $0 | $67,342 | $0 | $0 | $0 | $0 | $0 | $319,230 | $0 | $0 | $0 |
| HEATHER RAE IGNATIUS | ||||||||||||||
| CHIEF OF EXTERNAL AFFAIRS | $262,663 | $0 | $0 | $0 | $600 | $0 | $26,564 | $0 | $22,138 | $0 | $311,965 | $0 | $0 | $0 |
| MEISSA DIAW | ||||||||||||||
| CHIEF PEOPLE & DIVERSITY OFFICER | $274,904 | $0 | $0 | $0 | $18,457 | $0 | $0 | $0 | $291 | $0 | $293,652 | $0 | $0 | $0 |
| LAURIE WERNER MPA | ||||||||||||||
| DIR., CENTER OF DIG. & DATA EXCELLEN | $249,745 | $0 | $0 | $0 | $904 | $0 | $29,293 | $0 | $12,646 | $0 | $292,588 | $0 | $0 | $0 |
| NABEEL A GOHEER PHD | ||||||||||||||
| CHIEF OF AFRICA | $285,487 | $0 | $0 | $0 | $1,044 | $0 | $2,190 | $0 | $0 | $0 | $288,721 | $0 | $0 | $0 |
| BEN ALIWA MBA | ||||||||||||||
| CHIEF OF BUSINESS & FINANCE OFFICER | $0 | $238,853 | $0 | $0 | $0 | $432 | $0 | $22,048 | $0 | $0 | $0 | $261,333 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 1A | HOUSING ALLOWANCES & TAX INDEMNIFICATIONS ARE ONLY PROVIDED TO THOSE INDIVIDUALS WHO ARE EXPATRIATE EMPLOYEES. ALL BENEFIT PAYMENTS ARE MADE ACCORDING TO OUR EXPATRIATE POLICY. PART I, LINE 3: PATH ENGAGES WITH A CONSULTING FIRM TO REVIEW THE COMPENSATION FOR EACH OF THE SENIOR MANAGEMENT POSITIONS. PATH PROVIDES AN ANNUAL SALARY ADJUSTMENT EACH JANUARY BASED ON THE OVERALL LABOR MARKET MOVEMENT. |
| PART I, LINE 7 | BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II). |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 7 | ContributionCnt |
| Noncash Contributions Rpt F990 | $58,450 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FMV | MethodOfDeterminingRevenuesTxt |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | SOFTWARE/SUPP. | Desc |
| Contribution | 2 | ContributionCnt |
| Noncash Contributions Rpt F990 | $297,249 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | COST | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (1) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, COLUMN (B): | FormAndLineReferenceDesc |
| Explanation | THIS COLUMN REFLECTS THE NUMBER OF CONTRIBUTIONS. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (20 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION: | PATH IS A GLOBAL NONPROFIT DEDICATED TO ACHIEVING HEALTH EQUITY. WITH MORE THAN 40 YEARS OF EXPERIENCE FORGING MULTISECTOR PARTNERSHIPS, AND WITH EXPERTISE IN SCIENCE, ECONOMICS, TECHNOLOGY, ADVOCACY, AND DOZENS OF OTHER SPECIALTIES, PATH DEVELOPS AND SCALES UP INNOVATIVE SOLUTIONS TO THE WORLD'S MOST PRESSING HEALTH CHALLENGES. THE LARGEST INVESTMENTS IN PATH'S PROGRAMMATIC WORK IN 2023 WERE ORGANIZED INTO THREE PRIMARY PORTFOLIOS: PROGRAMS & INNOVATION, ESSENTIAL MEDICINES, AND THE ASIA, MIDDLE EAST AND EUROPE (AMEE) REGIONS. |
| FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: | TO INCREASE ACCESS TO G6PD TESTING, WE BROKERED A VOLUME GUARANTEE FOR THE SD BIOSENSOR STANDARD G6PD TEST, THE SOLE QUANTITATIVE POC DIAGNOSTIC FOR THIS TYPE OF MALARIA. THIS GUARANTEE, PROVIDED BY MEDACCESS, SUPPORTS SD BIOSENSOR TO REDUCE THE PRICE OF THEIR POC G6PD DEVICE AND TESTING STRIPS FOR LMICS AND, MORE IMPORTANTLY, ENSURES SUPPLY SECURITY OF THE TEST THROUGH COMMITMENTS FROM THE SOLE MANUFACTURER. IN 2023, PATH RECEIVED FUNDING TO EVALUATE THE USABILITY OF A NEW MULTIPLEX MOLECULAR PLATFORM IN LMICS. THESE STUDIES SEEK TO UNDERSTAND HEALTH CARE FACILITY LEVELS THAT THESE INSTRUMENTS CAN REASONABLY REACH. IN 2023, WE CONTINUED TO ADVANCE THE DEVELOPMENT OF A POINT-OF-CARE RAPID SCREENING TEST FOR PRIMARY IMMUNODEFICIENCY (PID) WITH LIFEASSAY DIAGNOSTICS LTD. PID DISORDERS ARE A RARE CLASS OF HEREDITARY DISEASES THAT AFFECT THE IMMUNE SYSTEM, RESULTING IN INCOMPLETE IMMUNE RESPONSES, WHICH MAKE INDIVIDUALS MORE VULNERABLE TO DISEASES. PEOPLE WITH SOME FORMS OF PID ARE AT RISK OF PROLONGED INFECTION AND SHEDDING OF POLIOVIRUS INTO THEIR COMMUNITIES. IDENTIFYING THOSE WITH PID CAN HELP DISRUPT COMMUNITY OUTBREAKS AND DISEASE CYCLES. IN PARTNERSHIP WITH FHI360, WE SUPPORTED USAID'S GLOBAL HEALTH SUPPLY CHAIN PROGRAM WITH QUALITY ASSURANCE TESTING OF RAPID TESTS FOR HIV, TUBERCULOSIS, AND SARS-COV-2. LOT TESTING HELPS TO ENSURE THAT RAPID TESTS PROCURED WITH UNITED STATES GOVERNMENT FUNDING ARE OF HIGH AND CONSISTENT QUALITY. WE ALSO PROVIDE TECHNICAL ASSISTANCE TO EVALUATE NEW RAPID TESTS, ASSESS THE SUITABILITY OF MANUFACTURERS, AND SUPPORT END USERS WHEN PROBLEMS WITH TESTS ARISE DURING ROUTINE USE. IN PARTNERSHIP WITH REDBUD LABS, AND SUPPORTED BY THE NATIONAL INSTITUTES OF HEALTH (NIH), WE ARE DEVELOPING POINT-OF-CARE PLATFORMS FOR A RANGE OF TARGETS: THE DETECTION AND DIFFERENTIATION OF THE CAUSATIVE AGENTS OF VIRAL HEMORRHAGIC FEVER, THE DETECTION AND VIRAL LOAD MEASUREMENT OF HIV, AND THE DETECTION AND VIRAL LOAD MEASUREMENT OF HEPATITIS C VIRUS (HCV). PATH IS RESPONSIBLE FOR THE DEVELOPMENT AND INTEGRATION OF THE NUCLEIC AMPLIFICATION ASSAYS IN THE PLATFORM. IN 2023, A SUPPLEMENT TO AN EXISTING AWARD ON OPEN-ACCESS RESOURCES TO ADVANCE PHOTOPLETHYSMOGRAPHY-DERIVED ARTIFICIAL INTELLIGENCE (AI) TECHNOLOGY ALLOWED THE EXPANSION OF THE PROJECT. THE GOAL WAS TO START BUILDING A PIPELINE OF TOOLS AND RESOURCES TO ACCELERATE THE EXTERNALIZATION OF AI MODELS TO PUBLIC HEALTH PRODUCTS, BOTH REGULATED AND NONREGULATED, FOR BETTER MANAGEMENT OF ILLNESS AND WELL-BEING, ESPECIALLY IN CHILDREN. PRODUCT-AGNOSTIC LEARNINGS WERE GENERATED AND MADE ACCESSIBLE TO EVERYONE IN THE AI-FOR-HEALTH SECTOR. MEDICAL DEVICES AND HEALTH TECHNOLOGIES THE MEDICAL DEVICES AND HEALTH TECHNOLOGIES PROGRAM SUPPORTS PRODUCT DEVELOPMENT AT PATH. THE PROGRAM WORKS WITH PUBLIC- AND PRIVATE-SECTOR PARTNERS AROUND THE WORLD TO DEVELOP, TEST, INTRODUCE, AND SCALE UP AFFORDABLE INNOVATIONS TO SAVE LIVES AND IMPROVE HEALTH. THROUGHOUT 2023, STAFF PUBLISHED 19 PEER-REVIEWED JOURNAL ARTICLES AND RESEARCH FINDINGS ON TOPICS INCLUDING MEASLES AND RUBELLA MICROARRAY PATCHES, VACCINE WASTAGE, USING NEW COLD CHAIN TECHNOLOGIES TO EXTEND THE VACCINE COLD CHAIN, AND ESTABLISHING INPATIENT CARE FOR SMALL AND SICK NEWBORNS. IN THE AREA OF VACCINE AND PHARMACEUTICAL TECHNOLOGIES, OUR TECHNICAL EXPERTS ARE ADVANCING THE DESIGN AND DEVELOPMENT OF MULTIPLE COMPACT, PREFILLED, AUTODISABLE DEVICES (CPAD) FOR THE DELIVERY OF CONTRACEPTIVE DRUGS. THE PATH MICROARRAY PATCH CENTER OF EXCELLENCE CONTINUED OUR CROSS-SECTOR WORK TO ADVANCE THIS NEEDLE-FREE DELIVERY TECHNOLOGY PLATFORM FOR CRITICAL VACCINES, SUCH AS FOR MEASLES AND RUBELLA, AND SERVED AS HOSTS OF THE 2023 INTERNATIONAL MICRONEEDLES CONFERENCE IN MAY. IN ADDITION, STAFF COMPLETED A RAPID ENVIRONMENTAL ANALYSIS USING LIFE CYCLE ANALYSIS MODELING TO EVALUATE THE POTENTIAL ENVIRONMENTAL IMPACT OF PRIORITY COMBINATION VACCINES, REGIONAL MANUFACTURING, AUTODISABLE SYRINGES, MICROARRAY PATCHES, CONTROLLED TEMPERATURE CHAIN STORAGE OF VACCINES, AND VACCINE BARCODING. MARKET DYNAMICS PATH'S MARKET DYNAMICS PROGRAM WORKS TO INCREASE EQUITABLE ACCESS TO HEALTH PRODUCTS AND SERVICES BY DIAGNOSING THE ROOT CAUSES OF MARKET FAILURES, DESIGNING APPROPRIATE SOLUTIONS, AND DEVELOPING SUSTAINABLE AND INCLUSIVE HEALTH MARKETS. THIS WORK IS DONE IN CLOSE COLLABORATION WITH NATIONAL MINISTRIES OF HEALTH, GLOBAL AGENCIES, COMMERCIAL PARTNERS, CIVIL SOCIETY ORGANIZATIONS, AND PATH'S COUNTRY PROGRAMS. IN 2023, OUR LARGEST AREAS OF WORK WERE: (1) IMPROVING ACCESS TO MEDICAL OXYGEN, RESPIRATORY CARE SYSTEMS, AND CRITICAL MEDICAL DEVICES IN LMICS. AS PART OF THAT WORK, WE CONTINUED TO SUPPORT GLOBAL AND COUNTRY EFFORTS IN RESPIRATORY CARE CAPACITY-BUILDING AND IMPLEMENTATION, STRENGTHENED ADVOCACY TO ELEVATE OXYGEN TO GLOBAL AND NATIONAL AGENDAS, AND ENHANCED RESEARCH AND MONITORING, EVALUATION, AND LEARNING ON OXYGEN. HIGHLIGHTS INCLUDED JOINING FORCES WITH THE GLOBAL OXYGEN ALLIANCE TO BOOST ACCESS TO OXYGEN ACCESS, ADVOCATING FOR THE ADOPTION OF THE RESOLUTION ON ACCESS TO OXYGEN AT THE WORLD HEALTH ASSEMBLY, DEVELOPING TOOLS FOR COUNTRIES TO INCLUDE OXYGEN INDICATOR SYSTEMS IN ROUTINE HEALTH MONITORING, AND BUILDING DIGITAL INSIGHTS PLATFORMS FOR COUNTRY MINISTRIES TO ANALYZE OXYGEN GAPS AND PRIORITIES FOR INVESTMENT. IN INDIA, KENYA, SENEGAL, AND TANZANIA, WE ADVANCED ACCESS TO PULSE OXIMETRY AND ELECTRONIC CLINICAL DECISION-SUPPORT ALGORITHMS AS CRITICAL TOOLS TO HELP HEALTH CARE WORKERS IDENTIFY SEVERELY ILL CHILDREN AND REFER THEM FOR TREATMENT WITHOUT DELAY. AS PART OF THIS WORK, WE COMPLETED THE DATA COLLECTION PHASE OF THE RESEARCH STUDIES WITH OVER 212,000 CHILDREN ENROLLED AND BEGAN DATA ANALYSIS AND DISSEMINATION EFFORTS. (2) SUPPORTING THE INTRODUCTION AND SCALE-UP OF MALARIA HEALTH PRODUCTS WITH THE AIM OF ELIMINATING THE P. VIVAX STRAIN OF MALARIA. WORKING WITH PARTNERS, WE GENERATED AND SHARED EVIDENCE TO INFORM POLICY AND GUIDELINE CHANGES, SUPPORTED THE REGISTRATION OF RADICAL CURE TOOLS, AND MONITORED THE PRODUCTION OF DIAGNOSTICS AND DRUGS TO MEET MARKET DEMANDS. EPIDEMIC PREPAREDNESS AND RESPONSE IN 2023, PATH'S EPIDEMIC PREPAREDNESS AND RESPONSE (EPR) GLOBAL PROGRAM REMAINED STEADFAST IN ITS COMMITMENT TO ASSISTING MINISTRIES OF HEALTH, AGRICULTURE, ENVIRONMENT, AND OTHER SECTORS TO COMBAT THE URGENT THREATS POSED BY ANTIMICROBIAL RESISTANCE, CLIMATE CHANGE, AND ZOONOTIC DISEASES THROUGH A COMPREHENSIVE ONE HEALTH APPROACH. THESE CHALLENGES DISRUPT ECOSYSTEMS, EXACERBATE NATURAL DISASTERS, AND THREATEN GLOBAL COMMUNITY HEALTH. THIS YEAR, EPR INTENSIFIED ITS FOCUS ON HUMANITARIAN RESPONSE BY DELIVERING CRITICAL TECHNICAL ASSISTANCE TO POPULATIONS MOST AT RISK FROM EMERGING HEALTH THREATS. THE TEAM SUCCESSFULLY CONTINUED TO IMPLEMENT TWO USAID PROJECTSINFECTIOUS DISEASE DETECTION AND SURVEILLANCE (IDDS) AND DISCOVERY AND EXPLORATION OF EMERGING PATHOGENS, VIRAL ZOONOSES (DEEP VZN)IN MULTIPLE COUNTRIES ACROSS AFRICA AND ASIA. WITH THE BACKING OF THE US CDC, PATH COLLABORATED WITH NATIONAL GOVERNMENTS IN SENEGAL, TANZANIA, AND VIETNAM TO BOLSTER THEIR EPIDEMIC PREPAREDNESS AND RESPONSE CAPABILITIES. THIS YEAR ALSO MARKED THE START OF A NEW, AMBITIOUS 5-YEAR USAID-FUNDED PROJECT: LOCALIZING GLOBAL HEALTH SECURITY. THIS INITIATIVE AIMS TO ADVANCE THE LOCALIZATION AGENDA BY DEVELOPING LOCAL CAPACITIES AND STRENGTHENING COMMUNITY-BASED HEALTH SYSTEMS TO IMPROVE THEIR RESILIENCE AGAINST EMERGING HEALTH THREATS. IT ALSO AIMS TO TRAIN LOCAL ACTORS AND INSTITUTIONS, ENSURING THAT KNOWLEDGE, RESOURCES, AND STRATEGIES FOR HEALTH SECURITY ARE DEEPLY ROOTED WITHIN COMMUNITIES. THIS PROJECT WILL PLAY A PIVOTAL ROLE IN ENHANCING LOCAL OWNERSHIP AND SUSTAINABILITY OF HEALTH SECURITY EFFORTS AND FOSTERING A MORE RESPONSIVE AND RESILIENT GLOBAL HEALTH INFRASTRUCTURE, INCLUDING LOCAL CAPACITY TO RESPOND TO REQUESTS FOR PROPOSALS AND IMPLEMENT GRANTS. PATH'S STRATEGIC AND COMPREHENSIVE APPROACH TO EPIDEMIC PREPAREDNESS IS A MODEL OF PROACTIVE AND COLLABORATIVE ACTION, HARNESSING THE POWER OF PARTNERSHIPS AND CUTTING-EDGE INNOVATIONS TO SAFEGUARD GLOBAL HEALTH. IN 2023, THROUGH ROBUST ALLIANCES WITH USAID, THE CDC, THE GATES FOUNDATION, WHO, AND AMAZON, ALONG WITH OTHER KEY PARTNERS, PATH ENABLED NATIONAL AND SUBNATIONAL LEADERS IN 20 COUNTRIES TO SIGNIFICANTLY ENHANCE THEIR EPIDEMIC PREPAREDNESS AND RESPONSE CAPABILITIES. BY REINFORCING DISEASE SURVEILLANCE AND LABORATORY SYSTEMS THROUGH A MULTISECTORAL ONE HEALTH APPROACH, PATH IS DRIVING CRITICAL IMPROVEMENTS IN GLOBAL HEALTH SECURITY. |
| FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: | MALARIA AND NEGLECTED TROPICAL DISEASES PATH PARTNERS WITH GOVERNMENTS, THE PRIVATE SECTOR, AND FUNDERS AROUND THE GLOBE TO BRING THE WORLD CLOSER TO MALARIA ERADICATION. OUR STRATEGY INCLUDES OPTIMIZING THE DELIVERY OF CURRENT TOOLS AND APPROACHES TO ENSURE THEY REACH THE PEOPLE WHO NEED THEM, DESIGNING NEW STRATEGIES AND DEVELOPING NEXT-GENERATION TOOLS TO OVERCOME EMERGING CHALLENGES, AND CREATING INNOVATIVE PARTNERSHIPS AND FUNDING MODELS TO ENSURE OUR PROGRAMS ARE SUSTAINABLE AND EFFECTIVE. IN 2023, OUR MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) PROGRAM CONTINUED TO SUPPORT THE GOVERNMENTS OF THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC), ETHIOPIA, SENEGAL, AND ZAMBIA TOWARD THEIR MALARIA ELIMINATION GOALS. MACEPA CONTINUED TO SUPPORT NATIONAL MALARIA PROGRAMS WITH THE AVAILABILITY AND USE OF HIGH-QUALITY DATA FOR DECISION-MAKING. THIS INCLUDED THE DEVELOPMENT AND STRENGTHENING OF DATA REPOSITORIES, AS WELL AS IMPROVING DATA QUALITY ACROSS EACH GEOGRAPHY. MACEPA PROVIDED TECHNICAL ASSISTANCE AND EXPERTISE TO TAILOR SUBNATIONAL INTERVENTIONS BASED ON RISK STRATIFICATION MAPS AND MODELING OF OPTIMAL INTERVENTION MIXES ACROSS ALL GEOGRAPHIES. ADDITIONALLY, MACEPA SUPPORTED THE PRIORITIZATION AND FUNDING OF TARGETED CONTROL STRATEGIES FOR HIGH-RISK POPULATIONS IN SENEGAL AND ETHIOPIA. MACEPA ALSO CONDUCTED EXPLORATORY ACTIVITIES IN MALAWI AND NIGERIA. FOR EXAMPLE, IN MALAWI, THEY QUANTIFIED COMMUNITY CASE MANAGEMENT NEEDS AND GAPS THROUGH LANDSCAPING AND BENCHMARKING ANALYSES. IN NIGERIA, MACEPA PARTNERED WITH THE NATIONAL MALARIA PROGRAM TO DEVELOP, VALIDATE, AND COST A SURVEILLANCE ROADMAP. THESE ACTIVITIES AIMED TO INFORM THE TECHNICAL ASSISTANCE NEEDS AND RECOMMENDATIONS FOR THESE GEOGRAPHIES. THE PROGRAM FOR ADVANCEMENTS OF MALARIA OUTCOMES (PAMO) PLUS PROJECT, FUNDED BY THE US PRESIDENT'S MALARIA INITIATIVE (PMI), PROVIDED TECHNICAL AND MATERIAL ASSISTANCE TO THE ZAMBIA MINISTRY OF HEALTH FOR MALARIA CASE MANAGEMENT, MALARIA IN PREGNANCY, SOCIAL BEHAVIOR CHANGE, DISEASE SURVEILLANCE, AND DATA MANAGEMENT AND USE. WORK IN 2023 INVOLVED MENTORING HEALTH WORKERS IN THE PROJECT'S FOUR FOCUS PROVINCES TO ENSURE ADHERENCE TO MALARIA CASE MANAGEMENT STANDARDS. THEY ALSO TRAINED, DEPLOYED, AND SUPPORTED COMMUNITY HEALTH WORKERS WHO TEST AND TREAT MALARIA AT THE COMMUNITY LEVEL. ADDITIONALLY, PAMO PLUS WORKED WITH ANTENATAL CARE PROVIDERS AND SAFE MOTHERHOOD ACTION GROUP MEMBERS TO INCREASE UPTAKE OF INSECTICIDE-TREATED NETS AND INTERMITTENT PRESUMPTIVE TREATMENT OF MALARIA AMONG PREGNANT WOMEN TO PREVENT MALARIA IN PREGNANCY. PAMO PLUS SUPPORTED IN DEVELOPING COMMUNITY ENGAGEMENT PLANS, PROVIDED ORIENTATION FOR COMMUNITY CHANGE AGENTS, CONDUCTED DATA QUALITY AUDITS, AND TRAINED MINISTRY OF HEALTH (MOH) STAFF IN DATA MANAGEMENT AND MENTORSHIP. PAMO PLUS CONTINUED IMPLEMENTING A MALARIA PRE-ELIMINATION PROGRAM, CONDUCTING RESEARCH IN LOW-BURDEN DISTRICTS OF EASTERN PROVINCE, ZAMBIA. IN SINDA DISTRICT, THEY INTRODUCED MALARIA CASE INVESTIGATION AND SINGLE LOW-DOSE PRIMAQUINE IN AN EFFORT TO ELIMINATE MALARIA. PAMO PLUS ALSO BEGAN SUPPORTING THE MOH THROUGH THE EXPANDED PROGRAM ON IMMUNIZATION AND THE NATIONAL MALARIA ELIMINATION PROGRAM TO PREPARE FOR THE INTRODUCTION OF THE MALARIA VACCINE. IN 2023, PATH CONCLUDED THE PRODUCT EVALUATION COMPONENTS OF THE NEW NETS PROJECT, WHICH WAS FUNDED BY UNITAID AND THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND). THE EVIDENCE GENERATED BY THE PROJECT SHOWED THAT THE NEWEST GENERATION OF BEDNETS, WHICH CONTAIN NOVEL COMBINATIONS OF INSECTICIDES INSTEAD OF JUST A SINGLE INSECTICIDE, ARE MORE EFFECTIVE AT PREVENTING MALARIA ACROSS AFRICA. THIS FINDING WAS AN INTEGRAL PART OF THE PACKAGE OF EVIDENCE THAT LED TO UPDATED WHO MALARIA CONTROL GUIDELINES. IN ZAMBIA, PATH LED THE DESIGN AND IMPLEMENTATION OF LABORATORY AND FIELD ACTIVITIES TO TEST ANOTHER NEW TOOL FOR MALARIA VECTOR CONTROL, KNOWN AS THE ATTRACTIVE TARGETED SUGAR BAIT (ATSB). WE COORDINATED PARTNERS WORKING ON ATSB RESEARCH IN KENYA, MALI, AND ZAMBIA. UNDER THE RAPID MALARIA ASSESSMENTS TO SUPPORT APPROPRIATELY TAILORED SUBNATIONAL INTERVENTION PACKAGES IN BURKINA FASO PROJECT, FUNDED BY THE GATES FOUNDATION, PATH ALSO PROVIDED TECHNICAL SUPPORT TO THE CENTRE NATIONAL DE RECHERCHE ET DE FORMATION SUR LE PALUDISME. THE OBJECTIVE WAS TO EXPLORE NEW DATA SOURCES, COLLECTION METHODS, AND INDICATORS TO PROVIDE GRANULAR AND TIMELY DATA FOR DECISION-MAKING, INCLUDING TO SUPPORT SUBNATIONAL PLANNING AND GLOBAL FUND GRANT ASSESSMENTS. THE FINAL RESULTS WERE PRESENTED TO THE GLOBAL FUND TECHNICAL TEAMS. THE INPUTS WERE INTEGRATED INTO FINAL REPORTS SUBMITTED FOR THE CLOSE-OUT OF THE PROJECT. PATH ALSO LED A USAID INITIATIVE TO SUPPORT MALARIA OPERATIONAL RESEARCH AND PROGRAM EVALUATION. UNDER THE PMI INSIGHTS PROJECT, PATH COORDINATED THE WORK OF SEVERAL PARTNERS TO STRENGTHEN NATIONAL POLICIES, STRATEGIES, AND GUIDELINES FOR MALARIA CONTROL AND ELIMINATION. IN THE DRC, PATH CONTINUED TO SUPPORT THE RECENTLY CREATED NATIONAL PUBLIC HEALTH INSTITUTE'S EFFORTS TO SET UP A SINGLE, CENTRAL EMERGENCY OPERATIONS CENTER (EOC). THE PURPOSE IS TO MANAGE THE MULTIPLE HEALTH EMERGENCIES THAT THE DRC HAS TO MANAGE, INCLUDING DEVELOPING AN INTEGRATED DATA PLATFORM TO SUPPORT DECISION-MAKING THAT INTEGRATES MALARIA AND POLIO. IN VIETNAM, PATH SUPPORTED THE INTEGRATION OF MALARIA INTO THE PUBLIC HEALTH EOC TO STRENGTHEN MALARIA SURVEILLANCE AND RESPONSE AND SUPPORT MALARIA ELIMINATION EFFORTS. PATH'S LABORATORY TEAM AT THE NATIONAL MALARIA ELIMINATION CENTRE IN LUSAKA, ZAMBIA, IS LEVERAGING THE COST-EFFECTIVE AND SCALABLE ANTIMALARIAL DRUG RESISTANCE ASSAY FOR P. FALCIPARUM MALARIA USING NANOPORE SEQUENCING TO CREATE A GENOTYPIC DRUG RESISTANCE PROFILE FOR THE COUNTRY. IN 2023, WITH FUNDING FROM THE GATES FOUNDATION, THE TEAM CONTINUED TO INTEGRATE NANOPORE SEQUENCING INTO ROUTINE MALARIA SURVEILLANCE IN ZAMBIA. THEY ALSO MADE GAINS IN CAPACITY-BUILDING AT PARTNER INSTITUTIONS IN THE DRC, KENYA, AND NAMIBIA TO SUPPORT LEVERAGING NANOPORE SEQUENCING ASSAYS TO IMPROVE AND EXPAND MALARIA SURVEILLANCE IN THESE LOCATIONS. THE VIVACTION PROJECT WORKS TO CATALYZE ADOPTION AND EVENTUAL SCALE-UP OF NEW TOOLS FOR P. VIVAX, INCLUDING THE DRUG TAFENOQUINE AND G6PD DIAGNOSTICS. THE GOAL IS TO SUPPORT UNIVERSAL ACCESS TO BEST PRACTICES FOR P. VIVAX CASE MANAGEMENT. IN ETHIOPIA, PATH HAS BEEN STUDYING THE OPERATIONAL FEASIBILITY OF INTEGRATING NEW RADICAL CURE TREATMENT OPTIONS INTO THE CASE MANAGEMENT OF P. VIVAX PATIENTS AS PART OF A REVISED TREATMENT ALGORITHM. IN 2023, PATH ADVANCED THE COUNTRY PROTOCOL TO PASS THROUGH THE NECESSARY ETHICS AND REGULATORY APPROVAL PROCESSES. REVIEWS AND FEEDBACK RESPONSES HAVE BEEN ONGOING AT DIFFERENT STAGES, AND PATH WAS ABLE TO OBTAIN APPROVALS FROM THE IMPLEMENTING PARTNER'S INSTITUTIONAL REVIEW BOARD, NATIONAL RESEARCH ETHICS REVIEW BOARD, WORLD HEALTH ORGANIZATION, AND THE ETHIOPIAN FOOD AND DRUG ADMINISTRATION AUTHORITY. PATH, BY GENERATING NATIONAL LANDSCAPE EVIDENCE AND DISSEMINATING IT WITH STAKEHOLDERS, ALSO LEADS INTEGRATION OF PHARMACOVIGILANCE (PV) IN A NATIONAL OFFICIAL DOCUMENT: 20242026 MALARIA NATIONAL STRATEGIC PLAN. AS PART OF THE PREPARATORY ACTIVITIES FOR THE OPERATIONAL FEASIBILITY STUDY IN 2024, PATH HAS BEEN WORKING WITH STAKEHOLDERS TO PROVIDE THE NECESSARY STUDY TOOLS, ESTABLISHING OVERSIGHT COMMITTEES, LEADING CONSULTATIVE WORKSHOPS WITH STAKEHOLDERS, AND DEVELOPING AND VALIDATING TRAINING MATERIALS WITH THE NATIONAL MALARIA ELIMINATION PROGRAM. IN INDIA, PATH PROVIDED STRATEGIC TECHNICAL ASSISTANCE AT THE NATIONAL AND SELECTED STATE LEVEL FOR BOTH NEGLECTED TROPICAL DISEASE (NTD) PROGRAM AND MALARIA ELIMINATION ACTIVITIES. OUR SPECIFIC SUPPORT TO VECTOR-BORNE DISEASE CONTROL PROGRAMS IN SELECTED STATES INCLUDED VISCERAL LEISHMANIASIS (VL) ELIMINATION, LYMPHATIC FILARIASIS (LF) ELIMINATION, MALARIA ELIMINATION, AND DENGUE-CHIKUNGUNYA CONTROL ACTIVITIES THROUGH CAPACITY-BUILDING, OUTBREAK INVESTIGATION AND RESPONSE, MONITORING/SUPPORTIVE SUPERVISION, VECTOR CONTROL, AND DATA MANAGEMENT FOR ENABLING EVIDENCE-BASED POLICY DECISION-MAKING AT MULTIPLE LEVELS. PATH ALSO SUPPORTED THE STATE OF UTTAR PRADESH IN SUSTAINING ELIMINATION-LEVEL TRANSMISSION OF VL IN VL-ENDEMIC DISTRICTS THROUGH DISEASE SURVEILLANCE AND VECTOR CONTROL MEASURES BY THE STATE HEALTH SYSTEM. IN ADDITION, IN 2023 PATH PROVIDED TECHNICAL SUPPORT FOR LF ELIMINATION THROUGH IMPLEMENTING A MASS DRUG ADMINISTRATION (MDA) CAMPAIGN THAT ADMINISTERED PROPHYLACTIC TREATMENT TO APPROXIMATELY 115 MILLION PEOPLE. IN UTTAR PRADESH, PATH SUPPORTED THE STATE HEALTH SYSTEM IN REDUCING THE CASE FATALITY RATIO FROM ACUTE ENCEPHALITIS SYNDROME TO LESS THAN 1% BY ESTABLISHING FUNCTIONAL ENCEPHALITIS TREATMENT CENTERS FOR EFFECTIVE CASE MANAGEMENT AND TIMELY REFERRAL SERVICES. |
| FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: | IN 2023, THE USAID SURVEILLANCE FOR MALARIA ELIMINATION (S4ME) ACTIVITY SUPPORTED MALARIA ELIMINATION EFFORTS IN ETHIOPIA BY DESIGNING AND TESTING EFFECTIVE SURVEILLANCE ACTIVITIES FOR ELIMINATION AT THE WOREDA (DISTRICT) LEVEL, INCLUDING HEALTH FACILITIES AND COMMUNITY PLATFORMS; SUPPORTING THE IDENTIFICATION AND TIMELY REPORTING OF MALARIA CASES BY UTILIZING REAL-TIME DATA FROM DIGITAL SYSTEMS TO INVESTIGATE AND CLASSIFY MALARIA CASES; AND SUPPORTING THE IMPLEMENTATION OF TARGETED MALARIA ELIMINATION INTERVENTIONS. DURING 2023, THROUGH FUNDING FROM GIVEWELL, PATH IMPLEMENTED THE PILOT PERENNIAL MALARIA CHEMOPREVENTION (PMC) INTERVENTION IN THE DRC TO CHILDREN UNDER TWO YEARS OF AGE AT ROUTINE VACCINATION VISITS. THE MAJORITY OF THE YEAR WAS SPENT PREPARING FOR IMPLEMENTATION (E.G., HIRING STAFF, PREPARING DATA COLLECTION AND REPORTING TOOLS), AS THE INTERVENTION OFFICIALLY BEGAN IN DECEMBER 2023. UNDER THE LEADERSHIP OF THE WORLD HEALTH ORGANIZATION AND WITH FUNDING FROM THE GATES FOUNDATION, PATH WORKED WITH NATIONAL NEGLECTED TROPICAL DISEASE (NTD) PROGRAMS IN SEVERAL COUNTRIES AND OTHER STAKEHOLDERS TO DESIGN AN INTEGRATED POST-VALIDATION/VERIFICATION SURVEILLANCE PLANNING TOOLKIT FOR NTDS WITH A SPECIFIC FOCUS ON ONCHOCERCIASIS AND LYMPHATIC FILARIASIS. IN MYANMAR PATH CONTINUED TO SUPPORT THE IMPLEMENTATION OF PMI'S ELIMINATE MALARIA PROJECT, WHICH AIMS TO CONTRIBUTE TO THE ELIMINATION OF INDIGENOUS TRANSMISSION OF P. FALCIPARUM MALARIA BY 2023 AND PUT MYANMAR ON THE PATH TO ELIMINATING ALL HUMAN MALARIA BY 2030. IN 2023, PATH ALSO PROVIDED TECHNICAL ASSISTANCE FOR THE ASSESSMENT OF EMERGENCY RESPONSE CAPABILITY AND DEVELOPED A STRATEGY FOR A MALARIA OUTBREAK DETECTION AND RESPONSE SYSTEM. ADDITIONALLY, PATH SUPPORTED AN ASSESSMENT OF FEASIBILITY TO DEVELOP AN APPROACH FOR THE PREVENTION OF RE-INTRODUCTION AND RE-ESTABLISHMENT OF MALARIA. PATH CONDUCTED THE ASSESSMENTS OF RECEPTIVITY, VULNERABILITY, HEALTH CARE QUALITY, AND COMMUNITY BEHAVIOR IN TWO TOWNSHIPS OF RAKHINE STATE, PRODUCING MALARIA RISK ASSESSMENT REPORTS FOR THOSE AREAS. PATH ALSO INTRODUCED NEW TOOLS AND APPROACHES IN MALARIA TREATMENT BY GENERATING AND MAKING AVAILABLE HIGH-QUALITY EVIDENCE FOR IMPLEMENTATION AND SCALE-UP AND OPTIMIZING THE RADICAL CURE FOR P. VIVAX. IN 2023, PATH WAS AWARDED THE FIVE-YEAR REACH MALARIA (REACHING EVERY AT-RISK COMMUNITY AND HOUSEHOLD WITH MALARIA SERVICES) CONTRACT BY USAID/PMI. THE PROJECT WILL PROVIDE IMPLEMENTATION SUPPORT AND TECHNICAL ASSISTANCE TO MINISTRIES OF HEALTH, LOCAL PARTNERS, AND THE GLOBAL MALARIA COMMUNITY IN UP TO 27 PMI PRIORITY COUNTRIES TO ACCELERATE PROGRESS IN PLANNING, DELIVERY, AND MONITORING OF FACILITY- AND COMMUNITY-BASED MALARIA SERVICES. EARLY CHILDHOOD DEVELOPMENT ACTION NETWORK IN 2023, THE EARLY CHILDHOOD DEVELOPMENT ACTION NETWORK (ECDAN), HOSTED BY PATH, CONTINUED TO ADVOCATE FOR YOUNG CHILDREN AND THEIR CAREGIVERS BY ELEVATING KEY POLICY PRIORITIES, SUCH AS CHILDCARE, PARENTING SUPPORT, AND CLIMATE CHANGE, WHILE ADOPTING A SYSTEMS APPROACH TO EARLY CHILDHOOD DEVELOPMENT (ECD) AND INCREASING FINANCING FOR THE EARLY YEARS. ECDAN PARTNERS PARTICIPATED IN HIGH-LEVEL GLOBAL EVENTS TO RAISE AWARENESS, MOBILIZE ACTION, AND ADVANCE POLICY. JOINT ADVOCACY EFFORTS LED TO A SIGNIFICANT BREAKTHROUGH IN CLIMATE CHANGE WHEN COP28 COMMITTED TO HOLDING AN EXPERT DIALOGUE ON THE DISPROPORTIONATE IMPACT OF CLIMATE CHANGE ON CHILDREN AND EXPLORING RELEVANT POLICY SOLUTIONS. THE GLOBAL CHILDCARE CAMPAIGN COLLABORATED WITH GENDER EMPOWERMENT AND LABOR MOVEMENTS TO ELEVATE THE IMPORTANCE OF CHILDCARE AT THE WOMEN DELIVER CONFERENCE. ECDAN ALSO CONTRIBUTED TO THE DRAFTING OF A GLOBAL ROADMAP FOR ACTION ON CARE AND STRENGTHENED RELATIONSHIPS AND COLLABORATION ACROSS SECTORS. ECDAN CONTINUED TO BUILD ON SUCCESSFUL MODELS FOR KNOWLEDGE DISSEMINATION AND FACILITATED DISCUSSIONS BY COORDINATING WORKING GROUPS, HOSTING WEBINARS AND EVENTS, PUBLISHING NEWSLETTERS AND PARTNER STORIES, AND ADDING TO THE ECD KNOWLEDGE GATEWAY. ECDAN RECRUITED A THIRD COHORT OF EARLY-CAREER ECD PROFESSIONALS FOR THE KNOWLEDGE FELLOWS PROGRAM. EACH FELLOW CO-CREATED A PROJECT PLAN WITH THE SECRETARIAT AND WAS THEN MATCHED WITH A SEASONED ECD PROFESSIONAL FOR MENTORING, NETWORKING, AND PROFESSIONAL DEVELOPMENT. THE GLOBAL INITIATIVE TO SUPPORT PARENTS, ONE OF ECDAN'S COLLABORATIVE INITIATIVES, LAUNCHED ITS KNOWLEDGE PLATFORM AND HOSTED THE FIRST ANNUAL GLOBAL PARENTING TOWNHALL TO ALLOW COUNTRIES TO SHARE THEIR WORK, PRIORITIES, CHALLENGES, AND SUCCESS STORIES ON PARENTING AND CAREGIVING. ECDAN WORKED WITH THE HARNESSING GLOBAL DATA FOR YOUNG CHILDREN COALITION TO CO-HOST A HIGH-LEVEL EVENT WITH THE GOVERNMENT OF RWANDA AND OTHERS TO DISCUSS HOW TO MEASURE ECD OUTCOMES AT THE COUNTRY LEVEL FOR EASTERN AND SOUTHERN AFRICA. ECDAN ALSO CO-CONVENED MEMBERS OF THE BANGLADESH EARLY CHILDHOOD DEVELOPMENT IN EMERGENCIES WORKING GROUP IN COX'S BAZAR TO DISCUSS SYSTEMS THINKING AS A TOOL FOR STRENGTHENING HUMANITARIAN SYSTEMS AND IMPROVING SUPPORT FOR YOUNG CHILDREN AND THEIR FAMILIES. IN JUNE, ECDAN BEGAN A SIX-MONTH PARTICIPATORY AND INCLUSIVE PROCESS TO REFRESH ITS STRATEGY FOR THE NEXT FIVE YEARS WITH CONSULTATIONS WITH THE EXECUTIVE LEADERSHIP COUNCIL, PARTNERS, AND OTHER STAKEHOLDERS. PRIMARY HEALTH CARE PATH'S PRIMARY HEALTH CARE (PHC) PROGRAM EMPLOYS A COMPREHENSIVE, ONE HEALTH, PEOPLE- AND COMMUNITY-CENTERED PHC MODEL THAT ADDRESSES BROADER DETERMINANTS OF HEALTH (E.G., SOCIAL, ECONOMIC, ENVIRONMENTAL). WE FOCUS ON INNOVATIVE, EVIDENCE-BASED TOOLS AND APPROACHES TO MEET PEOPLE'S NEEDS AND PREFERENCES ACROSS THEIR LIFETIME. PHC AT PATH IS COMPOSED OF SIX TEAMS(1) MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION; (2) EARLY CHILDHOOD DEVELOPMENT; (3) HEALTH SYSTEMS; (4) HIV, TUBERCULOSIS, AND VIRAL HEPATITIS; (5) NONCOMMUNICABLE DISEASES; (6) SEXUAL AND REPRODUCTIVE HEALTH--WHICH ARE DESCRIBED BELOW. (1) MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION TOGETHER WITH PARTNERS AROUND THE WORLD, PATH'S MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION (MNCHN) TEAM DEVELOPS, ADAPTS, AND SCALES UP TECHNOLOGIES AND SYSTEMS TO REDUCE ILLNESS AND DEATH AMONG MOTHERS AND CHILDREN AND GIVE CHILDREN THE BEST POSSIBLE START IN LIFE. TO ENSURE OPTIMAL NEWBORN NUTRITION, PATH FOCUSES ON PROMOTING BREASTFEEDING, PROVIDING SPECIALIZED LACTATION SUPPORT FOR MOTHERS OF SMALL AND SICK NEWBORNS, ENSURING THE AVAILABILITY OF SAFE DONOR MILK THROUGH LOCAL HUMAN MILK BANKS, AND ENCOURAGING THE UPTAKE AND USE OF GLOBAL STANDARDS FOR HUMAN MILK BANKING. IN 2023, PATH CONTINUED AS THE COORDINATING BODY TO ADVANCE WHO HUMAN MILK BANKING AND DONOR HUMAN MILK STANDARDS. PATH FACILITATED A VIRTUAL CONVENING OF A GUIDELINE DEVELOPMENT GROUP AND ALSO ISSUED A CALL FOR AUTHORS TO CONDUCT SYSTEMATIC REVIEWS. WHO STANDARDS ARE ANTICIPATED FOR RELEASE IN EARLY 2025. PATH CONTINUED A GLOBAL STUDY ON THE COMPOSITION OF DONOR MILK DURING THE ANALYSIS PERIOD AND PRESENTED THE FINDINGS TO THE HUMAN MILK BANKING ASSOCIATION OF NORTH AMERICA. PATH CONTINUED TO ADVANCE A GLOBAL CURRICULUM ON SPECIALIZED LACTATION SUPPORT FOR MOTHERS OF SMALL AND SICK NEWBORNS, FUNDED BY USAID. RELATED, PATH BEGAN PROVIDING TECHNICAL SUPPORT BY TAILORING THE CURRICULUM WITHIN RESEARCH LED BY ARIADNE LABS AND ADDIS ABABA UNIVERSITY FOCUSED ON INFANT NUTRITION. IN GHANA, PATH IS LEADING A FOUR-YEAR EFFORTADVANCED NEWBORN CARE IN GHANA: BEYOND MAKING EVERY BABY COUNT INITIATIVE (MEBCI 2.0)TO REDUCE PERINATAL MORTALITY IN FOUR HIGH-VOLUME REFERRAL HOSPITALS: RIDGE HOSPITAL (ALSO KNOWN AS THE GREATER ACCRA REGIONAL HOSPITAL), TEMA GENERAL HOSPITAL, EASTERN REGIONAL HOSPITAL (KOFORIDUA), AND BONO REGIONAL HOSPITAL (SUNYANI). IN COLLABORATION WITH THE GHANA HEALTH SERVICE (GHS), PATH IS FOCUSING ON ADVOCACY, POLICY, AND PROCUREMENT OF LIFESAVING NEONATAL EQUIPMENT TO IMPROVE ADVANCED NEONATAL CARE IN ALL FOUR HOSPITALS. AS PART OF THE INITIATIVE, PATH HAS INSTALLED EQUIPMENT IN FOUR FACILITIES AND TRAINED HOSPITAL STAFF ON ITS PROPER USE. ADDITIONALLY, PATH AND GHS DEVELOPED A COMPREHENSIVE TRAINING MANUAL, IN PARTNERSHIP WITH KYBELE, OUR IMPLEMENTING PARTNER, TO ORIENT NURSES AT ANTENATAL AND POSTNATAL CARE DELIVERY POINTS. THE MANUAL WAS ALSO USED TO ORIENT FACILITY AND DISTRICT HEALTH PROMOTION OFFICERS, AS WELL AS REGIONAL NEWBORN CHAMPIONS, ON THE IMPORTANCE OF THE CONTINUUM OF CARE FOR SMALL AND SICK NEWBORNS. |
| FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: | PATH ALSO DOCUMENTED FOUR CASE STUDIES ON FREQUENT STAFF ROTATION IN THE FOUR TARGET HOSPITALS. THE DOCUMENT WAS PRESENTED TO GHS TO DEVELOP GUIDELINES TO HELP REGULATE STAFF ROTATION, PARTICULARLY SPECIALIZED STAFF IN NEONATAL INTENSIVE CARE UNITS AND MATERNITY WARDS. PATH HAS ALSO TRANSLATED THREE VIDEOS ON THE CARE OF SICK AND SMALL NEWBORNS INTO TWO GHANAIAN LANGUAGES TO ENHANCE EDUCATION AT ANTENATAL AND POSTNATAL CLINICS IN THE PROJECT FACILITIES AS WELL AS OTHER NEARBY FACILITIES. THE VIDEOS, ORIGINALLY MADE AND SHARED ONLINE BY GLOBAL HEALTH MEDIA PROJECT, WERE TRANSLATED INTO TWI AND GA LANGUAGES. PATH RESPIRATORY THERAPISTS SUPPORTED AFRICAN HEALTH SUPPLIES TO UNDERTAKE TWO ROUNDS OF TRAINING FOR 30 CLINICAL ENGINEERS AND CRITICAL CARE PROVIDERS IN THE NEONATAL INTENSIVE CARE UNITS OF THE FOUR PROJECT HOSPITALS AND ONE AT THE NATIONAL LEVEL. THEY WERE TRAINED TO USE, MAINTAIN, CLEAN, TROUBLESHOOT, AND FIX MINOR PROBLEMS ON FIREFLY AND COLIBRI PHOTOTHERAPY DEVICES, DOLPHIN CPAP, RADIANT WARMERS, PATIENT MONITORS, AND INCUBATORS. PATH ALSO DEVELOPED VIDEO DOCUMENTATION OF VARIOUS ACTIVITIES WITHIN THE MEBCI 2.0 PROJECT DEPICTING IMMEDIATE OUTPUTS OF THE INITIATIVE. THE VIDEO INCLUDED PERSPECTIVES FROM HEALTH PROVIDERS IN THE PROJECT FACILITIES, POLICYMAKERS, AND PRIMARY BENEFICIARIES. THE MEBCI 2.0 PROJECT STRENGTHENED GHANA'S NEWBORN CARE SUBCOMMITTEE AND SUPPORTED ORGANIZATION OF THREE MEETINGS IN 2023. DURING THESE MEETINGS, THE NEWBORN CARE POLICY WAS EXAMINED AND A REVIEW WAS PROPOSED. MEBCI 2.0 ALSO SUPPORTED THE ANNUAL NATIONAL NEWBORN HEALTH CONFERENCE IN CAPE COAST IN 2023, IN WHICH OVER 300 HEALTH CARE WORKERS, NEWBORN CARE CHAMPIONS, AND POLICYMAKERS TOOK PART. IN THIS CONFERENCE, EXPERIENCES, INNOVATIONS, CHALLENGES, LESSONS, AND PROJECTIONS IN NEWBORN CARE WERE SHARED, INFORMING PLANS FOR 2024. THE PROJECT ALSO SUPPORTED THE 2023 MATERNAL HEALTH CONFERENCE, DURING WHICH PLANS TO IMPROVE MATERNAL HEALTH AND DELIVERY OUTCOMES WERE MADE. IN COLLABORATION WITH THE GHANA HEALTH SERVICE AND WITH FUNDING FROM THE PFIZER FOUNDATION, PATH CONTINUED IMPLEMENTING THE INTEGRATED ANTENATAL CARE PROJECT IN THE BONO EAST REGION OF GHANA. THE PROJECT AIMS TO AVERT INFECTIOUS DISEASE MORTALITY AND MORBIDITY IN NEONATES AND MOTHERS BY IMPLEMENTING AN IMPROVED, COMPREHENSIVE INFECTIOUS DISEASE SCREENING PROGRAM DURING PREGNANCY. AS OF DECEMBER 2023, NEARLY 20,000 WOMEN HAVE BEEN SCREENED FOR INFECTIONS, INCLUDING SEXUALLY TRANSMITTED INFECTIONS AND URINARY TRACT INFECTIONS. NEARLY 700 HEALTH WORKERS HAVE BEEN TRAINED IN SCREENING AND MANAGING MATERNAL INFECTIONS, WITH A FURTHER 338 HEALTH PROMOTION OFFICERS, COMMUNITY HEALTH NURSES, AND COMMUNITY MOBILIZERS TRAINED IN SOCIAL AND BEHAVIOR CHANGE COMMUNICATION (SBCC) APPROACHES. MORE THAN 740,000 COMMUNITY MEMBERS WERE REACHED THROUGH COMMUNITY MOBILIZATION, OUTREACH, AND SENSITIZATION ACTIVITIES INCLUDING MASS MEDIA CAMPAIGNS FOR DEMAND CREATION. ADDITIONALLY IN GHANA, BUILDING ON EARLIER WORK AROUND OPTIMIZING THE ANTENATAL CARE PLATFORM, PATH WAS AWARDED NEW FUNDING BY THE PFIZER FOUNDATION IN MAY 2023 TO INVESTIGATE THE FEASIBILITY OF USING THE ANTENATAL CARE PLATFORM FOR THE INTRODUCTION AND SCALE-UP OF ADDITIONAL MATERNAL VACCINES. IN 2023, THE ACTIVITIES CONDUCTED UNDER THIS GRANT RELATED PRIMARILY TO LAYING THE GROUNDWORK FOR FORMATIVE RESEARCH INCLUDING PROTOCOL DEVELOPMENT AND PARTNER IDENTIFICATION. IN LAOS, PATH SERVED AS A SHORT-TERM TECHNICAL ASSISTANCE PARTNER TO JOHN SNOW INC. (JSI) ON A USAID MATERNAL, NEWBORN, AND CHILD HEALTH PROJECT OPERATING FROM SEPTEMBER 2021 TO AUGUST 2026 ACROSS FIVE PROVINCES IN THE NORTH, CENTRAL, AND SOUTH REGIONS OF THE COUNTRY. PATH'S CORE TECHNICAL RESPONSIBILITIES FOCUSED ON NEWBORN AND CHILD HEALTH, NUTRITION, AND ECD. LAOS MOH OPERATIONAL REQUIREMENTS SHIFTED TO ALLOW ONLY ONE IMPLEMENTING PARTNER ON THIS USAID AWARD AND AS A RESULT, PATH'S ROLE WAS UNEXPECTEDLY ELIMINATED. PATH WORKED CLOSELY WITH JSI AND USAID TO ENSURE HIGH-QUALITY CLOSE-OUT OF OUR ROLE IN THIS PROJECT IN 2023. RECOGNIZING THAT NUTRITION IS AFFECTED BY A VARIETY OF ECONOMIC AND ENVIRONMENTAL FACTORS, PATH'S NUTRITION TEAM DRIVES NOVEL APPROACHES TO ADDRESS THE MASSIVE BURDEN OF MALNUTRITION IN COMMUNITIES AROUND THE WORLD. TOGETHER WITH PATH'S CLIMATE CHANGE COMMUNITY OF PRACTICE, PATH'S NUTRITION TEAM CONTINUED TO ADVOCATE FOR SUSTAINABLE CLIMATE-FRIENDLY ALTERNATIVES, SUCH AS CULTURED PROTEINS AND EDIBLE INSECTS, INCLUDING INITIATING RESEARCH ACTIVITIES IN MADAGASCAR WITH PARTNERS FROM CORNELL UNIVERSITY. WHERE POLICY OR GUIDELINES SUPPORTING FORTIFIED RICE ALREADY EXISTED, PATH CONTINUED ITS WORK WITH GOVERNMENTS, THE PRIVATE SECTOR, THE WORLD FOOD PROGRAM, AND NONGOVERNMENTAL ORGANIZATIONS (NGOS) ON ROLLOUT. AS A PARTNER IN THE DEMOGRAPHIC AND HEALTH SURVEYS PROGRAM, PATH SUPPORTED BIOMARKER DATA COLLECTION INCLUDING BOTH STANDARDIZED, ROUTINE MONITORING OF KEY NUTRITION INDICATORS LIKE STUNTING AND ANEMIA AND INNOVATIONS TO EXPAND BIOMARKER MEASUREMENT IN HOUSEHOLD-BASED SURVEYS CONDUCTED AROUND THE WORLD. (2) EARLY CHILDHOOD DEVELOPMENT (ECD) IN 2023, PATH WORKED WITH A CONSTELLATION OF PARTNERS IN ETHIOPIA, KENYA, AND MOZAMBIQUE TO FACILITATE COLLECTIVE ACTION AT NATIONAL AND SUBNATIONAL LEVELS TO PROMOTE ECD THROUGH ENHANCED PLANNING, COORDINATION, AND RESOURCING, WHILE ALSO TRANSITIONING KEY IMPLEMENTATION WORKSTREAMS TO GOVERNMENT OWNERSHIP. PATH ALSO CONDUCTED MULTIPLE ROUNDS OF HUMAN-CENTERED DESIGN TO IMPROVE THE QUALITY OF ECD SERVICE DELIVERY. PATH ENGAGED COMMUNITIES, SERVICE PROVIDERS, AND KEY STAKEHOLDERS TO DETERMINE SPECIFIC TOUCHPOINTS AND REFINED SOLUTIONS THAT MAXIMIZE CAREGIVER EXPOSURE TO ECD MESSAGES AND IMPROVE ADOPTION OF KEY BEHAVIORS. ADDITIONALLY, PATH HAS STARTED LANDSCAPING CHILDCARE MODELS IN GHANA THAT STRENGTHEN LINKAGES WITH EXISTING PRIMARY HEALTH CARE SERVICES. DATA FROM THE LANDSCAPING WILL BE USED TO DESIGN DEMONSTRATION PILOTS. (3) HEALTH SYSTEMS THE HEALTH SYSTEMS TEAM SERVES AS AN ORGANIZING MECHANISM FOR PATH PROJECTS AND INITIATIVES THAT STRENGTHEN HEALTH SYSTEMS AND CONTRIBUTE TO STRONGER PRIMARY HEALTH CARE. BOTH WITHIN PATH AND IN COLLABORATION WITH EXTERNAL PARTNERS, THE TEAM LEADS COMPLEX EVALUATIONS OF HEALTH PROGRAMS, ENGAGES IN IMPLEMENTATION RESEARCH, FACILITATES INTERVENTION SCALE-UP, AND IMPROVES DATA QUALITY AND USE FOR DECISION-MAKING. IN 2023, CONTINUATION OF MAJOR ACTIVITIES INCLUDED (1) LEADERSHIP OF MONITORING, EVALUATION, AND LEARNING WITHIN USAID'S MOMENTUM ROUTINE IMMUNIZATION TRANSFORMATION AND EQUITY (M-RITE) PORTFOLIO ACROSS SEVERAL COUNTRIES IN AFRICA AND SOUTHEAST ASIA; (2) IMPLEMENTATION OF THE THIRD PHASE OF THE GATES FOUNDATION-SUPPORTED MATERNAL, NEWBORN, AND CHILD HEALTH AND NUTRITION ASSET TRACKER, INCLUDING THE ADDITION OF EIGHT ASSETS; AND (3) TECHNICAL BACKSTOPPING OF THE SENEGAL COUNTRY PROGRAM IN IMPLEMENTING THE USAID URBAN HEALTH SYSTEM STRENGTHENING PROJECT IN DAKAR. IN 2023, THE HEALTH SYSTEMS TEAM LAUNCHED A NEW FIVE-YEAR LEARNING GRANT FROM THE GATES FOUNDATION: ROUTINE IMMUNIZATION STRENGTHENING IN HIGH-RISK POLIO GEOGRAPHIES (RISP). THIS PROJECT FOCUSED ON DRC, NIGER, PAKISTAN, AND SOMALIA. THROUGHOUT 2023, THE TEAM CONTINUED TO SUPPORT BUSINESS DEVELOPMENT EFFORTS, INCLUDING POSITIONING FOR SEVERAL USAID HEALTH SYSTEMS STRENGTHENING (HSS) OPPORTUNITIES ON THE HORIZON IN 2024. (4) HIV, TUBERCULOSIS, AND VIRAL HEPATITIS PATH'S HIV, TUBERCULOSIS (TB), AND VIRAL HEPATITIS TEAM CONTINUED TO FOCUS ON FACILITATING IMPROVED ACCESS, UPTAKE, AND CONTINUITY IN HIV, TB, AND VIRAL HEPATITIS SERVICES BY DEVELOPING AND INTRODUCING NEW HEALTH CARE TOOLS AND TECHNOLOGIES AND OPTIMIZING SERVICE DELIVERY THROUGH INTEGRATED PEOPLE-CENTERED MODELS OF HEALTH CARE ACROSS AFRICA AND ASIA. PATH KICKED OFF THE HCV COMBINATION PREVENTION IN PERSONS WHO INJECT DRUGS AND PRISONERS PROJECT (HEPC3P), FUNDED BY UNITAID, TO ADDRESS KEY ACCESS BARRIERS THAT PREVENT THE INTRODUCTION AND SCALE-UP OF HCV PRODUCTS AND INTERVENTIONS WHILE WORKING WITH STAKEHOLDERS TO ACCELERATE UPTAKE OF HCV PREVENTION AND TREATMENT SERVICES. IN ITS FIRST YEAR, PATH AND PARTNERS WORKED TO SET UP A SOLID FOUNDATION FOR RESEARCH, MARKET SHAPING, AND COMMUNITY ENGAGEMENT ACTIVITIES WITHIN THE PROJECT COUNTRIESINDIA, NIGERIA, SOUTH AFRICA, UKRAINE, AND VIETNAM. MAJOR ACHIEVEMENTS IN 2023 INCLUDED THE DEVELOPMENT OF HIGH-QUALITY RESEARCH PROTOCOLS THROUGH STRONG COLLABORATION WITH AN ESTABLISHED COMMUNITY ADVISORY BOARD, PARTNERS, AND EXTERNAL EXPERTS; SUCCESSFUL NEGOTIATION TO SECURE SIGNIFICANT PRICE REDUCTIONS IN HCV PREVENTION PRODUCTS FOR USE IN THE STUDIES; AND THE ESTABLISHMENT OF STRONG PARTNERSHIPS AND ENGAGEMENT WITH KEY COUNTRY STAKEHOLDERS TO SECURE SUPPORT FOR THE PROJECT. |
| FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: | THROUGH THE UNITAID-FUNDED STAR-III PROJECT, PATH WORKED TO SUCCESSFULLY SCALE UP ACCESS TO HIV SELF-TESTING (HIVST) IN INDIA, INDONESIA, AND UGANDA. IN 2023, THE PROJECT PROVIDED DIRECT TECHNICAL SUPPORT TO IN-COUNTRY PARTNERS TO DISTRIBUTE HIVST THROUGH DIVERSIFIED DISTRIBUTION MODELS, INFORMED BY A PROJECT-LED ASSESSMENT AND CO-DESIGN PROCESS. THE PROJECT TEAM ALSO SUPPORTED WILLINGNESS-TO-PAY ASSESSMENTS TO GENERATE MARKET-SHAPING DATA TO INFORM NATIONAL GUIDELINES AND PLANS FOR SUSTAINING HIVST. BY THE END OF THE PROJECT IN AUGUST 2023, PATH HAD SUPPORTED DISTRIBUTION OF MORE THAN 375,000 HIVST KITS ACROSS INDIA, INDONESIA, AND UGANDA. PATH ALSO WORKED TO ADVANCE SELF-TESTING FOR COVID-19 AND HEPATITIS C (HCVST) AS AN EXPANSION OF THE STAR INITIATIVE WITH FUNDING FROM UNITAID. IN BRAZIL, INDIA, AND UGANDA, PATH GENERATED EVIDENCE ON THE ACCEPTABILITY, FEASIBILITY, AND EFFECTIVENESS OF COVID-19 SERVICES AND DELIVERY MODELS. BY THE END OF THE PROJECT IN DECEMBER 2023, PATH HAD SUPPORTED THE ADMINISTRATION OF MORE THAN 59,000 COVID-19 TESTS AND DISSEMINATED VALUABLE INSIGHTS AND LESSONS LEARNED TO COUNTRY STAKEHOLDERS TO INFORM POLICY AND FUTURE PANDEMIC/EPIDEMIC PREPAREDNESS. PATH IS CONTINUING WORK INTO 2024 UNDER THE STAR INITIATIVE TO TEST AND EVALUATE SUITABLE DELIVERY, DISTRIBUTION, AND LINKAGE MODELS FOR HCVST IN INDIA AND VIETNAM. PATH ALSO LAUNCHED THE CDC GLOBAL TB TECHNICAL ASSISTANCE PROJECT. AFTER DISCUSSIONS AND CONSULTATIONS WITH CDC TEAMS AND NATIONAL TB PROGRAMS, YEAR ONE ACTIVITIES WERE SELECTED BASED ON FUNDING LEVELS AVAILABLE AND POTENTIAL ACTIVITY IMPACT. ALL ACTIVITIES SELECTED WILL STRENGTHEN TB SCREENING AND CASE FINDING. IN INDIA, EXPAND ELEVATE (E2; ENGAGING LOCAL EXPERTS IN VALIDATING AND ANALYZING TB DATA TO END TB) ACTIVITIES PREVIOUSLY IMPLEMENTED BY SHARE INDIA WERE TRANSITIONED TO PATH. IN TANZANIA, WE WILL ADAPT CLICQ! (CLINIC-LAB INTERFACE CONTINUOUS QUALITY IMPROVEMENT), WHICH WAS PREVIOUSLY PILOTED IN NIGERIA AND UGANDA. IN ZAMBIA, THREE ACTIVITIES WERE SELECTED: STRENGTHENING THE HOUSEHOLD CONTACT TRACING MODEL AND EXTENDING IT TO SOCIAL NETWORKS WITH CHILD-FRIENDLY SAMPLE COLLECTION, MAPPING TB HOTSPOTS, AND STRENGTHENING DATA QUALITY AND USE FOR DECISION-MAKING. PATH PROVIDED EXPERTISE TO DISSEMINATE CLINICAL PROJECT ACHIEVEMENTS AND FINDINGS ON TB PREVENTIVE TREATMENT AND DRUG-RESISTANT TB MANAGEMENT IN KAZAKHSTAN, TAJIKISTAN, AND UZBEKISTAN AT REGIONAL AND INTERNATIONAL FORUMS, AND STRENGTHENED TB TREATMENT PROVISION IN UZBEKISTAN BY FACILITATING GOVERNMENT ACCESS TO INTERNATIONAL POOLED PLATFORMS FOR TB DRUG PROCUREMENT THROUGH THE GLOBAL DRUG FACILITY. IN TANZANIA, THE USAID-FUNDED INFECTIOUS DISEASE DETECTION AND SURVEILLANCE (IDDS) PROJECT SUPPORTED QUALITY MANAGEMENT AT ZONAL LABORATORIES, EQUIPMENT UPGRADES, AND CONNECTIVITY FOR ACCURATE DATA REPORTING. THROUGH PROJECT SUPPORT, 276 GENEXPERT SITES WERE CONNECTED TO GXALERT IN 2023 COMPARED TO 106 PRIOR TO PROJECT START (A 160% INCREASE). ADDITIONALLY, PATH PROVIDED TECHNICAL EXPERTISE TO INTRODUCE THE NEW TRUENAT DIAGNOSTIC METHOD, TRAINING 30 SUPER-USERS AND 50 END USERS AND INSTALLING 30 TRUENAT INSTRUMENTS. PATH CONTINUED TO IMPLEMENT THE USAID-FUNDED SUPPORT TB CONTROL EFFORTS IN UKRAINE (STBCEU) PROJECT, WHICH FOCUSES ON PREVENTION, DETECTION, AND TREATMENT OF TB, DRUG-RESISTANT TB, AND TB/HIV. IN 2023, A TOTAL OF 2,833 PEOPLE WITH MULTIDRUG-RESISTANT TB WERE INITIATED ON TREATMENT IN PROJECT-SUPPORTED REGIONS. THE NUMBER OF PEOPLE WITH TB USING DIGITAL ADHERENCE TECHNOLOGIES REACHED 3,733, WITH AN ADHERENCE RATE OF 82% IN 2023. ESSENTIAL HEALTH SERVICES WERE PROVIDED AT NEWLY INTRODUCED HEALTH ACCESS POINTS, INCLUDING 4,878 HYPERTENSION SCREENINGS AND 4,070 POST-TRAUMATIC STRESS DISORDER (PTSD) SCREENINGS. ADDITIONALLY, PEDIATRIC TB RESOURCE ROOMS WERE ROLLED OUT AT TWO TB CENTERS, REACHING 109 CHILDREN AND 31 PARENTS. STBCEU ALSO COMPLETED FORMATIVE ASSESSMENTS TO DESIGN NEW ACTIVITIES FOR MENTAL HEALTH AND PSYCHOSOCIAL SUPPORT. BUILDING ON A HISTORY OF SUPPORTING THE HIV RESPONSE IN UKRAINE, PATH BEGAN OPERATIONS FOR THE PEPFAR/USAID-FUNDED REACH 95 PROJECT. ACTIVITIES INCLUDED DESIGNING BASELINE ASSESSMENT TOOLS, DRAFTING MEMORANDA OF UNDERSTANDING, HOLDING REGIONAL MEETINGS AT PUBLIC HEALTH CARE FACILITIES TO SELECT THE FACILITIES THAT WILL RECEIVE PROJECT SUPPORT, AND PROVIDING TARGETED TRAINING SUPPORT ON PROVIDER-INITIATED HIV COUNSELING AND TESTING. WITH FUNDING FROM THE STOP TB PARTNERSHIP'S TB REACH PROGRAM, PATH ALSO BEGAN OPERATIONS IN MYANMAR AND DRC TO TEST INTEGRATED MODELS FOR TB AND OTHER HEALTH SERVICES. IN MYANMAR, PATH BUILT PARTNERSHIPS WITH THE PRIVATE SECTOR TO STRENGTHEN CASE-FINDING PATHWAYS, ENGAGING 168 PRIVATE PROVIDERS WHO STARTED ACTIVELY REFERRING PEOPLE WITH SYMPTOMS OF TB AND PILOTED MODELS TO INTEGRATE TB PREVENTION AND CARE WITH SERVICE DELIVERY FOR DIABETES, HIV, AND MENTAL HEALTH SERVICES. IN THE DRC, PATH AND A LOCAL PARTNER TRAINED AND EQUIPPED MORE THAN 60 COMMUNITY HEALTH WORKERS TO PROVIDE DOOR-TO-DOOR INTEGRATED SCREENING FOR TB, DIABETES, HYPERTENSION, AND HIV WITHIN HOUSEHOLDS OF 40 ECONOMICALLY DISADVANTAGED, PERI-URBAN HEALTH AREAS. IN ONLY TWO MONTHS, TRAINED COMMUNITY HEALTH WORKERS COUNSELED 10,896 PEOPLE ON TB, NONCOMMUNICABLE DISEASES, AND HIV. OF THOSE, 60% ACCEPTED SCREENINGS FOR TB, 31% FOR HYPERTENSION, AND 23% FOR DIABETES. ADDITIONALLY, 37% OF PEOPLE WITH PRESUMPTIVE TB ACCEPTED HIV SCREENING SERVICES, AND 86% OF THOSE WITH PRESUMPTIVE TB WERE SUCCESSFULLY REFERRED TO LINKED HEALTH FACILITIES. AMONG THE 247 PEOPLE CONFIRMED WITH TB DIAGNOSIS, 92% (228) WERE INITIATED ON TB TREATMENT. UNDER THE PEPFAR/USAID PROGRAM ACTIVITY IN MYANMAR, PATH PROVIDED TECHNICAL SUPPORT TO PROJECT PARTNERS IN TB AND HIV SERVICES. THE AIM WAS TO ACCELERATE TB ELIMINATION EFFORTS AND ADVANCE TOWARD HIV EPIDEMIC CONTROL TARGETS ACROSS FIVE REGIONS AND STATES OF MYANMAR. HIGHLIGHTS FROM 2023 INCLUDED FINALIZING AND ROLLING OUT TRAINING ON THE MINIMAL ESSENTIAL PACKAGE OF EFFECTIVE MESSAGES FOR DRUG-SUSCEPTIBLE TB COUNSELING AND TELE-COUNSELING; ACTIVELY FACILITATING IMPLEMENTATION OF CHEST X-RAY-AIDED TB DETECTION BY DEVELOPING AN OPERATIONS MANUALS AND A CONTEXT-SPECIFIC QUALITY ASSURANCE GUIDE AS WELL AS LAUNCHING A STUDY ON USE OF COMPUTER-AIDED CHEST X-RAY TO SUPPORT TB DETECTION AMONG CHILDREN AND YOUNG ADOLESCENTS; ENCOURAGING PRIVATE-SECTOR ENGAGEMENT (PSE) IN TB PROGRAMMING BY HOLDING A WORKSHOP TO PRIORITIZE AND PLAN ROLLOUT OF PSE INTERVENTIONS FOR TB; SUPPORTING IMPLEMENTATION OF DIFFERENTIATED PRE-EXPOSURE PROPHYLAXIS (PREP) MODELS BY DEVELOPING AND RELEASING AN IMPLEMENTATION GUIDE ON DELIVERING MOBILE AND VIRTUAL PREP SERVICES FOR THE MYANMAR CONTEXT; AND CONDUCTING A FORMATIVE ASSESSMENT TO INFORM RECOMMENDATIONS TO OPTIMIZE PREP AND HIV SELF-TESTING COMMUNICATIONS AND DEMAND-GENERATION CAMPAIGNS. THROUGH THE USAID SUPPORT FOR TECHNICAL EXCELLENCE AND PRIVATE-SECTOR SUSTAINABILITY IN VIETNAM (STEPS) PROJECT, PATH CONTINUED EFFORTS TO FACILITATE MARKET GROWTH FOR PRIVATE-SECTOR HIV GOODS AND SERVICES TO SUPPORT THE GOVERNMENT OF VIETNAM TO ADVANCE TOWARD A SUSTAINABLE RESPONSE TO THE HIV EPIDEMIC. 2023 PROJECT EFFORTS FOCUSED ON STRENGTHENING PSE IN VIETNAM'S HIV RESPONSE BY SUPPORTING THE VIETNAM ADMINISTRATION FOR HIV/AIDS CONTROL TO DEVELOP AND ADOPT THEIR FIRST-EVER NATIONAL AND PROVINCIAL (DONG NAI) PSE STRATEGY AND FOSTERING AN ECOSYSTEM OF LOCAL PARTNERS LEVERAGING GLINK ACADEMY, VIETNAM'S FIRST PEER-TO-PEER LEARNING AND INCUBATION MODEL, TO SUPPORT NASCENT KEY-POPULATION-LED COMMUNITY ORGANIZATIONS WITH THEIR BUSINESS GROWTH. THROUGH GLINK ACADEMY'S SERIES OF BUSINESS INNOVATIVE TALKS, DIGITAL MARKET FORUMS, AND TRAININGS ON BUSINESS STRATEGY AND MARKETING, COMPLEMENTED BY OTHER PROJECT TECHNICAL ASSISTANCE EFFORTS, STEPS HAS DIRECTLY SUPPORTED THE LAUNCH OF FIVE KEY-POPULATION-LED/FOCUSED CLINICS AND COMMUNITY PHARMACIES, INCLUDING VIETNAM'S FIRST-EVER TRANSGENDER-OWNED CLINIC. IN INDIA, PATH CONTINUED PROVIDING TECHNICAL ASSISTANCE TO THE NATIONAL AIDS CONTROL PROGRAM TO STRENGTHEN THE CONTINUUM OF HIV PREVENTION, CASE-FINDING, AND TREATMENT SERVICES IN MUMBAI AND THREE NORTHEASTERN STATES (MANIPUR, MIZORAM, AND NAGALAND). THE PROJECT SERVES AS A TESTING GROUND FOR PILOTING AND REFINING INTEGRATED, PEOPLE-CENTERED MODELS FOR HIV AND PHC SERVICES, INCLUDING A COMMUNITY-RUN TRANSGENDER HEALTH AND WELLNESS CENTER PROVIDING HIV TESTING AND TREATMENT AND GENDER-AFFIRMING SERVICES; SIX INTEGRATED YOUTH CENTERS CO-LOCATED AT COLLEGES AND UNIVERSITIES OFFERING HIV, SEXUAL AND REPRODUCTIVE HEALTH (INCLUDING SEXUALLY TRANSMITTED INFECTIONS), VIRAL HEPATITIS, MENTAL HEALTH, AND HARM REDUCTION SERVICES FOR STUDENTS AND YOUTH IN NEARBY COMMUNITIES; AND VIRTUAL TESTING-AND-COUNSELING CENTERS PROVIDING FAST-TRACKED HIV CONFIRMATORY DIAGNOSIS AND TREATMENT ENROLLMENT SERVICES TO PEOPLE REACHED ONLINE WITH HIV PREVENTION AND TESTING COUNSELING. |
| FORM 990, PART III, LINE 4A, DESCRIPTION OF PROGRAM SERVICE: | IN 2023, PATH KENYA CONTINUED TO PROVIDE TECHNICAL ASSISTANCE AND SUPPORT TO COUNTY GOVERNMENTS, LOCAL IMPLEMENTING PARTNERS, AND 337 HEALTH FACILITIES TO DELIVER A HOLISTIC PACKAGE OF HEALTH AND RELATED SERVICES TO PEOPLE LIVING WITH AND AFFECTED BY HIV, ADOLESCENTS AND YOUNG PEOPLE, AND ORPHANS AND VULNERABLE CHILDREN (OVC) AND THEIR HOUSEHOLDS IN SEVEN COUNTIES OF WESTERN KENYA. IN 2023, A TOTAL OF 64,039 OVC WERE PROVIDED WITH A PACKAGE OF TAILORED HEALTH, EDUCATION, ECONOMIC STRENGTHENING, AND SOCIAL PROTECTION SERVICES, WITH 15,175 ACHIEVING RESILIENCE AND GRADUATING FROM THE PROJECT'S OVC PROGRAM. ADDITIONALLY, 43,275 ADOLESCENT GIRLS AND YOUNG WOMEN RECEIVED A COMPREHENSIVE SUITE OF PREVENTION, EDUCATION, ECONOMIC EMPOWERMENT, HEALTH, AND LIFE SKILLS SERVICES, WITH 95% (41,049) COMPLETING HIV AND GENDER-BASED VIOLENCE PREVENTION INTERVENTIONS. ANOTHER 10,890 ADOLESCENT GIRLS AND YOUNG WOMEN AND PARTNERS OR CONTACTS OF PEOPLE LIVING WITH HIV WERE NEWLY ENROLLED ON HIV PRE-EXPOSURE PROPHYLAXIS TO PREVENT HIV. LASTLY, 89,428 PEOPLE LIVING WITH HIV RECEIVED SUPPORT TO REMAIN ON HIV TREATMENT, WITH 71,595 (80%) ACHIEVING VIRAL SUPPRESSION. (5) NONCOMMUNICABLE DISEASES PATH IS AT THE FOREFRONT OF THE FIGHT AGAINST NONCOMMUNICABLE DISEASES (NCDS), SUCH AS DIABETES, CARDIOVASCULAR DISEASE, AND MENTAL HEALTH CONDITIONS IN LOW-RESOURCE SETTINGS WORLDWIDE, WHERE THE BURDEN OF THESE DISEASES IS RISING DISPROPORTIONATELY. IN 2023, PATH CONTINUED TO SERVE AS THE SECRETARIAT OF THE COALITION FOR ACCESS TO NCD MEDICINES AND PRODUCTS. THIS GLOBAL, MULTISECTORAL COLLABORATION WORKS TO INCREASE ACCESS TO NCD MEDICINES AND HEALTH PRODUCTS IN LMICS. IN ADDITION TO GLOBAL ADVOCACY, THE COALITION CONTINUED TO LEAD THE IMPLEMENTATION OF A FORECASTING PROGRAM FOR NCD MEDICINES AND PRODUCTS IN GHANA, KENYA, AND UGANDA AND PROVIDED TECHNICAL SUPPORT TO THE DIABETES CAREPAK, A BUNDLING SOLUTION FOR PEOPLE LIVING WITH DIABETES. IN MULTIPLE COUNTRIES (INCLUDING GHANA, KENYA, MALI, MOZAMBIQUE, RWANDA, SENEGAL, TANZANIA, UGANDA, AND VIETNAM), PATH IMPLEMENTED NCD PROJECTS THAT BUILD STRONGER PHC SYSTEMS, GREATER ACCESS TO ESSENTIAL NCD MEDICINES AND PRODUCTS, AND DATA-DRIVEN DECISION-MAKINGALL CRITICAL COMPONENTS OF HEALTH SYSTEM RESILIENCY. OUR EFFORTS IN GHANA INCLUDED PILOTING THE INTEGRATION OF INSULIN INTO THE VACCINE COLD CHAIN IN ONE DISTRICT. IN PARTNERSHIP WITH THE GHANA HEALTH SERVICES, WE COMPLETED A FORECASTING INITIATIVE THAT DEMONSTRATED THE GAP BETWEEN THE MEDICINES CURRENTLY PROCURED AND THE FORECASTED NEED FOR THE COUNTRY. PATH'S HEALTHY HEART AFRICA PROJECT CONDUCTED MORE THAN 700,000 BLOOD PRESSURE SCREENINGS AND LINKED THOSE DIAGNOSED TO TREATMENT. THE PROGRAM ALSO EXPANDED FROM HYPERTENSION TO INCLUDE CHRONIC KIDNEY DISEASE. IN KENYA, PATH CLOSED OUT A CUTTING-EDGE PROGRAM THAT ENABLED COMMUNITY AND HOUSEHOLD SCREENINGS FOR HYPERTENSION, REMOTE BLOOD PRESSURE AND BLOOD SUGAR MONITORING, TELEMEDICINE, COMMUNITY-BASED DRUG DELIVERY, AND ENHANCED DATA MANAGEMENT. WE CONTINUED TO PROVIDE TECHNICAL ASSISTANCE TO THE MINISTRY OF HEALTH TO SUPPORT NCD NAVIGATOR USE. WE CONTINUED IMPLEMENTING SEVERAL INNOVATIONS TO STRENGTHEN SUPPLY CHAINS, SUCH AS A STOCK TRACKER, AN ELECTRONIC MEDICAL RECORDS MODULE FOR NCD FACILITY DATA, AND LAST-MILE DISTRIBUTION. IN 2023, WE LAUNCHED A COMMUNITY SPORT AND HEALTH INITIATIVE IN PARTNERSHIP WITH THE INTERNATIONAL OLYMPIC COMMITTEE IN VIETNAM. THE AIM WAS TO BRING TOGETHER THE SPORT AND HEALTH COMMUNITIES AND INCREASE ACCESS TO HEALTH-ENHANCING COMMUNITY SPORT. ADDITIONAL COUNTRIES WILL LAUNCH THE INITIATIVE IN 2024. IN SENEGAL, TANZANIA, AND RWANDA, PATH IMPLEMENTED THE HEALTHY HEART AFRICA PROJECT FOCUSED ON HYPERTENSION MANAGEMENT AT THE COMMUNITY LEVEL. TARGETED INITIATIVES WERE IMPLEMENTED IN THE GAMBIA, MOZAMBIQUE, AND ZAMBIA. PATH ALSO CONTINUED TO IMPLEMENT AND EXPAND THE DIABETES CAREPAK IN KENYA, MALI, MOZAMBIQUE, TANZANIA, AND UGANDAAN INNOVATIVE BUNDLING SOLUTION OF THE COMMODITIES NEEDED FOR SAFE ADMINISTRATION OF INSULIN AND DIABETES SELF-CARE. WE CONTINUED A SECONDARY RESEARCH PROJECT ON THE MENTAL HEALTH LANDSCAPE OF 22 COUNTRIES TO OUTLINE THE RESEARCH, POLICIES, AND PRACTICES AROUND MENTAL HEALTH IN A VARIETY OF LOW-, MIDDLE-, AND HIGH-INCOME COUNTRIES. FINALLY, PATH LED AND CONTRIBUTED TO CONVENINGS TO RAISE AWARENESS OF NCDS AND ORCHESTRATE ACTION TO IMPROVE ACCESS TO NCD PREVENTION AND CARE. (6) SEXUAL AND REPRODUCTIVE HEALTH PATH'S WORK IN SEXUAL AND REPRODUCTIVE HEALTH (SRH) IS GUIDED BY THE PRINCIPLES OF CHOICE, EQUITY, AND DIGNITY FOR ALL PEOPLE AND GROUNDED IN AN UNDERSTANDING OF THE COMPLEX SOCIAL, BEHAVIORAL, AND GENDER DIMENSIONS OF SRH THROUGHOUT THE LIFE CYCLE. WE ADVANCE HEALTH SERVICES AND PRODUCTS THAT ARE SPECIFICALLY DESIGNED BY AND FOR WOMEN AND GIRLS. OUR OBJECTIVE IS TO ADDRESS THEIR NEEDS AT EVERY STAGE OF THEIR LIVES, FROM START TO FINISH. WE BELIEVE ALL PEOPLE HAVE THE RIGHT TO INFORMATION, PRODUCTS, AND QUALITY FAMILY PLANNING (FP) SERVICESREGARDLESS OF WHERE THEY LIVE, THEIR AGE, THEIR MARITAL STATUS, OR THEIR WEALTH. WITH ASSISTANCE FROM PATH AND PARTNERS, COUNTRIES HAVE CONTINUED TO ACCELERATE SCALE-UP OF THE SELF-INJECTABLE CONTRACEPTIVE SUBCUTANEOUS DMPA (DMPA-SC). LED BY PATH IN PARTNERSHIP WITH THE CLINTON HEALTH ACCESS INITIATIVE (CHAI), INSUPPLY HEALTH, JHPIEGO, AND JSI, THE INJECTABLES ACCESS COLLABORATIVE IN 2023 PROVIDED TECHNICAL ASSISTANCE TO 23 COUNTRIES AND COLLECTED DATA FROM 14 COUNTRIES SHOWING MORE THAN 1.7 MILLION CLIENT SELF-INJECTION VISITS SINCE 2018. IN UGANDA, PATH AND THE MOH HAVE IMPLEMENTED GROUNDBREAKING PROGRAMS TO DEMONSTRATE HOW SELF-INJECTION CAN BE OFFERED AT SCALE. AS OF 2023, THE MOH AND PARTNERS HAVE TRAINED 3,500 FACILITY PROVIDERS IN PUBLIC-SECTOR FACILITIES AND INTEGRATED SELF-INJECTION INTO PRESERVICE TRAINING FOR NURSES, MIDWIVES, AND CLINICAL OFFICERS, REACHING MORE THAN 7,000 NEW PROVIDERS. PATH ALSO LAUNCHED A NEW PROJECT IN 2023 TO STRENGTHEN THE ENABLING ENVIRONMENT FOR PRIVATE-SECTOR PROVISION OF SRH IN UGANDA. THIS INCLUDES QUALITY ASSURANCE FOR SRH SERVICE DELIVERY IN PHARMACIES AND DRUG SHOPS AND DEVELOPMENT OF EQUITABLE AND SUSTAINABLE MARKETS FOR SRH PRODUCTS THROUGH THE PRIVATE-SECTOR CHANNELS THAT MANY ADOLESCENTS AND YOUTH PREFER. WE ALSO PROVIDED TECHNICAL SUPPORT AND LEADERSHIP TO DEVELOP, SCALE UP, AND MAINSTREAM EVIDENCE-DRIVEN INNOVATIONS, INCLUDING THOSE RESPONSIVE TO DIVERSE ADOLESCENT AND YOUTH POPULATIONS. IN SENEGAL, PATH PARTNERED WITH HCDEXCHANGE AND YUX DESIGN TO BUILD A FRANCOPHONE WEST AFRICAN NETWORK OF HUMAN-CENTERED DESIGN (HCD) PRACTITIONERS TO DEVELOP HCD RESOURCES AND CREATE GLOBAL LINKAGES TO IMPROVE ADOLESCENT AND YOUTH SRH. PATH ALSO COLLABORATED WITH WHO, THE SENEGAL MOH, AND YOUTH-LED ORGANIZATIONS TO DEVELOP A HIGH-IMPACT STRATEGY AND COSTED OPERATIONAL PLAN TO DECREASE EARLY MARRIAGE AND REDUCE UNINTENDED PREGNANCY AMONG MARRIED AND UNMARRIED ADOLESCENTS. IN UGANDA, WE ENGAGED YOUNG WOMEN AND HEALTH WORKERS IN HCD TO STRENGTHEN INTEGRATION OF HIV PREVENTION WITH FAMILY PLANNING SERVICES. AS MANY YOUNG WOMEN WANT TO PREVENT BOTH PREGNANCY AND HIV, INTEGRATED SERVICE DELIVERY HAS THE POTENTIAL TO OFFER MORE HOLISTIC AND CONVENIENT CARE. PATH AND YOUTH THEMSELVES CONDUCTED AN HCD STUDY TO CO-CREATE MODELS OF INTEGRATED SERVICE DELIVERY AND ASSESS THEIR FEASIBILITY, SCALABILITY, AND ACCEPTABILITY. PATH CONTINUES TO BE A LEADER IN THE SELF-CARE MOVEMENT, SUPPORTING INDIVIDUALS AND FAMILIES WHO CHOOSE TO MANAGE THEIR OWN HEALTH. IN SENEGAL, WE SUPPORT THE MINISTRY OF HEALTH'S LEADERSHIP OF A NATIONAL SELF-CARE NETWORKTHE SELF-CARE PIONEERSTHROUGH THE SELF-CARE TRAILBLAZER GROUP. THESE LOCAL CHAMPIONS DEVELOPED SENEGAL'S SELF-CARE GUIDELINES, AMONG THE FIRST NATIONAL SELF-CARE GUIDELINES IN THE WORLD, AND THE FIRST IN FRANCOPHONE AFRICA. PATH ALSO CONTINUES TO SERVE AS THE SECRETARIAT FOR THE REPRODUCTIVE HEALTH SUPPLIES COALITION, A GLOBAL PARTNERSHIP OF MORE THAN 540 PUBLIC AND PRIVATE ENTITIES AND NGOS WORKING TO EXPAND ACCESS TO CRITICAL SRH AND FP SUPPLIES AND SERVICES. |
| FORM 990, PART III, LINE 4B, DESCRIPTION OF PROGRAM SERVICE: | PATH ADVANCED HEALTH ECONOMICS RESEARCH IN MULTIPLE COUNTRIES IN AFRICA AND ASIA AIMED AT INFORMING DECISION-MAKING AROUND RESPIRATORY SYNCYTIAL VIRUS (RSV) PREVENTION, MATERNAL IMMUNIZATION, AND MONOCLONAL ANTIBODY INTRODUCTION. PATH ALSO PUBLISHED SEVERAL ARTICLES ON THE ECONOMIC IMPACT OF RSV AND OTHER ACUTE RESPIRATORY INFECTIONS AMONG INFANTS IN LMICS. WHO AND PATH LAUNCHED A COMMUNICATIONS TOOLKIT TO SUPPORT AWARENESS RAISING AROUND RSV PREVENTION AND NEW PREVENTION PRODUCTS AMONG LMIC STAKEHOLDERS. IN COLLABORATION WITH WHO, PATH ALSO ADVANCED A PREGNANCY REGISTRY LANDSCAPE ANALYSIS AND RESEARCH ON ANTENATAL CARE TIMING TO INFORM MATERNAL IMMUNIZATION STRATEGIES AND DECISION-MAKING. ADDITIONALLY, PATH UPDATED OUR RSV VACCINE AND MONOCLONAL ANTIBODY SNAPSHOT, WHICH PROVIDES AN OVERVIEW OF THE INTERVENTION PRODUCT LANDSCAPE, AND OUR CLINICAL TRIAL TRACKER, WHICH PROVIDES INFORMATION ON RELATED CLINICAL TRIALS. DRUG DEVELOPMENT THROUGH OUR WORK ON DRUG DEVELOPMENT AND INTRODUCTION, PATH HELPS ENSURE THAT PEOPLE AROUND THE WORLD, ESPECIALLY CHILDREN IN LOW-RESOURCE SETTINGS, HAVE RELIABLE ACCESS TO LIFESAVING MEDICINES. OVER THE YEARS, OUR WORK HAS ADVANCED SOLUTIONS FOR A RANGE OF URGENT GLOBAL HEALTH CHALLENGES, INCLUDING ENTERIC AND DIARRHEAL DISEASES, NEGLECTED TROPICAL DISEASES, HIV/AIDS, AND MALARIA. DRAWING ON AN ENDURING COMMITMENT TO HEALTH EQUITY AND A UNIQUE PARTNERSHIP APPROACH THAT SPANS THE ACADEMIC, PRIVATE, NONPROFIT, AND GOVERNMENT SECTORS, OUR WORK OVERTURNS BARRIERS TO HEALTH AT EVERY STAGE OF DRUG DEVELOPMENT AND USEFROM EARLY RESEARCH TO INTRODUCTION. THERE ARE NO NOTABLE UPDATES FOR 2023. |
| FORM 990, PART III, LINE 4D, DESCRIPTION OF PROGRAM SERVICE: | ETHIOPIA IN ETHIOPIA, PATH'S INITIATIVES FOCUS ON STRENGTHENING HEALTH SYSTEMS THROUGH INNOVATIVE APPROACHES IN MALARIA ELIMINATION, IMMUNIZATION, AND VACCINE HESITANCY. COLLABORATING WITH LOCAL PARTNERS, THESE PROGRAMS AIM TO ENHANCE HEALTH CARE DELIVERY, IMPROVE DISEASE SURVEILLANCE, AND EXPAND VACCINATION COVERAGE, CONTRIBUTING TO SIGNIFICANT IMPROVEMENT IN PUBLIC HEALTH OUTCOMES ACROSS THE COUNTRY. THE SURVEILLANCE FOR MALARIA ELIMINATION (S4ME) PROJECT, FUNDED BY THE US PRESIDENT'S MALARIA INITIATIVE (PMI), TRAINED OVER 3,000 HEALTH CARE PROVIDERS AND HEALTH EXTENSION WORKERS IN MALARIA ELIMINATION SURVEILLANCE AND DATA QUALITY. TRAINING OF TRAINERS FOR 161 DISTRICT AND ZONAL MALARIA FOCAL PERSONS FACILITATED THIS CASCADE TRAINING. IN COLLABORATION WITH THE ETHIOPIAN PUBLIC HEALTH INSTITUTE (EPHI) AND HAWASSA UNIVERSITY, THE PROJECT ORGANIZED THE 13TH MALARIA RESEARCH NETWORK OF ETHIOPIA SYMPOSIUM, FEATURING 20 ORAL AND 8 POSTER PRESENTATIONS, ATTENDED BY 150 PARTICIPANTS FROM ACADEMIC AND HEALTH SECTORS. A NATIONAL CONSULTATIVE WORKSHOP ADDRESSED THE EMERGENCE OF THE NEW MALARIA VECTOR, ANOPHELUS STEPHENSI, IN ETHIOPIA, WITH 35 PARTICIPANTS FROM RESEARCH INSTITUTES, UNIVERSITIES, THE MINISTRY OF HEALTH, AND PARTNERS. THE WORKSHOP LED TO A RESOLUTION RECOGNIZING THE VECTOR'S PRESENCE AND THE NEED FOR FURTHER RESEARCH. THE HUMAN PAPILLOMAVIRUS VACCINE ACCELERATION PROGRAM PARTNERS INITIATIVE (HAPPI) CONSORTIUM PROJECT, IN PARTNERSHIP WITH THE FEDERAL MINISTRY OF HEALTH (FMOH), REGIONAL HEALTH BUREAUS, AND PRIMARY HEALTH CARE FACILITIES, SUPPORTED THE SCALE-UP OF THE HUMAN PAPILLOMAVIRUS (HPV) VACCINE PROGRAM, AIDING IN THE TRANSITION FROM A TWO-DOSE TO A SINGLE-DOSE REGIMEN AND PLANNING A MULTI-AGE CAMPAIGN. PATH FACILITATED THE PRINTING OF 1.5 MILLION VACCINATION CARDS AND 385,000 TALLY SHEETS FOR THE CAMPAIGN, CONTRIBUTING TO THE GLOBAL EFFORT TO ELIMINATE CERVICAL CANCER. A GAVI TARGETED COUNTRY ASSISTANCE (TCA) PROJECT SUPPORTED THE FMOH IN AFAR, BENISHANGUL GUMUZ, AND SOMALI REGIONS TO ENHANCE IMMUNIZATION COVERAGE, FOCUSING ON ZERO-DOSE AND UNDER-IMMUNIZED CHILDREN AND MISSED COMMUNITIES. PATH FACILITATED IDENTIFICATION AND VACCINATION OF OVER 6,000 ZERO-DOSE OR UNDER-IMMUNIZED CHILDREN. THE GATES FOUNDATION COVID-19 VACCINE HESITANCY IN ETHIOPIA PROJECT TACKLED VACCINE HESITANCY IN ADDIS ABABA AND BAHIR DAR THROUGH DATA-DRIVEN, CULTURALLY SENSITIVE COMMUNICATION STRATEGIES, RESULTING IN A 19% INCREASE IN VACCINE UPTAKE. PATH DEVELOPED INCLUSIVE SOCIAL AND BEHAVIOR CHANGE COMMUNICATION STRATEGIES SHARED WITH KEY STAKEHOLDERS. FOR GAVI COVID-19 VACCINE DELIVERY SUPPORT, PATH PROVIDED TECHNICAL SUPPORT TO THE NATIONAL AND REGIONAL EPI TEAMS, FOCUSING ON LEADERSHIP, MANAGEMENT, GOVERNANCE, DEMAND GENERATION, AND DATA QUALITY IMPROVEMENT. THIS INCLUDED MENTORING, SUPPORTIVE SUPERVISION, AND THE DEVELOPMENT OF THE BIG CATCH-UP OPERATIONAL GUIDE TO ADDRESS ZERO-DOSE AND UNDER-IMMUNIZED CHILDREN. THE PAVE/VIVACTION PROJECT PREPARED TO STUDY THE FEASIBILITY OF INTEGRATING NEW RADICAL CURE TREATMENT OPTIONS FOR MANAGING P. VIVAX, INCLUDING TAFENOQUINE AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DIAGNOSTICS. IN 2023, PATH SUPPORTED DEVELOPMENT OF A COUNTRY PROTOCOL, WHICH PASSED THROUGH THE NECESSARY ETHICS AND REGULATORY APPROVAL PROCESSES AND WAS APPROVED BY THE ARMAUER HANSEN RESEARCH INSTITUTE'S INSTITUTIONAL REVIEW BOARD, NATIONAL RESEARCH ETHICS REVIEW BOARD, WHO, AND THE ETHIOPIAN FOOD AND DRUG ADMINISTRATION AUTHORITY. PATH GENERATED NATIONAL LANDSCAPE EVIDENCE, WHICH WAS DISSEMINATED TO STAKEHOLDERS. PATH ALSO LED THE INTEGRATION OF PHARMACOVIGILANCE IN THE MALARIA NATIONAL STRATEGIC PLAN 202426. THE MACEPA PROJECT SUPPORTED MODELING WORK TO IDENTIFY EFFECTIVE VECTOR-CONTROL INTERVENTIONS AND UNDERSTAND THE MOVEMENT PATTERNS OF SEASONAL MIGRANT WORKERS IN THE AMHARA REGION. THE PROJECT ALSO SUPPORTED STANDARDIZATION OF THE MALARIA ROUTINE DATA QUALITY ASSESSMENT SYSTEM. GHANA IN GHANA, PATH HAS IMPLEMENTED A VARIETY OF INITIATIVES AIMED AT ENHANCING MATERNAL, NEWBORN, AND CHILD HEALTH, AS WELL AS IMPROVING WATER SANITATION, IMMUNIZATION, AND NONCOMMUNICABLE DISEASE MANAGEMENT. IN COLLABORATION WITH NATIONAL HEALTH SERVICES AND INTERNATIONAL PARTNERS, THESE PROJECTS FOCUS ON POLICY DEVELOPMENT, TRAINING, AND INNOVATIVE SOLUTIONS TO STRENGTHEN HEALTH CARE SYSTEMS AND ADDRESS KEY HEALTH CHALLENGES. PATH EFFORTS TOWARD QUALITY IMPROVEMENTS IN MATERNAL, NEWBORN, AND CHILD HEALTH, AS WELL AS WATER, SANITATION, AND HYGIENE (WASH), INCLUDE: PATH, IN COLLABORATION WITH THE GHANA HEALTH SERVICE (GHS), EVALUATED 18 AQUA RESEARCH STREAM CHLORINE GENERATORS IN 12 HEALTH CARE FACILITIES ACROSS CENTRAL, VOLTA, AND AHAFO REGIONS IN 2023. BASED ON POSITIVE RESULTS, PATH SUPPORTED DEVELOPMENT OF A DISTRICT IMPLEMENTATION AND NATIONAL SCALE-UP PLAN TO INTRODUCE THE TECHNOLOGY MORE WIDELY, AIMING TO STRENGTHEN PRIMARY HEALTH CARE. SELECT WATER QUALITY DATA COLLECTED DURING THIS EVALUATION HIGHLIGHTED THE DUAL USE OF THE AQUA STREAM DEVICE FOR WATER TREATMENT, WHICH WILL BE PILOTED IN 2024. ADDITIONALLY, PATH, GHS, AND THE LOCAL DISTRIBUTOR FOR THE ELLAVI UTERINE BALLOON TAMPONADE (UBT) DEVELOPED A POLICY BRIEF SUBMITTED TO THE MINISTRY OF HEALTH TO INCLUDE THE DEVICE IN ESSENTIAL MATERNAL HEALTH COMMODITIES AND THE NATIONAL HEALTH INSURANCE MEDICINES LIST, CURRENTLY UNDER PARLIAMENTARY REVIEW. PATH SUPPORTED THE NATIONAL NEWBORN CARE COMMITTEE IN ORGANIZING THE ANNUAL NEWBORN CONFERENCE, WHICH GATHERED PARTNERS TO DISCUSS KEY RECOMMENDATIONS FOR POLICY AND PROGRAM INTEGRATION. WITH FUNDING FROM PFIZER, PATH SUPPORTED DEVELOPMENT OF TRAINING MANUALS FOR INFECTION CONTROL AND SOCIAL BEHAVIOR CHANGE, TRAINING HEALTH CARE PROFESSIONALSESPECIALLY MIDWIVES AND COMMUNITY HEALTH NURSESIN THE BONO EAST REGION. A REAL-TIME APP WAS DEVELOPED TO CAPTURE CLIENT DATA WITH APPROPRIATE FEEDBACK PROVIDED. BY THE END OF 2023, 15,638 PREGNANT WOMEN HAD BEEN ENROLLED, SCREENED, AND TESTED; 156,066 INDIVIDUALS WERE REACHED THROUGH VARIOUS COMMUNITY ENGAGEMENT ACTIVITIES; AND 37 FUNCTIONAL PREGNANCY SCHOOLS WERE ESTABLISHED ACROSS FIVE DISTRICTS. PATH, IN PARTNERSHIP WITH KYBELE INC. AND THROUGH FUNDING FROM CHILDREN'S INVESTMENT FUND FOUNDATION, EQUIPPED FOUR REGIONAL HOSPITAL NICUS WITH NEWBORN EQUIPMENT THROUGH THE BEYOND MAKING EVERY BABY COUNT INITIATIVE (MEBCI 2.0) PROJECT. THE HOSPITALS ARE SUNYANI HOSPITAL, RIDGE HOSPITAL, TEMA HOSPITAL, AND KOFORIDUA HOSPITAL IN BONO, GREATER ACCRA, AND THE EASTERN REGIONS, RESPECTIVELY. OVER 250 HEALTH CARE WORKERS FROM ALL FOUR FACILITIES WERE TRAINED IN EQUIPMENT USE AND MAINTENANCE. THE PATH GHANA MEBCI 2.0 PROJECT, IN COLLABORATION WITH GHS, DEVELOPED A TRAINING MANUAL FOR PRIMARY HEALTH CARE PROVIDERS ON CARING FOR CRITICALLY ILL AND SMALL BABIES, EFFECTIVE COMMUNICATION WITH MOTHERS, AND REFERRAL PROTOCOLS. A TOTAL OF 126 PROVIDERS FROM 24 FACILITIES WERE TRAINED, WITH KNOWLEDGE SHARED AMONG PEERS AND COMMUNITIES. PATH CONTINUED ITS EFFORTS TO IMPROVE NEWBORN CARE IN GHANA BY TRANSLATING EDUCATIONAL VIDEOS ON CARING FOR SMALL AND SICK NEWBORNS INTO TWO COMMON LOCAL LANGUAGES, ENHANCING ACCESSIBILITY AT HEALTH CARE FACILITIES AND IN COMMUNITIES. IN 2023, PATH MADE SIGNIFICANT STRIDES IN STRENGTHENING GHANA'S IMMUNIZATION AGENDA. PATH FACILITATED THE INTRODUCTION OF HPV VACCINE INTO ROUTINE IMMUNIZATION AND EXPANDED THE USE OF MALARIA VACCINES TO 51 NEW DISTRICTS, REACHING AT LEAST 336,392 CHILDREN. PATH SUPPORTED THE REVIEW OF EPI POLICIES, DEVELOPED MANUALS FOR COVID-19 VACCINATION INTEGRATION, AND ENHANCED VACCINE DATA MANAGEMENT CAPACITY BY TRAINING 83 STAFF FROM 42 DISTRICTS IN THREE REGIONS. THEY ALSO EXPANDED THE USE OF GEO-ENABLED DIGITAL MICROPLANNING. THROUGH THE GAVI CDS AND USAID M-RITE PROJECTS, 143 HEALTH WORKERS FROM 15 NEW DISTRICTS AND 4 NEW REGIONS WERE TRAINED, AND TOGETHER, WITH GHS, ANOTHER 125 HEALTH WORKERS FROM 32 NEW DISTRICTS IN 16 REGIONS WERE TRAINED. PATH SUPPORTED INTRODUCTION OF IMMUNIZATION SERVICE DELIVERY THROUGH COMMUNITY PHARMACISTS. ADDITIONALLY, PATH SUPPORTED THE DEVELOPMENT OF NEW VACCINE APPLICATIONS FOR IPV, MALARIA VACCINE EXPANSION, AND MEASLES-RUBELLA AND ASSISTED IN NATIONAL RESPONSES TO THE COVID-19 PANDEMIC AND OTHER OUTBREAKS, SUCH AS MARBURG AND LASSA FEVER CONTAINMENT. |
| FORM 990, PART III, LINE 4D, DESCRIPTION OF PROGRAM SERVICE: | PATH'S EFFORTS IN NONCOMMUNICABLE DISEASE (NCD) PROGRAMMING FOCUSED ON HYPERTENSION CARE THROUGH THE ASTRAZENECA-FUNDED HEALTHY HEART AFRICA PROGRAM. THROUGH THIS PROJECT, SERVICE DELIVERY WAS IMPROVED IN ASHANTI AND BONO EAST REGIONS BY PROVIDING OVER 350 BLOOD PRESSURE (BP) DEVICES AND TRAINING OVER 200 HEALTH WORKERS ON HYPERTENSION PREVENTION AND TREATMENT. OVER 2.3 MILLION PEOPLE WERE SCREENED, OVER 530,000 WERE FOUND WITH ELEVATED BP, AND 115,000 WERE LINKED TO TREATMENT. THE PROGRAM INTEGRATED HYPERTENSION CARE INTO VARIOUS HEALTH CARE SETTINGS AND CONDUCTED ASSESSMENTS FOR FUTURE EXPANSION INTO CHRONIC KIDNEY DISEASE AND DIABETES MANAGEMENT. WITH FUNDING FROM ACCESS ACCELERATED PARTNERSHIP, PATH STRENGTHENED SUPPLY CHAIN LEADERSHIP AND GOVERNANCE IN GHANA. PATH INTRODUCED A FORECASTING TOOL FOR NCD AND MENTAL HEALTH COMMODITIES, TRAINING HEALTH CARE PROVIDERS IN PROCUREMENT, SUPPLY MANAGEMENT, AND DATA HANDLING. THIS HELPS POLICYMAKERS IDENTIFY GAPS AND PLAN EFFECTIVELY OVER A FIVE-YEAR HORIZON. ADDITIONALLY, PATH CONDUCTED A BASELINE STUDY ON INTEGRATING INSULIN INTO THE COLD CHAIN SYSTEM, DEVELOPING TRAINING MATERIALS AND SUCCESSFULLY PILOTING THE INTERVENTION IN THE GA-WEST MUNICIPAL AREA. THESE EFFORTS AIM TO IMPROVE THE AVAILABILITY OF ESSENTIAL MEDICINES AT THE COMMUNITY LEVEL FOR PEOPLE LIVING WITH NCDS, WITH FINDINGS GUIDING DECISION-MAKERS ON ENHANCING INSULIN ACCESSIBILITY FOR DIABETIC PATIENTS AT LOWER LEVELS OF CARE. IN 2023, PATH-DIGITAL SQUARE COLLABORATED WITH GHS THROUGH THE DIGITAL INNOVATION IN PANDEMIC CONTROL (DIPC) PROJECT TO ENHANCE GHANA'S DIGITAL HEALTH INFRASTRUCTURE. THE PROJECT FOCUSED ON THREE KEY AREAS: ENHANCING THE DHIS2 E-TRACKER TO SERVE AS A NATIONAL IMMUNIZATION INFORMATION SYSTEM, UPDATING E-LEARNING CONTENT TO IMPROVE HEALTH WORKERS' DIGITAL SKILLS, AND SUPPORTING THE INTEROPERABILITY OF DIGITAL IMMUNIZATION TOOLS. THESE EFFORTS AIMED TO CREATE A MORE ROBUST, EFFICIENT, AND INTERCONNECTED DIGITAL HEALTH ECOSYSTEM, PARTICULARLY FOR IMMUNIZATION SERVICES IN GHANA. KENYA USAID NURU YA MTOTO, IN CLOSE COLLABORATION WITH SEVEN COUNTY GOVERNMENTS, SERVED 90,020 ORPHANS AND VULNERABLE CHILDREN BY PROVIDING ESSENTIAL HEALTH CARE AND SOCIAL SERVICES. ADDITIONALLY, 21,697 ADOLESCENT GIRLS AND YOUNG WOMEN RECEIVED HIV PREVENTION SERVICES THROUGH THE DREAMS INITIATIVE, AND 91,694 PEOPLE LIVING WITH HIV RECEIVED LIFESAVING HIV CARE AND TREATMENT SERVICES. THE GATES FOUNDATION-FUNDED LIVING LABS INITIATIVE SUPPORTED THE NATIONAL VACCINE AND IMMUNIZATION PROGRAM IN ASSESSING AND ADDRESSING THE REASONS FOR LOW DEMAND FOR VACCINES. THE HUMAN-CENTERED DESIGN (HCD) ACTIVITY CONDUCTED IN TURKANA, GARISSA, KISUMU, AND KAKAMEGA COUNTIES INVOLVED ENGAGEMENT WITH A DIVERSE GROUP OF USERS, INCLUDING CAREGIVERS, HEALTH CARE WORKERS, COMMUNITY OPINION LEADERS, AND OTHER KEY STAKEHOLDERS. THIS ACTIVITY GENERATED NINE PRIORITY CONCEPTS TO INCREASE DEMAND AMONG TARGET GROUPS. BEYOND THE ACTIVITIES FUNDED BY THE GATES FOUNDATION, LIVING LABS CONTINUED TO SUPPORT INTEGRATION OF HCD IN OTHER PATH PROJECTS INCLUDING SUPPORTING THE REFINEMENT OF THE INTEGRATED EARLY CHILDHOOD DEVELOPMENT WORK IN SIAYA AND HOMABAY COUNTIES AND DEVELOPMENT OF A NEWBORN NUTRITION DIGITAL ADAPTATION KIT TO ENHANCE TIMELY SERVICE DELIVERY FOR SMALL AND SICK NEWBORN BABIES AT PUMWANI MATERNITY HOSPITAL. PATH/DIGITAL SQUARE IS SUPPORTING THE KENYA MINISTRY OF HEALTH (MOH) TO ACCELERATE COVID-19 VACCINATION RATES THROUGH IMPROVEMENTS TO THE AVAILABILITY AND USE OF HIGH-QUALITY VACCINATION DATA AND INTEGRATION OF COVID-19 VACCINATION WITH ROUTINE IMMUNIZATION. THIS PROJECT DEVELOPED OPENCHANJO, A FHIR (FAST HEALTHCARE INTEROPERABILITY RESOURCES) NATIVE WEB AND MOBILE APPLICATION THAT FOLLOWS THE WHO SMART GUIDELINES FRAMEWORK. WORKING WITH THE DIRECTORATE OF DIGITAL HEALTH, POLICY, AND RESEARCH TO ROLL OUT THE KENYA DIGITAL HEALTH SUPERHIGHWAY, THIS PROJECT HAS BUILT CAPACITY FOR THE MOH ON CYBERSECURITY, FHIR, AND OPENHIE (OPEN HEALTH INFORMATION EXCHANGE) STANDARDS. WE HAVE SUPPORTED THE DEVELOPMENT OF FHIR PROFILES FOR KENYA AND THE HEALTH DATA TERMINOLOGY SERVICES. ADDITIONALLY, WE HAVE DEVELOPED A FACILITY DIGITAL READINESS ASSESSMENT TOOL, WHICH IS BEING USED TO ASSESS THE READINESS OF PRIMARY CARE NETWORK FACILITIES (HUB AND SPOKE) FOR DIGITIZATION. THE MALARIA VACCINE IMPLEMENTATION PROGRAM, WITH FUNDING FROM GAVI, THE GLOBAL FUND, AND UNITAID, AND IN PARTNERSHIP WITH WHO AND THE MOH, SUPPORTED THE PILOT INTRODUCTION OF THE MALARIA VACCINE IN MALARIA-ENDEMIC PARTS OF KENYA FROM 2016 TO 2023. EXPANSION TO ADDITIONAL AREAS WAS IMPLEMENTED IN 2023 WITH SUPPORT FROM GIVEWELL. THE USAID-FUNDED M-RITE PROJECT WORKED IN TWO KENYAN COUNTIES (VIHIGA AND HOMABAY) AND AT THE NATIONAL LEVEL TO STRENGTHEN ROUTINE IMMUNIZATION PROGRAMS. THE AIM WAS TO OVERCOME ENTRENCHED OBSTACLES THAT CONTRIBUTE TO DECLINING IMMUNIZATION RATES AND ADDRESS BARRIERS TO REACHING ZERO-DOSE AND UNDER-IMMUNIZED CHILDREN WITH LIFESAVING VACCINES AND OTHER HEALTH SERVICES. COVID-19 DELIVERY SUPPORT FROM GAVI WAS INITIALLY DEVELOPED TO SUPPORT URGENT GAPS WITH ROLLOUT AND SCALE-UP OF COVID-19 VACCINE. HOWEVER, IT HAS BEEN REPROGRAMMED TO INTEGRATE COVID-19 VACCINES INTO ROUTINE IMMUNIZATION STARTING IN 2023. THE TYPHOID VACCINE ACCELERATION CONSORTIUM (TYVAC), A PARTNERSHIP BETWEEN THE CENTER FOR VACCINE DEVELOPMENT AT THE UNIVERSITY OF MARYLAND, THE OXFORD VACCINE GROUP AT OXFORD UNIVERSITY, AND PATH, SUPPORTED DEVELOPMENT OF THE GAVI APPLICATION FOR TYPHOID CONJUGATE VACCINES (TCV) WITH VACCINE INTRODUCTION PLANNED FOR 2025. THE SOURCE (STRENGTHENING OXYGEN UTILIZATION AND RESPIRATORY CARE ECOSYSTEM) PROJECT TRAINED 105 GOVERNMENT BIOMEDICAL ENGINEERS IN THE REPAIR AND MAINTENANCE OF OXYGEN GENERATING SYSTEMS (PRESSURE SWING ADSORPTION [PSA] PLANTS) AND OTHER RESPIRATORY CARE EQUIPMENT. IT ALSO TRAINED OFFICIALS FROM SEVEN COUNTIES ON QUANTIFYING THEIR OXYGEN NEEDS. THE SCALE (SCALING ACCESS TO LIFESAVING EQUIPMENT) PROJECT SUPPORTED SEVEN COUNTIES IN TAKING AND ANALYZING INVENTORY DATA OF MEDICAL DEVICES IN ALL THEIR HEALTH FACILITIES AND TRAINED OFFICIALS OF SEVEN COUNTIES ON COMPUTING CAPITAL EXPENDITURE (CAPEX) AND OPERATING EXPENDITURE (OPEX) FOR MEDICAL DEVICES. NEWBORN NUTRITION (AFRICA DIVISION) HAS BEEN ENGAGING VARIOUS STAKEHOLDERS AT THE NATIONAL AND SUBNATIONAL LEVEL TO IMPLEMENT A COMPREHENSIVE MODEL FOR NEWBORN NUTRITION DUBBED THE MOTHER BABY FRIENDLY INITIATIVE PLUS MODEL THAT WAS DESIGNED BY PATH AND IMPLEMENTED IN NAIROBI, KENYA, AS A PILOT AT PUMWANI MATERNITY HOSPITAL. AS A RESULT OF THESE ENGAGEMENTS, PATH CONDUCTED A NATIONAL STAKEHOLDER MEETING AT THE REQUEST OF THE MOH TO DISCUSS THE SCALE-UP PLAN TO OTHER FACILITIES WITH MOH AND COUNTY LEADERS. AS A SUBCONTRACTOR TO JHPIEGO FOR THE AMPLI-PPHI (ACCELERATING MEASURABLE PROGRESS AND LEVERAGING INVESTMENTS FOR PPH IMPACT) PROJECT, WE ARE INVOLVED WITH MARKET SHAPING. THIS INCLUDES PREPARING THE MARKET AND STRENGTHENING HEALTH SYSTEMS FOR KEY DRUGS USED IN THE MANAGEMENT OF POSTPARTUM HEMORRHAGE (PPH). IN 2023, THE PATH TEAM HELPED TO DEVELOP THE FORECASTING AND QUANTIFICATION REPORT, WHICH IS NOW BEING USED BY THE KENYAN MEDICAL SUPPLIES AUTHORITY TO INITIATE PROCUREMENT OF 360,000 AMPOULES OF HEAT-STABLE CARBETOCIN AT A NEGOTIATED PRICE. ADDITIONALLY, WE HAVE VALIDATED, FINALIZED, AND DISSEMINATED THE SUPPLY CHAIN ASSESSMENT REPORT WITH THE COUNTY HEALTH LEADERSHIP IN MAKUENI AND NAIROBI COUNTIES. WE ARE NOW EMBARKING ON STRENGTHENING HEALTH SYSTEMS AND ENSURING COMMODITY SECURITY FOR THE KEY DRUGSMISOPROSTOL, TRANEXAMIC ACID, HEAT-STABLE CARBETOCIN, AND OXYTOCINWITHIN THESE TWO COUNTIES. THROUGH ADVOCACY AND POLICY WORK, PATH SUPPORTED THE MOH TO BUILD THE CAPACITY OF 248 PRIMARY CARE NETWORK (PCN) TECHNICAL TRAINERS, ENABLING SCALE-UP OF PRIMARY HEALTH CARE (PHC) IMPLEMENTATION EFFORTS ACROSS ALL 47 COUNTIES. PATH ALSO SUPPORTED IMPROVEMENTS IN PHC POLICY AND FINANCING, WHICH WILL BE ADVANCED THROUGH KEY LEGISLATION ENACTED IN 2023: THE PHC ACT, THE FACILITY IMPROVEMENT FINANCING ACT, AND THE SOCIAL HEALTH INSURANCE ACT. THROUGH PATH'S TECHNICAL SUPPORT, KENYA RATIFIED THE AFRICAN MEDICINES AGENCY (AMA) TREATY, STRENGTHENING REGULATION FOR HEALTH PRODUCTS AND TECHNOLOGIES. PATH HAS PLAYED A KEY ROLE IN INFORMING THE GOVERNMENT'S LOCAL MANUFACTURING AGENDA, RESULTING IN A PRESIDENTIAL COMMITMENT TO PRODUCING AT LEAST 50% OF HEALTH PRODUCTS AND TECHNOLOGIES. ACCESS ACCELERATED FUNDED A PROJECT ON NCD CARE AT THE PHC LEVEL IN KENYA. THE PROJECT PROVIDED TECHNICAL AND IMPLEMENTATION SUPPORT FOR THE MOH DIVISION OF NCDS AND ONE HIGH-BURDEN COUNTY. THE GOAL WAS TO ROLL OUT A PATIENT-CENTERED COMPREHENSIVE NCD CARE PROGRAM AT THE PHC LEVEL LEVERAGING TECHNOLOGY. THIS ENTAILED ESTABLISHING AN INTEGRATED PERFORMANCE TRACKING TOOL CALLED THE NCD NAVIGATOR AS WELL AS SUPPORTING CONTINUED IMPLEMENTATION OF THE KENYA STRATEGY FOR NCD PREVENTION AND CONTROL. |
| FORM 990, PART III, LINE 4D, DESCRIPTION OF PROGRAM SERVICE: | PATH, WITH SUPPORT FROM VARIOUS FUNDERS (IFPMA, NOVO NORDISK, AND ROCHE), APPLIED A HUMAN-CENTERED DESIGN WITH HEALTH EXPERTS, PATIENTS WITH DIABETES, AND CAREGIVERS TO DEVELOP A SELF-CARE BUNDLE AS PART OF THE DIABETES CAREPAK PROJECT. THIS PACK IS BEING SCALED UP IN FOUR COUNTRIES IN AFRICA. MALAWI THE MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) PROJECT IN MALAWI FOCUSED ON OPTIMIZING ACCESS TO PRIMARY HEALTH CARE IN RURAL AREAS BY EVALUATING HEALTH SURVEILLANCE ASSISTANTS (HSAS) AND DEVELOPING A PLACEMENT MODEL. THIS EVALUATION HIGHLIGHTED TRAINING NEEDS AND GAPS AMONG HSAS. ADDITIONALLY, MACEPA CONDUCTED A MALARIA RISK STRATIFICATION ANALYSIS FOR 2022, IDENTIFYING DISTRICTS WITH THE HIGHEST MALARIA BURDEN TO INFORM 2024 INTERVENTION PLANNING AND MOSQUITO NET DISTRIBUTION. THE GATES FOUNDATION SOURCE PROJECT CONTRIBUTED TO DEVELOPING MEDICAL OXYGEN TREATMENT GUIDELINES AND INDICATORS FOR HEALTH CARE WORKER TRAINING IN MALAWI. IT ALSO CREATED A TOOL FOR BUDGETING AND PLANNING MEDICAL EQUIPMENT MAINTENANCE AND ESTIMATING ANNUAL SPARE PARTS NEEDS. THE GATES FOUNDATION SCALING UP ACCESS TO LIFESAVING EQUIPMENT (SCALE) PROJECT REVISED THE PHYSICAL ASSETS MANAGEMENT POLICY, OUTLINING MANAGEMENT PRACTICES FOR HEALTH ASSETS, AND DEVELOPED A COSTED IMPLEMENTATION PLAN. IT ALSO SUPPORTED THE CREATION OF WORKFLOWS FOR A MEDICAL EQUIPMENT MANAGEMENT SYSTEM BY EVALUATING USER REQUIREMENTS AND SECURING MOH ADOPTION. MALARIA VACCINE EXPANSION EFFORTS, FUNDED BY GIVEWELL, PROVIDED FINANCIAL AND TECHNICAL SUPPORT TO THE MINISTRY OF HEALTH'S EXPANDED PROGRAM ON IMMUNIZATION (MOH-EPI) ACROSS 11 DISTRICTS TO BOOST MALARIA VACCINE UPTAKE. THE TYVAC PROJECT FACILITATED THE INTRODUCTION OF THE TYPHOID CONJUGATE VACCINE THROUGH AN INTEGRATED CAMPAIGN IN MAY 2023. PATH SUPPORTED THE MOH-EPI BY DEVELOPING WORKPLANS, TRAINING DOCUMENTS, COMMUNICATION STRATEGIES, AND EDUCATIONAL MATERIALS, ENSURING EFFECTIVE DISTRIBUTION AND USE. PATH'S EXPERTISE IN VACCINE INTRODUCTION GARNERED $100,000 IN GAVI FUNDING TO AMPLIFY TYPHOID VACCINE MESSAGES THROUGH COMMUNITY RADIO STATIONS IN GAVI-SUPPORTED DISTRICTS OF CHITIPA, MZIMBA NORTH, MZIMBA SOUTH, KASUNGU, NTCHISI, DOWA, LILONGWE, MCHINJI, AND BLANTYRE. IN DIGITAL HEALTH TRANSFORMATION, PATH SUPPORTED MALAWI'S DIGITAL HEALTH TECHNICAL WORKING GROUP (TWG) AS SECRETARIAT, FACILITATING MEETINGS AND SUPPORTING A TOTAL OF THREE TWGS. PATH HAS SECONDED TWO STAFF MEMBERS TO MALAWI'S DIGITAL HEALTH DIVISION: A TECHNICAL ADVISOR AND A SOFTWARE DEVELOPER. THE ADVISOR COORDINATES MULTIPLE DIGITAL HEALTH INTERVENTIONS, INCLUDING ASSET MANAGEMENT, IMMUNIZATION REGISTRY, LEADERSHIP PROGRAMS, AND UPCOMING SUPPLY CHAIN PROJECTS. BOTH STAFF SUPPORT THE DEVELOPMENT OF AN INTEROPERABILITY LAYER, FOCUSING ON THE TERMINOLOGY REGISTRY. THIS REGISTRY, A KEY COMPONENT OF THE OPEN HEALTH INFORMATION EXCHANGE (OPENHIE) FRAMEWORK, STORES STANDARDIZED MEDICAL CONCEPTS TO ENSURE CONSISTENT TERMINOLOGY ACROSS HEALTH SYSTEMS. IT WORKS IN TANDEM WITH OTHER COMPONENTS LIKE THE HEALTH FACILITY REGISTRY AND PRODUCT CATALOG TO FACILITATE SYSTEM-WIDE INTEROPERABILITY. THIS APPROACH DEMONSTRATES PATH'S COMMITMENT TO STRENGTHENING MALAWI'S DIGITAL HEALTH INFRASTRUCTURE, ENHANCING SYSTEM EFFICIENCY AND DATA CONSISTENCY. MOZAMBIQUE IN MOZAMBIQUE, PATH, IN COLLABORATION WITH VARIOUS PARTNERS, HAS MADE SIGNIFICANT STRIDES IN EARLY CHILDHOOD DEVELOPMENT (ECD), MATERNAL MENTAL HEALTH, DIABETES CARE, AND DISEASE PREVENTION. THESE EFFORTS AIM TO INTEGRATE VITAL HEALTH SERVICES INTO THE NATIONAL HEALTH CARE SYSTEM, IMPROVING ACCESS AND OUTCOMES FOR DIVERSE POPULATIONS. THE FOLLOWING SUMMARY HIGHLIGHTS THE MAJOR ACHIEVEMENTS AND ONGOING EFFORTS IN THESE AREAS: THE CONRAD H. HILTON FOUNDATIONFUNDED EARLY CHILDHOOD DEVELOPMENT (ECD) PROJECT, PARTICULARLY IN PHASES 4 AND 5, SUPPORTED THE COMPLETION OF MOZAMBIQUE'S FIRST SUBNATIONAL MULTISECTORAL ECD ACTION PLAN, WHICH WAS APPROVED BY THE GOVERNOR OF MAPUTO PROVINCE. THIS ECD PROJECT ALSO PILOTED PERINATAL DEPRESSION SCREENING IN MATERNAL HEALTH SERVICES; CONDUCTED HUMAN-CENTERED DESIGN STUDY FOR ECD INTERVENTIONS IN PRIMARY HEALTH CARE; AND ASSISTED IN INTEGRATING ECD, NUTRITION, AND MATERNAL MENTAL HEALTH INTO NATIONAL POLICIES. THE DIABETES CAREPAK PROJECT, FUNDED BY THE HELMSLEY CHARITABLE TRUST, MAPPED THE CARE JOURNEY OF PEOPLE LIVING WITH DIABETES, CO-CREATED AND PILOTED A DIABETES CAREPAK WITH 50 PEOPLE LIVING WITH DIABETES, AND TRAINED 45 HEALTH PROVIDERS ON CAREPAK DISTRIBUTION AND SUPPORT. COMPLEMENTING THIS WORK, THE ASTRAZENECA HEALTHY HEARTS INITIATIVE ADDRESSED CO-MORBIDITY BETWEEN DIABETES AND HYPERTENSION, TRAINING 17 HEALTH PROFESSIONALS ON IMPROVED SCREENING AND MANAGEMENT AND EQUIPPING FACILITIES WITH BLOOD PRESSURE MONITORS AND EDUCATIONAL MATERIALS. PATH'S INVOLVEMENT IN THE DIGITAL COMMUNITY HEALTH INITIATIVE, FUNDED BY THE PRESIDENT'S MALARIA INITIATIVE, FOCUSED ON STRENGTHENING THE GOVERNANCE OF THE COMMUNITY HEALTH INFORMATION SUBSYSTEM, INCLUDING DIGITAL HEALTH TOOLS. THIS INCLUDED IMPROVING COLLABORATION BETWEEN PRIMARY HEALTH CARE AND HEALTH INFORMATION SYSTEMS DEPARTMENTS AND DEVELOPING AN IMPLEMENTATION PLAN FOR THE COMMUNITY HEALTH INFORMATION SUBSYSTEM. LASTLY, PATH CONDUCTED THE GLOBAL INSTITUTE FOR DISEASE ELIMINATION CLIMATE CHANGE AND INFECTIOUS DISEASES FORMATIVE STUDY ON THE USE OF CLIMATE DATA FOR HEALTH SYSTEM PREPAREDNESS IN RESPONSE TO INFECTIOUS DISEASE OUTBREAKS. THE PROJECT USED CYCLONE FREDDY, WHICH STRUCK MOZAMBIQUE IN EARLY 2023, AS A TEST CASE. THE RESULTS DEMONSTRATED THAT THE NATIONAL HEALTH INSTITUTE IS MAKING GOOD STRIDES IN PILOTING EARLY WARNING SYSTEMS AND MAINTAINS A CLIMATE AND HEALTH OBSERVATORY, BUT THAT HEALTH SYSTEM ACTORS ARE STILL NOT USING THE INFORMATION FOR TIMELY DECISION-MAKING. THE FINDINGS WERE PRESENTED AT A COP28 WEBINAR, AND A MANUSCRIPT IS CURRENTLY UNDER REVIEW FOR PUBLICATION IN THE JOURNAL OF CLIMATE CHANGE AND HEALTH. SENEGAL IN 2023, PATH SENEGAL CONTINUED TO PLAY A VITAL ROLE IN IMPROVING PUBLIC HEALTH THROUGH A RANGE OF IMPACTFUL PROJECTS. THESE EFFORTS INCLUDED ADVANCING MALARIA CONTROL AND ELIMINATION, ENHANCING COMMUNITY HEALTH INITIATIVES, STRENGTHENING OXYGEN AND RESPIRATORY CARE ECOSYSTEMS, AND IMPROVING CHILD ILLNESS MANAGEMENT. BY COLLABORATING WITH LOCAL HEALTH AUTHORITIES AND INTERNATIONAL PARTNERS, PATH'S WORK IS ESSENTIAL IN BUILDING A RESILIENT HEALTH CARE SYSTEM IN SENEGAL, ADDRESSING BOTH INFECTIOUS AND NONCOMMUNICABLE DISEASES, AND ENSURING SUSTAINABLE HEALTH IMPROVEMENTS FOR THE POPULATION. IN 2023, PATH SENEGAL WORKED PRIMARILY ON SIX PROJECTS: MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) IV, COMMUNITY CHAMPION PROJECT, COMMUNITY-BASED TEST AND TREATMENT RESPONSE TO MALARIA, SENEGAL STRENGTHEN OXYGEN UTILISATION AND RESPIRATORY CARE ECOSYSTEMS PROJECT, TOOLS FOR INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS (TIMCI), AND GLOBAL HEALTH SECURITY AGENDA (GHSA). BELOW ARE HIGHLIGHTS OF WHAT WE ACHIEVED UNDER EACH PROJECT. THE MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) IV FOCUSES ON ADVANCING DATA-DRIVEN, SUBNATIONALLY TAILORED MALARIA INTERVENTIONS AND TRANSITIONING FROM PRIORITIZED ELIMINATION AREAS IN HIGH-BURDEN AFRICAN REGIONS. IN 2023, MACEPA DEVOLVED MALARIA CASE INVESTIGATION ACTIVITIES TO THE HEALTH SYSTEM, PROVIDING TECHNICAL ASSISTANCE IN CAPACITY-BUILDING, DATA MANAGEMENT, RAPID REPORTING AUDITS, AND MONITORING. CAPACITY-BUILDING ACTIVITIES WERE CONDUCTED ACROSS REGIONS: 18 ACTIVITIES TRAINED 176 INDIVIDUALS IN THE NORTH, 30 ACTIVITIES TRAINED 205 PROVIDERS IN THE CENTRAL-WEST, AND 316 PROVIDERS ALONG WITH 400 COMMUNITY ACTORS WERE TRAINED IN THE SOUTHEAST. THESE EFFORTS ENABLED THE IMPLEMENTATION OF MALARIA CASE INVESTIGATION STRATEGIES DURING LOW TRANSMISSION PERIODS. MACEPA SUPPORTED DATA MANAGEMENT BY AIDING DISTRICTS IN CONFIGURING SMARTPHONES, INSTALLING THE DHIS2 TRACKER APPLICATION, AND MONITORING DATA. THE DATA WERE ANALYZED, DISSEMINATED, AND INCLUDED IN THE NATIONAL PROGRAM TO COMBAT MALARIA'S QUARTERLY REVIEWS. IN 2023, UNDER NATIONAL MALARIA CONTROL PROGRAM (NMCP) SUPERVISION, MACEPA EVALUATED THE PRIOR YEAR'S MALARIA INVESTIGATION ACTIVITIES THROUGH WORKSHOPS IN THIES, FATICK, AND SAINT LOUIS, INVOLVING PARTNERS LIKE PMI, CHEMONICS, WHO, AND UNIVERSIT GASTON BERGER. RECOMMENDATIONS WERE MADE TO IMPROVE ELIMINATION ACTIVITIES. SUPERVISION WAS CONDUCTED IN NORTHERN DISTRICTS AND THREE SAINT LOUIS HOSPITALS. A CENTRAL MACEPA MISSION VISITED REGIONS TO DISCUSS STAFF STATUS, TECHNICAL ASSISTANCE, THE USE OF UNITS MIXTES DE COORDINATION AVANCE (JOINT ADVANCED COORDINATION UNITS), AND FUTURE COLLABORATION PROSPECTS. |
| FORM 990, PART III, LINE 4D, DESCRIPTION OF PROGRAM SERVICE: | IN 2023, PATH DEVELOPED AND SHARED THE PROJECT MONITORING AND EVALUATION PLAN FOR THE COMMUNITY CHAMPION PROJECT, HELD A HARMONIZATION MEETING WITH SODEFITEX, AND LAUNCHED THE PROJECT WITH A WORKSHOP. WE TRAINED SUPERVISORS, REGIONAL AND DISTRICT MANAGEMENT TEAMS, AND COMMUNITY CHAMPIONS, UPDATED PROJECT MANAGEMENT TOOLS, IMPLEMENTED ACTIVITIES, AND MONITORED DATA QUALITY IN THE DHIS2 TRACKER. JOINT SUPERVISION OF STAKEHOLDERS WAS ORGANIZED, AND PROJECT DOCUMENTATION WAS INITIATED BY THE COMMUNICATIONS MANAGER. COMMUNITY CHAMPIONS CONDUCTED 3,723 HOME VISITS AND 635 TALKS, REACHING 26,979 PEOPLE16,482 THROUGH HOME VISITS AND 10,497 THROUGH TALKSON PREVENTING THE PROJECT'S FOUR TARGET ENDEMICS. ADDITIONALLY, 179 ADVOCACY AND 109 COMMUNITY DIALOGUES WERE HELD ACROSS ALL DISTRICTS OF THE TAMBACOUNDA REGION. THE YEAR 2023 CONSTITUTED THE FULL YEAR OF THE IMPLEMENTATION OF THE COMMUNITY-BASED TEST-AND-TREAT RESPONSE TO MALARIA, FUNDED BY WHO. WE ORGANIZED WEEKLY RESPONSE OUTINGS IN THE HOTSPOT VILLAGES OF THE INTERVENTION POSTS. WE HAD WEEKLY SUPERVISION OF HEAD NURSES AND MONTHLY SUPERVISION OF THE DISTRICT MANAGEMENT TEAM. WE ORGANIZED MONTHLY COORDINATION MEETINGS AT HEALTH POST LEVEL AND QUARTERLY SUPERVISION FROM THE CENTRAL LEVEL. WE CONDUCTED BI-WEEKLY VIRTUAL MONITORING MEETINGS OF PROJECT STAKEHOLDERS. IN RESPONSE TO THE COVID-19 PANDEMIC AND THE PROLIFERATION OF NATIONAL OXYGEN STRATEGIC PLANS, PATH COLLABORATED WITH THE SENEGAL MINISTRY OF HEALTH TO CONDUCT A BIOMEDICAL EQUIPMENT SURVEY IN HEALTH FACILITIES FROM NOVEMBER TO DECEMBER 2023. THIS SURVEY, INVOLVING MULTIPLE PARTNERS, PROVIDED A BASELINE OF OXYGEN DEVICE INVENTORIES AND IDENTIFIED GAPS IN SUPPLY. PATH VISITED 110 HEALTH FACILITIES IN 14 REGIONS AND OUTLINED SHORTCOMINGS THAT COULD HINDER OXYGEN SCALE-UP. THESE FINDINGS ARE INTEGRATED INTO THE SENEGAL OXYGEN ROADMAP, WITH DEMAND QUANTIFICATION AND FINAL ROADMAP DEVELOPMENT SUPPORTED BY UNICEF. TO ADDRESS THE LACK OF OXYGENOTHERAPY TRAINING HIGHLIGHTED BY THE SURVEY, PATH PLANS TO TRAIN PEDIATRICIANS, DOCTORS, MIDWIVES, NURSES, AND NEONATAL UNIT HEADS ON OXYGENOTHERAPY AT THE CHILD AND MATERNAL HEALTH CENTER OF EXCELLENCE IN CHEIKH ANTA DIOP UNIVERSITY, IN PARTNERSHIP WITH ALBERT ROYER CHILDREN HOSPITAL, IN MAY AND JUNE 2024. THE ELMA FOUNDATIONFUNDED SIMULATION AND MAINTENANCE LABORATORY IS NOW FULLY FUNCTIONAL, OFFERING REGULAR TRAINING FOR HEALTH WORKERS, BIOMEDICAL ENGINEERS, AND EXPERTS ON MAINTENANCE, ELECTRICITY NORMS, STANDARDS, AND RISK MANAGEMENT. FUTURE TRAINING PLANS INCLUDE ELECTRICAL CERTIFICATION IN ACCORDANCE WITH NFC 18-510, FIRE SAFETY TRAINING FOR AUDITORS, AND LOW VOLTAGE STANDARDS. PATH CONTINUES TO ADVOCATE FOR THE INCLUSION OF OXYGEN THERAPY TRAINING AT THE CENTER OF EXCELLENCE AND ALBERT ROYER CHILDREN HOSPITAL TO ENHANCE HEALTH CARE WORKERS' SKILLS IN REDUCING HYPOXEMIA AND NEONATAL MORTALITY. IN 2023, WE LEARNED THAT GATES FOUNDATION ANCHOR INVESTMENTS, SUCH AS SOURCE, ARE CATALYTIC IN ENABLING MINISTRIES OF HEALTH TO ENGAGE BROADER PARTNERS FOR CO-INVESTMENT, INCLUDING USAID (VIA FHI360), THE WORLD BANK, AND THE GLOBAL FUND, TO SUSTAIN GATES FOUNDATION ACHIEVEMENTS. DESPITE POLITICAL UNREST AND A TWO-YEAR HEALTH WORKER STRIKE IN SENEGAL, PATH REMAINED PROACTIVE AND ADAPTABLE, FINALIZING SUPPORT TO THE NEGLECTED TROPICAL DISEASE (NTD) PROGRAM. THIS INCLUDED PILOT TRAINING ON NTD PROCUREMENT AND SUPPLY CHAIN GUIDELINES, DEVELOPED EARLIER BY ACCESS DELIVERY AND PARTNERSHIP (ADP) FUNDED BY THE GOVERNMENT OF JAPAN. ADP WAS IMPLEMENTED BY A CONSORTIUM INCLUDING THE UNITED NATIONS DEVELOPMENT PROGRAMME, WHO, PATH, AND TDR/OMS. PATH WAS RESPONSIBLE FOR THE SUPPLY CHAIN STRENGTHENING. WE TRAINED 400 HEALTH WORKERS AND 6,438 AGENTS ON DRUG MANAGEMENT AND ADMINISTRATION, WITH DRUG WASTE AT 1% OR LESS AND HIGH COVERAGE TARGETS ACHIEVED (73% FOR FILARIOSIS AND 82% FOR SCHISTO-GEOHELMINTHIASIS). THE TRAINING ALSO PREPARED FOR PEDIATRIC PRAZIQUANTEL ROLLOUT IN SENEGAL. THE MINISTRY OF HEALTH COORDINATED A PREPARATORY MEETING ON RTS,S/R21 VACCINE INTRODUCTION, STRATEGIZING FOR PEDIATRIC MALARIA VACCINE ROLLOUT. WE ALSO PARTICIPATED IN THE RTS,S/R21 PLANNING MEETING IN GUINEA. MEETINGS WITH THE DIRECTORATE OF DISEASE CONTROL, THE DEPARTMENT OF NATIONAL INFORMATION SYSTEM, AND THE NATIONAL REGULATORY AUTHORITY'S PHARMACOVIGILANCE DEPARTMENT DISCUSSED USING MEDSAFETY FOR PEDIATRIC PRAZIQUANTEL DISTRIBUTION DUE TO ITS INTERACTIVITY WITH THE VIGIFLOW APP. FUTURE MEETINGS WITH THE SPECIAL UNITED NATIONS PROGRAM FOR RESEARCH AND OTHER COUNTRIES USING THE APP ARE PLANNED FOR EXPERIENCE SHARING AND SUPPORT. TOOLS FOR INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS (TIMCI) IS A GLOBAL PROJECT FUNDED BY UNITAID AIMED AT ENHANCING THE DIAGNOSTIC CAPABILITIES OF PRIMARY HEALTH CARE WORKERS. THE PROJECT EQUIPS WORKERS WITH PULSE OXIMETRY (POX) AND ELECTRONIC CLINICAL DECISION-SUPPORT ALGORITHMS (ECDSA) AND PROMOTES THE DEVELOPMENT OF NON-INVASIVE DEVICES THAT MEASURE ADDITIONAL VITAL SIGNS. LAUNCHED IN 2019 AND SCHEDULED TO CONCLUDE IN JUNE 2024, TIMCI IS IMPLEMENTED IN INDIA, KENYA, SENEGAL, AND TANZANIA. IN SENEGAL, TIMCI IS ACTIVE IN 60 HEALTH POSTS ACROSS FIVE DISTRICTS IN THE THIES REGION, MANAGED BY A CONSORTIUM INCLUDING THE MINISTRY OF HEALTH, PATH, SWISS TPH, AND UNIVERSIT CHEIKH ANTA DIOP. IN 2023, THE PROJECT PROVIDED SUPPORTIVE SUPERVISION, ON-SITE COACHING, AND SUPPORT FOR ESSENTIAL DRUG AND EQUIPMENT SUPPLY, ALONG WITH COMMUNITY ENGAGEMENT ACTIVITIES. RESEARCH CONTINUED IN 20 OF THE 60 PILOT SITES, AND A HYBRID STUDY TO TEST MULTIMODAL PULSE OXIMETER DEVICES WAS INITIATED IN TWO SITES. THE GLOBAL HEALTH SECURITY AGENDA (GHSA), A FIVE-YEAR PROJECT FUNDED BY THE US CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC), BEGAN IN 2015 TO STRENGTHEN PUBLIC HEALTH SYSTEMS IN COUNTRIES INCLUDING SENEGAL. PATH SENEGAL'S CONTRIBUTION TO GHSA ENCOMPASSES SIX KEY AREAS: PRIORITY DISEASE SURVEILLANCE, LABORATORY NETWORK STRENGTHENING, ANTIMICROBIAL RESISTANCE SURVEILLANCE, INFORMATION SYSTEMS ENHANCEMENT, VACCINATION, AND BIOSAFETY/BIOSECURITY. THESE ACTIVITIES ARE IMPLEMENTED IN PARTNERSHIP WITH VARIOUS DIRECTORATES OF THE MINISTRY OF HEALTH AND SOCIAL ACTION. (A) STRENGTHENING THE EPIDEMIOLOGICAL SURVEILLANCE SYSTEM: PATH SUPPORTED THE MINISTRY OF HEALTH AND SOCIAL ACTION IN IMPLEMENTING AND SCALING THE DHIS2 TRACKER TO ENHANCE DISEASE SURVEILLANCE FOR COVID-19 AND OTHER PRIORITY DISEASES IN SENEGAL. DEPLOYED IN 76 HEALTH DISTRICTS, TRAINED 152 DATA MANAGERS AND 10 OUTBREAK TREATMENT CENTER WORKERS, IMPROVING DATA COLLECTION, REPORTING, AND INTEROPERABILITY WITH LABORATORY RESULTS FOR A UNIFIED SURVEILLANCE PLATFORM. PATH ORGANIZED WORKSHOPS TO DEVELOP STANDARD OPERATING PROCEDURES FOR CASE-BY-CASE REPORTING AND MONITORING. SUPPORT INCLUDED SETTING UP THE DP'S SERVER AND COORDINATING QUARTERLY SURVEILLANCE TECHNICAL WORKING GROUP MEETINGS WITH THE DP AND THE HEALTH AND SOCIAL INFORMATION SYSTEM DIVISION (DSISS). PATH ALSO SUPERVISED STAFF IN DAKAR'S 20 MOST AFFECTED HEALTH DISTRICTS FOR COVID-19 DATA UPDATES AND ADAPTED DATA QUALITY ASSURANCE (AQD) TOOLS FOR THE DHIS2 TRACKER. A NOTABLE ACHIEVEMENT WAS DEVELOPING THE DHIS2 TRACKER FOR PRIORITY DISEASES, ENABLING CASE-BASED SURVEILLANCE AND STORING LABORATORY RESULTS IN THE SAME DATABASE. A NATIONAL-LEVEL TASK FORCE WAS ESTABLISHED TO TRAIN ALL HEALTH STRUCTURES IN SENEGAL. FOLLOWING A PILOT PHASE IN KAOLACK, SURVEILLANCE FOCAL POINTS (SFPS) FROM VARIOUS DISTRICTS WERE TRAINED ON NOTIFIABLE DISEASES VIA THE DHIS2 TRACKER, WITH 201 SFPS IN 46 DISTRICTS ACROSS 10 REGIONS TRAINED THIS YEAR, SETTING UP A CASE-BASED SURVEILLANCE SYSTEM AT THE CENTRAL LEVEL. (B) STRENGTHENING THE LABORATORY NETWORK: PATH SUPPORTED THE DIRECTORATE OF LABORATORIES (DL) IN IMPLEMENTING LABBOOK V3.0 IN VARIOUS LABORATORIES, INCLUDING THIAROYE NATIONAL HEALTH CENTER; REGIONAL HOSPITALS IN ZIGUINCHOR, THIS, FATICK, OUROSSOGUI, NDIOUM, AND KEDOUGOU; AND HEALTH CENTERS IN KHOMBOLE, THIS, AND PASSY. SUPERVISION ENSURED PROPER USE OF PATIENT DATA MANAGEMENT SOFTWARE, WITH POSITIVE FEEDBACK ON THE SPEED AND ACCURACY OF ANALYSES. ALL LABORATORY STAFF RECEIVED TRAINING IN BEST PRACTICES FOR DATA MANAGEMENT. PATH ALSO ASSISTED THE DL IN UPDATING AND ANALYZING LABORATORY MAPPING DATA FOR HUMAN RESOURCES AND EQUIPMENT ADVOCACY. DATA WERE COLLECTED FROM LABORATORIES IN DAKAR, THIS, KEDOUGOU, SDHIOU, LOUGA, TAMBACOUNDA, FATICK, KOLDA, MATAM, KAFFRINE, DIOURBEL, SAINT LOUIS, AND ZIGUINCHOR. THIS INITIATIVE AIMED TO PROVIDE ACCESSIBLE LABORATORY SERVICES ACROSS ALL LEVELS OF THE HEALTH SYSTEM, ENSURING PATIENTS RECEIVE TIMELY AND INFORMED CARE. PATH'S SUPPORT ENABLED THE DL TO CREATE A NATIONAL PLATFORM FOR LABORATORY SERVICES INFORMATION. |
| FORM 990, PART III, LINE 4D, DESCRIPTION OF PROGRAM SERVICE: | (C) STRENGTHENING ANTIMICROBIAL RESISTANCE SURVEILLANCE: PATH SUPPORTED THE DIRECTORATE OF LABORATORIES IN QUALITY ASSURANCE AND ANALYSIS OF ANTIMICROBIAL RESISTANCE (AMR) DATA IN DHIS2. IN MAY 2022, A WORKSHOP WAS HELD TO PRESENT THE ANALYSIS OF AMR DATA COLLECTED BETWEEN 2016 AND 2020. RECOMMENDATIONS INCLUDED UPDATING THE DHIS2 PLATFORM TO MONITOR TARGETED BACTERIA, IMPROVING DATA MANAGEMENT FOR BACTERIAL RESISTANCE SURVEILLANCE, AND ALLOWING DETAILED ENTRY OF BACTERIA IDENTITIES. ANOTHER WORKSHOP IN AUGUST 2022 DISCUSSED THE VALIDITY OF RESULTS AND PROVIDED RECOMMENDATIONS FOR IMPROVING AMR DATA COLLECTION, SHARING, AND PERFORMANCE ACTION PLANS. SOUTH AFRICA IN 2023, PATH'S ADVOCACY AND PUBLIC POLICY TEAM CONTINUED TO DRIVE SUSTAINABLE POLICY CHANGE IN SOUTH AFRICA. THE TEAM PARTICIPATED IN COALITIONS LIKE THE SOUTH AFRICAN HEALTH TECHNOLOGIES ADVOCACY COALITION (SAHTAC), PROVIDING STRATEGIC INPUT AND TECHNICAL EVIDENCE TO ACHIEVE SHARED GOALS. ANOTHER MILESTONE WAS THE DESIGNATION OF THE SOUTH AFRICAN HEALTH PRODUCTS REGULATORY AUTHORITY (SAHPRA) AS A REGIONAL CENTRE OF REGULATORY EXCELLENCE FOR VACCINE REGULATORY OVERSIGHT FOR A FOUR-YEAR PERIOD. PATH FACILITATED THIS BY ALERTING SAHPRA TO THE OPPORTUNITY AND CONNECTING THEM WITH THE PRIVATE OFFICE OF THE PRESIDENT TO GARNER POLITICAL SUPPORT FOR SOUTH AFRICA HOSTING THE REGIONAL CENTRE OF REGULATORY EXCELLENCE (RCORE). IN JUNE 2023, PATH LEVERAGED THE AFRICA HEALTH EXCON TO ENGAGE HIGH-PROFILE DECISION-MAKERS, PROVIDING TECHNICAL EXPERTISE TO SHAPE THE EVENT'S AGENDA FOR THE THREE-DAY PUBLIC HEALTH TRACK. THIS PLATFORM ENABLED US TO PROGRESS THE CONVERSATION ON REGULATORY SYSTEMS STRENGTHENING, ADVOCATE FOR THE RATIFICATION AND OPERATIONALIZATION OF THE AFRICAN MEDICINES AGENCY (AMA), CREATE INCREASED VISIBILITY FOR THE MANUFACTURING PRINCIPLES, AND GATHER SUPPORT FOR FUNDING TOWARD THE AFRICAN UNION (AU) EPIDEMIC FUND. PATH SUPPORTED THE DRAFTING OF A CALL TO ACTION TO ENSURE ALIGNMENT WITH GLOBAL AND REGIONAL COMMITMENTS AND POLICY EFFORTS. THIS DIRECTLY INFLUENCED PRESIDENT RAMAPHOSA'S REMARKS TO AFRICAN HEADS OF STATE AT THE AU MID-TERM SUMMIT IN JULY 2023. PATH CONTRIBUTED TO THE DEVELOPMENT OF THE HEALTH TECHNOLOGIES MASTERPLAN THROUGH VARIOUS TECHNICAL WORKING GROUPS, SHARING MANUFACTURING LANDSCAPES TO ENSURE THE PLAN IS GROUNDED IN CURRENT MARKET REALITIES. PATH DRAFTED A JOINT WORKPLAN WITH THE MEDICAL DEVICE AND DIAGNOSTIC INNOVATION CLUSTER (MEDDIC), WHICH LEADS THE WORKING GROUP FOR CREATING AN ENABLING ECOSYSTEM, AND PROVIDED FEEDBACK TO THE DEPARTMENT OF TRADE, INDUSTRY AND COMPETITION REPRESENTATIVE ON THE DRAFT POLICY. IN PARTICULAR, WE SHARED MANUFACTURING LANDSCAPES PRODUCED BY PATH'S DIAGNOSTICS AND VACCINES TEAMS TO ENSURE THE PLAN IS GROUNDED IN CURRENT MARKET REALITIES. WHILE THIS WORK SLOWED IN 2023 DUE TO COMPETING GOVERNMENT PRIORITIES, PATH CONTINUES TO ENGAGE WITH KEY STAKEHOLDERS. PATH EXPANDED ITS TECHNICAL ASSISTANCE TO THE PRIVATE OFFICE OF THE PRESIDENT (POP) IN SOUTH AFRICA, SUPPORTING PRESIDENT RAMAPHOSA'S ADVOCACY FOR LOCAL MANUFACTURING, PANDEMIC PREPAREDNESS, AND EQUITABLE ACCESS TO HEALTH PRODUCTS. THIS SUPPORT INCLUDED DRAFTING MATERIALS FOR HIGH-LEVEL EVENTS LIKE THE UN GENERAL ASSEMBLY (UNGA) AND G20. PERHAPS MOST NOTABLY, AT THE UNGA, AT THE REQUEST OF THE POP, WE PROVIDED FINANCIAL, TECHNICAL, AND LOGISTIC SUPPORT TO HOST A HIGH-LEVEL SIDE EVENT, "ADVANCING PANDEMIC PREVENTION, PREPAREDNESS AND RESPONSE: A FOCUS ON LOCAL MANUFACTURE OF HEALTH PRODUCTS AND TECHNOLOGIES IN AFRICA," WHICH WAS ATTENDED BY AROUND 250 PEOPLE INCLUDING PRESIDENT RAMAPHOSA, THE AUC CHAIRPERSON, THE DIRECTOR GENERAL OF AFRICA CDC, US ADMINISTRATION OFFICIALS, AND MINISTERS FROM SEVERAL AU MEMBER STATES. WE ALSO SUPPORTED THE POP'S ENGAGEMENT AT THE BRICS SUMMIT, NAMELY IN A SESSION ORGANIZED WITH AFRICA CDC, AFRICA HEALTH BUSINESS, AND THE SOUTH AFRICAN CHAPTER OF THE BRICS BUSINESS COUNCIL, WHERE PARTICIPANTS DELIBERATED ON THE POTENTIAL AU AND BRICS FRAMEWORK OF COOPERATION FOR PANDEMIC PREPAREDNESS, PREVENTION, RESPONSE, AND RECOVERY (3P2R). FINALLY, WE SUPPORTED THE POP'S ENGAGEMENT AT THE 18TH HEADS OF STATE AND GOVERNMENT SUMMIT OF THE G20. THIS SUMMIT IN 2023 WAS A SIGNIFICANT MILESTONE AS THREE BRICS FOUNDING MEMBERSINDIA (2023), BRAZIL (2024), AND SOUTH AFRICA (2025)FORMED THE "GLOBAL SOUTH" G-20 TROIKA. PATH SUPPORTED IN THE DEVELOPMENT OF STRATEGIC AGENDA DOCUMENTS THAT THE PRESIDENT USED TO RALLY SUPPORT FROM THE G20 AND TROIKA TO STRENGTHEN HEALTH SYSTEMS FOR 3P2R. TANZANIA PATH HAS BEEN INSTRUMENTAL IN ADVANCING VARIOUS HEALTH INITIATIVES IN TANZANIA, FOCUSING ON DIGITAL HEALTH, DATA USE, AND SYSTEM STRENGTHENING ACROSS MULTIPLE PROJECTS. THE DATA USE PARTNERSHIP (DUP), FUNDED BY THE GATES FOUNDATION, SUPPORTED THE ESTABLISHMENT OF THE CENTRE FOR DIGITAL HEALTH, WHICH AIMS TO INTEGRATE DIGITAL HEALTH INTERVENTIONS ACROSS ALL LEVELS OF THE HEALTH SYSTEM. CONCURRENTLY, THE HEALTH INFORMATION SYSTEM STRENGTHENING INITIATIVE FOR HIV AND TB IMPLEMENTED A BIOMETRIC FINGERPRINT MODEL AT 2,415 SITES, IDENTIFYING NEARLY 869,611 UNIQUE AND DUPLICATE CLIENTS, WHILE ALSO IMPROVING HEALTH FACILITY REGISTRATION AND TRAINING HEALTH CARE WORKERS ON DIGITAL SYSTEMS. THE CENTRE OF DIGITAL AND DATA EXCELLENCE (CODE) PROJECT COLLABORATED WITH THE TANZANIA MINISTRY OF HEALTH TO DEVELOP AND IMPLEMENT A UNIFIED COMMUNITY SYSTEM IN 21 REGIONS. THIS INITIATIVE ALSO SUPPORTED THE IMPLEMENTATION OF HEALTH INFORMATION MEDIATORS IN BOTH TANZANIA AND ZANZIBAR, IMPROVING DATA EXCHANGE AND QUALITY ACROSS HEALTH SYSTEMS. PATH'S WORK IN IMMUNIZATION WAS BOLSTERED BY THE GAVI-TCA FUNDED PROJECT, WHICH ENHANCED THE ELECTRONIC IMMUNIZATION SYSTEM, INCLUDING THE TANZANIA ELECTRONIC IMMUNIZATION REGISTRY. THIS PROJECT PROVIDED TECHNICAL SUPPORT TO 184 DISTRICTS AND ASSISTED IN THE DEVELOPMENT OF A DIGITAL IMMUNIZATION CAMPAIGN SYSTEM. THE USAID-FUNDED INFECTIOUS DISEASE DETECTION AND SURVEILLANCE (IDDS) PROJECT IMPROVED AMR AWARENESS, SPECIMEN REFERRAL, AND TUBERCULOSIS (TB) TESTING CAPABILITIES. IT SUPPORTED THE REVIEW OF THE NATIONAL AMR SURVEILLANCE FRAMEWORK AND TRAINED LABORATORY STAFF ON NEW TECHNOLOGIES FOR PEDIATRIC TB TESTING. THE TOOLS FOR INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESSES (TIMCI) PROJECT ACCELERATED THE ADOPTION OF TOOLS TO IDENTIFY SEVERE ILLNESS IN CHILDREN UNDER FIVE, PROVIDING APPROPRIATE MANAGEMENT TO OVER 59,000 CHILDREN THROUGH CLINICAL DECISION-SUPPORT ALGORITHMS. THE DIABETES CAREPAK PROJECT INTRODUCED AN INNOVATIVE SOLUTION TO ENHANCE ACCESS TO NECESSARY PRODUCTS AND INFORMATION FOR PEOPLE WITH DIABETES. A STUDY OF 50 INDIVIDUALS USING THE CAREPAK PROTOTYPE SHOWED HIGH ACCEPTANCE AND USAGE, WITH A MEAN REDUCTION IN HBA1C LEVELS. LASTLY, THE STRENGTHENING OXYGEN UTILIZATION AND RESPIRATORY CARE ECOSYSTEMS (SOURCE) PROJECT AIMED TO IMPROVE ACCESS TO HIGH-QUALITY MEDICAL OXYGEN SERVICES ACROSS TANZANIA'S HEALTH CARE SYSTEM. THIS INITIATIVE INCLUDED TRAINING ON MEDICAL EQUIPMENT MANAGEMENT, PREVENTIVE MAINTENANCE, AND THE IMPLEMENTATION OF A MEDICAL EQUIPMENT AND INFRASTRUCTURE MANAGEMENT INFORMATION SYSTEM. THESE DIVERSE PROJECTS DEMONSTRATE PATH'S COMPREHENSIVE APPROACH TO IMPROVING HEALTH SYSTEMS AND OUTCOMES IN TANZANIA, WITH A STRONG FOCUS ON LEVERAGING DIGITAL TECHNOLOGIES AND DATA-DRIVEN SOLUTIONS. UGANDA IN 2023, PATH'S ADVOCACY AND PUBLIC POLICY PROJECT IN UGANDA ADVANCED THE TRANSITION OF MUCH OF THE NATIONAL-LEVEL ADVOCACY WORK TO LOCALLY LED ORGANIZATIONS, BUILDING ON THE APPROVED TRANSITION MODEL AND DOCUMENTING LESSONS LEARNED ON ENABLERS FOR SUCCESSFUL TRANSITIONS. FOLLOWING ADDITIONAL CAPACITY STRENGTHENING IN EARLY 2023, INCLUDING THE TRAINING OF A COHORT OF 15 TRAINERS TO CASCADE PATH'S ADVOCACY STRATEGY DEVELOPMENT APPROACH AND ONGOING MENTORSHIP, WE CONTINUED TO WITNESS EVIDENCE OF GROWTH FROM THE REPRODUCTIVE, MATERNAL, NEWBORN, ADOLESCENT, AND CHILD HEALTH (RMNACH) PLATFORM, THE PHC THINK TANK, THE MEDICAL OXYGEN COALITION, AND THE IMMUNIZATION PARTNERS WORKING GROUP. THIS GROWTH INCLUDED STRONG COORDINATION THAT ENABLED THEM TO INFLUENCE KEY POLICY PROCESSES. |
| FORM 990, PART III, LINE 4D, DESCRIPTION OF PROGRAM SERVICE: | PATH SUPPORTED THE IMPLEMENTATION OF THE NATIONAL IMMUNIZATION STRATEGY THAT WE HELPED DEVELOP IN PREVIOUS YEARS AND CONDUCTED A NONPARTISAN ANALYSIS OF THE UGANDA PUBLIC HEALTH (AMENDMENT) ACT 2022 AND ITS IMPLICATIONS FOR THE COUNTRY'S IMMUNIZATION PROGRAM. THIS ANALYSIS WAS SHARED WITH THE UGANDA NATIONAL EXPANDED PROGRAM ON IMMUNIZATION (UNEPI) TO INFORM ITS PROGRAMMING, AND WITH UGANDA'S PARLIAMENTARY HEALTH COMMITTEE. PATH ALSO PROVIDED SUPPORT TO THE MOH TO UPDATE NATIONAL CHOLERA POLICIES. WE HELD SUCCESSFUL WORKSHOPS TO DEVELOP DRAFT STRATEGIC PLANS. IN UGANDA, PATH SUPPORTED THE GOVERNMENT IN UPDATING KEY EXISTING BUT OUTDATED POLICIES FOR MNCH AND MEDICAL OXYGEN. A KEY WIN AND VALIDATION OF OUR APPROACH WAS THE FINALIZATION AND LAUNCH OF UGANDA'S REVISED REPRODUCTIVE MATERNAL NEWBORN CHILD ADOLESCENT & HEALTHY AGING AND NUTRITION SHARPENED PLAN 2021/222025/26. SIMILARLY, PATH PROVIDED TECHNICAL ASSISTANCE TO THE MOH TO UPDATE THE EXPIRED NATIONAL MEDICAL OXYGEN SCALE-UP PLAN. BUILDING ON WORK DONE IN 2022 TO DRAFT THE NEW ITERATION OF THE PLAN, WE WORKED TO ENSURE THE PLAN HAS ADEQUATE STRATEGIES FOR STAKEHOLDER ENGAGEMENT AND INCLUDES ESTABLISHMENT OF A MEDICAL OXYGEN TECHNICAL WORKING GROUP, AS WELL AS INCLUSION OF RESOURCE MOBILIZATION INDICATORS. THE UGANDA SELF-INJECTION (SI) SCALE-UP PROJECT, LED BY THE MOH WITH SUPPORT FROM PATH AND OTHER PARTNERS, SUCCESSFULLY EXPANDED THE ACCESSIBILITY AND PRACTICE OF SI CONTRACEPTION ACROSS UGANDA. KEY ACHIEVEMENTS INCLUDED TRAINING OVER 3,500 PUBLIC-SECTOR PROVIDERS AND MORE THAN 6,000 NEW HEALTH PROVIDERS ON SI. COMMUNITY OUTREACH EFFORTS RESULTED IN LAY HEALTH WORKERS NOW COMPRISING OVER 75% OF SI PROVIDERS, WITH DRUG SHOPS APPROVED TO OFFER SI SERVICES. UGANDA'S SI PROTOCOL ALLOWED WOMEN TO SELF-INJECT AT THEIR FIRST VISIT AND RECEIVE A YEAR'S SUPPLY OF CONTRACEPTION. IT WAS ALSO NOTED THAT SI DATA COLLECTION EXPANDED TO 55 DISTRICTS WITH OVER 900 FACILITIES REPORTING. UGANDA HAD THE HIGHEST PERCENTAGE OF DMPA-SC VISITS, WITH ONE-THIRD OF DMPA-SC VISITS FOR SI AS OF Q2 2023. RESPONDING TO CHALLENGES IN STOCK MANAGEMENT, PATH IMPLEMENTED TRAINING ON INVENTORY TRACKING AND STOCK RECONCILIATION TO ADDRESS SUPPLY CHAIN ISSUES. ANOTHER CHALLENGE WAS RESOURCE LIMITATIONS, WHICH WERE ADDRESSED BY ONGOING EFFORTS TO RESOLVE FUNDING SHORTAGES IMPACTING DISTRIBUTION. FUTURE DIRECTIONS INCLUDE A FOCUS ON RESOLVING SUPPLY CHAIN CHALLENGES. IT WAS RECOMMENDED THAT THERE SHOULD BE CONTINUITY OF EXPANDING ACCESS AND MAINTAINING SERVICE DELIVERY STANDARDS, AND TO SUSTAIN MOH SUPPORT AND ENHANCE PARTNER COLLABORATION. IN MARCH 2023, AN ACTION PLANNING MEETING IDENTIFIED ACTIONS TO IMPROVE DMPA-SC AND SI SCALE-UP, INCLUDING STAKEHOLDER COORDINATION, DATA MANAGEMENT, LAST-MILE DISTRIBUTION, AND PHARMACY CHANNEL EXPANSION. PATH AND PARTNERS ALSO ADVOCATED FOR THE MINISTRY OF HEALTH TO ADOPT AN HMIS (HEALTH MANAGEMENT INFORMATION SYSTEM) ADDENDUM FOR REPORTING DMPA-SC ADMINISTRATION AND SI, WITH UPDATES BEING IMPLEMENTED IN DHIS2. AS OF JUNE 2023, THE DMPA-SC ACCESS COLLABORATIVE PROJECT HAD ACHIEVED 93% OF THE PUBLIC-SECTOR SERVICE DELIVERY POINTS PROVIDING SELF-INJECTION. PATH HOSTED THE ZAMBIAN DELEGATION TO SHOWCASE UGANDA'S COMMUNITY-BASED SI SERVICES AND LEARN ABOUT ZAMBIA'S PHARMACY-BASED SERVICES. ADDITIONALLY, WE IMPLEMENTED A SUPPLY CHAIN ASSESSMENT THAT RECOMMENDED TRAINING-OF-TRAINERS ON THE IMPACT TEAM, DATA REVIEW APPROACH, AND DISSEMINATION OF SUPPLY CHAIN POLICIES IN THREE DISTRICTS. PATH PRESENTED ON PRODUCT SCALE-UP AND RECOMMENDED INDICATORS FOR SI SERVICE DELIVERY AT THE INTERNATIONAL CONFERENCE ON FAMILY PLANNING. THE UGANDA MOH APPROVED THE NATIONAL INTRODUCTION/SCALE-UP AND USE OF THE AQUA RESEARCH STREAM DISINFECTANT GENERATOR (STREAM) FOR THE UGANDA HEALTH SYSTEM IN JUNE 2023. THE STREAM IS AN ON-SITE CHLORINE GENERATOR THAT PRODUCES A CONSISTENT 0.5% (OR 5000 MG/L) OF HYPOCHLORITE SOLUTION USING COMMONLY AVAILABLE INPUTS: SALT, WATER, AND ELECTRICITY. THE DEVICE IS A PRACTICAL TOOL FOR HEALTH CARE STAFF TO IMPROVE INFECTION PREVENTION AND CONTROL PRACTICES, AS WELL AS WATER TREATMENT. IN SEPTEMBER 2023, PATH AND THE MOH PRESENTED THE RESULTS OF THE STREAM EVALUATION TO KEY STAKEHOLDERS. THE ACTING COMMISSIONER OF CLINICAL SERVICES DEPARTMENT (MOH) PRESENTED 18 MONTHS OF DATA FROM TEN STREAM UNITS DEPLOYED TO TEN HEALTH FACILITIES IN UGANDA, RANGING FROM HEALTH CENTRES III TO REGIONAL REFERRAL HOSPITALS. RESULTS SHOWED THAT OVER 76,000 LITERS OF HYPOCHLORITE SOLUTION HAD BEEN PRODUCED AND USED BY THE HEALTH FACILITIES BETWEEN 2020 AND 2023. USAGE OF THE STREAM DEVICES RESULTED IN A 35% COST SAVINGS PER LITER. HEALTH PROFESSIONALS FOUND THE STREAM TO BE HIGHLY USEFUL FOR INFECTION PREVENTION AND CONTROL (IPC) PRACTICES. THE MINISTER OF HEALTH CALLED UPON PARTNERS TO SUPPORT PROCUREMENT OF THE DEVICE FOR HEALTH FACILITIES WITH HEAVY WORKLOADS AND EXPRESSED HER GRATITUDE FOR PATH'S PAST AND FUTURE SUPPORT OF OFFERING 50 STREAM DEVICES ACROSS THE COUNTRY. THE MINISTER OF HEALTH CALLED UPON PATH AND AQUA RESEARCH TO EXPLORE FINANCING MODELS THAT WOULD ENABLE THE GOVERNMENT TO INSTALL STREAM DEVICES ACROSS THE 2,600 HEALTH FACILITIES UNDER ITS JURISDICTION TO SUPPORT INFECTION PREVENTION AND CONTROL THROUGH ON-SITE CHLORINE PRODUCTION. THE APPROVAL OF THE STREAM FOR NATIONAL SCALE-UP REPRESENTS A CRITICAL MILESTONE FOR THE HEALTH SECTOR AND PATH, PAVING THE WAY FOR NATIONAL SCALE-UP AND DISTRICT IMPLEMENTATION PLANS. THE BECKON FOUNDATION FUNDED A PROJECT TO ENGAGE YOUNG WOMEN IN CO-CREATING INTEGRATED SERVICE DELIVERY MODELS FOR HIV PREVENTION (PRE-EXPOSURE PROPHYLAXIS, OR PREP) AND FAMILY PLANNING IN UGANDA USING A HUMAN-CENTERED DESIGN APPROACH. TEN PATH UGANDA STAFF WERE TRAINED IN THIS APPROACH BY LIVING LABS ZAMBIA. FOUR YOUNG WOMEN WERE IDENTIFIED, TRAINED, AND MENTORED AS PEER RESEARCHERS, WHO COLLECTED AND ANALYZED DATA, WROTE REPORTS, AND ONE EVEN SUBMITTED AN ABSTRACT ACCEPTED FOR PRESENTATION AT AIDS2024 IN GERMANY. THE PROJECT ENGAGED 128 STAKEHOLDERS TO EXPLORE SERVICE DELIVERY MODELS FOR INTEGRATING HIV PREVENTION (PREP) AND FAMILY PLANNING FOR YOUNG WOMEN. CO-CREATION WORKSHOPS WITH YOUNG WOMEN AND HEALTH CARE PROVIDERS WERE HELD TO DEVELOP THESE INTEGRATED SERVICE DELIVERY MODELS. FINDINGS FROM STAKEHOLDER ENGAGEMENT WERE DISSEMINATED TO THE MOH, THE TECHNICAL ADVISORY BOARD, AND DISTRICT LEADERSHIP. A MANUSCRIPT WAS SUBMITTED TO HEALTH FRONTIER JOURNAL AND IS AWAITING FEEDBACK. THE CO-CREATED SERVICE DELIVERY MODELS ARE NOW AWAITING PILOTING AND POTENTIAL SCALE-UP. THROUGHOUT THE PROJECT, THERE WAS MONTHLY ENGAGEMENT WITH NATIONAL AND GLOBAL TECHNICAL WORKING GROUPS FOR GUIDANCE DURING IMPLEMENTATION. THE USAID INFECTIOUS DISEASE DETECTION AND SURVEILLANCE (IDDS) PROJECT AIMS TO ENHANCE DIAGNOSTIC CAPACITY, REAL-TIME SURVEILLANCE, AND THE DETECTION OF DRUG-RESISTANT TB IN UGANDA. BY STRENGTHENING THE NATIONAL LABORATORY SYSTEM, IMPROVING DATA ANALYSIS TOOLS, AND EXPANDING DIAGNOSTIC CAPABILITIES, PATH IS CONTRIBUTING TO MORE EFFECTIVE DISEASE MANAGEMENT AND IMPROVED HEALTH OUTCOMES IN UGANDA. PATH ENHANCED DIAGNOSTIC CAPACITY IN UGANDA'S ANIMAL HEALTH SECTOR BY DEVELOPING QUALITY MANAGEMENT SYSTEMS AS PART OF NATIONAL LABORATORY SYSTEM STRENGTHENING. THIS EFFORT HELPED TWO VETERINARY LABORATORIESTHE MBALE VETERINARY AND DIAGNOSTICS LABORATORY AND THE UGANDA WILDLIFE AUTHORITY DIAGNOSTICS AND RESEARCH LABORATORYMOVE TOWARD INTERNATIONAL ACCREDITATION FROM THE SOUTH AFRICAN NATIONAL ACCREDITATION SYSTEM (SANAS) BASED ON ISO/IEC 17025:2017 STANDARDS. SUPPORTED BY THE IDDS PROJECT, THE ACCREDITATION APPLICATIONS WERE SUBMITTED DURING THE THIRD QUALITY MANAGEMENT SYSTEM MENTORSHIP FROM AUGUST 13-25, 2023. PATH WORKED TO IMPROVE REAL-TIME SURVEILLANCE AND DATA ANALYSIS OF PRIORITY ZOONOTIC DISEASES IN UGANDA'S ANIMAL HEALTH SECTOR BY DEVELOPING A MACRO-ENABLED EXCEL TOOL FOR ENHANCED DATA ENTRY AT SURVEILLANCE SITES. PILOTED IN 2021 IN FOUR DISTRICTS (GULU, MBALE, MBARARA, AND MOROTO), THE TOOL AUTOMATES TASKS AND INTEGRATES WITH OTHER DIGITAL TOOLS FOR INDICATOR-BASED SURVEILLANCE TO COLLECT, MONITOR, AND ANALYZE DISEASE OUTBREAK DATA. AFTER FEEDBACK FROM AN EARLY 2022 PILOT, THE REVISED TOOL WAS LAUNCHED IN 34 OF UGANDA'S 111 DISTRICTS DURING A HYBRID WORKSHOP ON JUNE 19, 2023, IN JINJA DISTRICT. |
| FORM 990, PART III, LINE 4D, DESCRIPTION OF PROGRAM SERVICE: | PATH EXPANDED UGANDA'S DIAGNOSTIC CAPACITY FOR DRUG-RESISTANT TB BY PROCURING AND INSTALLING TWO GENEXPERT INSTRUMENTS AT LIRA AND MBARARA REGIONAL REFERRAL LABORATORIES. SUPPORTED BY THE IDDS PROJECT, THIS INITIATIVE INCLUDED TRAINING HOSPITAL STAFF FROM JUNE 5-9, 2023. THE ADVANCED GENEXPERT INSTRUMENTS DETECT MULTIPLE MYCOBACTERIUM TUBERCULOSIS MUTATIONS FROM A SINGLE SPECIMEN, IDENTIFYING RESISTANCE TO ISONIAZID, FLUOROQUINOLONES, AND OTHER SECOND-LINE DRUGS. THIS TECHNOLOGY ENHANCES DRUG SUSCEPTIBILITY TESTING, ENABLING FASTER, MORE ACCURATE RESULTS, AND ALLOWING IMMEDIATE ADJUSTMENT OF TREATMENTS TO IMPROVE PATIENT OUTCOMES AND REDUCE HEALTH CARE COSTS. PATH SUPPORTED UGANDA'S MOH IN IMPLEMENTING WHO'S THIRD ROLLOUT OF INTEGRATED DISEASE SURVEILLANCE AND RESPONSE (IDSR) IN BUIKWE AND BUVUMA DISTRICTS IN THE SSEZIBWA REGION. IN FEBRUARY 2023, 109 STAFF, INCLUDING HEALTH WORKERS FROM 32 HEALTH FACILITIES AND VETERINARIANS, WERE TRAINED IN BUIKWE. IN THE REMOTE BUVUMA DISTRICT, CONSISTING OF 52 SCATTERED ISLANDS, 30 STAFF, INCLUDING HEALTH WORKERS, A FISHERIES OFFICER, AND VETERINARIANS, RECEIVED TRAINING IN OCTOBER 2023. THESE NEW IDSR GUIDELINES ENHANCE THE DISTRICTS' CAPACITY TO REPORT CASES AND DETECT PRIORITY DISEASES, IMPROVING THEIR ABILITY TO PREVENT AND RESPOND TO EMERGING THREATS. THE DIGITAL RESULTS IMPROVE VACCINE EQUITY (DRIVE) DEMAND PROJECT EVALUATED THREE DIGITAL HEALTH TOOLS AT NATIONAL AND SUBNATIONAL LEVELS, SHARING DOCUMENTED RESULTS WITH BOTH. TRAINING INCLUDED 14 NATIONAL-LEVEL TRAINERS AND OVER 150 BIOSTATISTICIANS AND DATA OFFICERS FROM ALL 146 DISTRICTS OF UGANDA IN GEOSPATIAL INFORMATION SYSTEMS. ADDITIONALLY, 24 DATA MANAGERS IN WAKISO DISTRICT WERE TRAINED ON DATA USE AND QUALITY IMPROVEMENT, AND 106 HEALTH WORKERS WERE MENTORED IN DATA QUALITY IMPROVEMENT THROUGH SUPPORTIVE SUPERVISION. THE PROJECT ALSO ENGAGED 25 ELEMENTARY SCHOOL TEACHERS IN AN SBC WORKSHOP TO ADDRESS VACCINE HESITANCY AND ACCEPTANCE, EQUIPPING THEM AS LOCAL TRUSTED CHAMPIONS. A SUSTAINABILITY ROADMAP WAS DEVELOPED WITH INPUT FROM 25 MOH PERSONNEL DURING AN ENGAGEMENT WORKSHOP. TWO NATIONAL-LEVEL HPV REVITALIZATION MEETINGS WERE HOSTED AS PART OF THE PARTNER ENGAGEMENT FRAMEWORK (PEF) TARGETED COUNTRY ASSISTANCE (TCA). THE AIM WAS TO REVIEW AND ALIGN PARTNERS' TECHNICAL ASSISTANCE WITH THE UPDATED HPV COVERAGE IMPROVEMENT AND REVITALIZATION PLAN. THE DEVELOPMENT OF UGANDA SCHOOL HEALTH GUIDELINES WAS SUPPORTED, AND A READINESS ASSESSMENT FOR COLD CHAIN EQUIPMENT DEPLOYMENT WAS CONDUCTED IN OVER 500 HEALTH FACILITIES NATIONWIDE. TWO CIVIL SOCIETY ORGANIZATIONS (CSOS)INPACT AND BUSOGA HEALTH FORUMWERE SUBGRANTED TO SUPPORT HPV VACCINATION DEMAND GENERATION IN ANKOLE AND BUSOGA REGIONS, LEADING TO INCREASED HPV VACCINE COVERAGE. ADVOCACY MEETINGS WITH PARLIAMENTARIANS AND CSOS WERE HELD TO PUSH FOR INCREASED DOMESTIC FINANCING FOR IMMUNIZATION. FINALLY, PATH DEVELOPED AND IMPLEMENTED A STAKEHOLDER ENGAGEMENT PLAN FOR THE UGANDA LEARNING HUB CONSORTIUM AS PART OF THE GAVI IMMUNIZATION LEARNING HUB. ACTIVITIES INCLUDED CONDUCTING A DESK REVIEW, SECONDARY DATA ANALYSIS, KEY INFORMANT INTERVIEWS, AND IN-DEPTH INTERVIEWS, AS WELL AS DOCUMENTING REPORTS ON BARRIERS TO REACHING ZERO-DOSE CHILDREN AND LEARNING PRIORITIES FOR THE COUNTRY. ZAMBIA IN 2023, PATH CONTINUED TO COLLABORATE WITH ZAMBIA'S MINISTRY OF HEALTH NATIONAL MALARIA ELIMINATION PROGRAM (NMEP) THROUGH MALARIA CONTROL AND ELIMINATION PARTNERSHIP IN AFRICA (MACEPA) AND THE USAID PROGRAM FOR ADVANCEMENTS OF MALARIA OUTCOMES (PAMO) PLUS PROJECTS. BY THE END OF 2023, THE MULTIYEAR PAMO PLUS PROJECT HAD SUPPORTED TRAINING OVER 4,000 COMMUNITY HEALTH WORKERS (CHWS) TO TEST, TREAT, AND TRACK MALARIA CASES IN THE COMMUNITY AGAINST THE LIFE OF THE PROJECT TARGET OF 5,000. THE CHWS ARE CONSTANTLY ENGAGED, AND THEIR CLINICAL SKILLS ARE IMPROVED THROUGH MONITORING, MENTORSHIP, AND MOTIVATIONAL VISITS. FURTHERMORE, MENTORSHIP AND TECHNICAL SUPPORTIVE SUPERVISION CONTINUOUSLY ENHANCE THEIR REPORTING AND TRACKING SKILLS. PAMO PLUS ALSO SUPPORTS THE PREVENTION OF MALARIA IN PREGNANCY PROGRAMS BY MENTORING ANTENATAL CARE (ANC) PROVIDERS THROUGH OUTREACH TRAINING AND SUPPORTIVE SUPERVISION IN MICROSCOPY AND NON-MICROSCOPY FACILITIES. PAMO PLUS WORKS WITH SAFE MOTHERHOOD ACTION GROUP VOLUNTEERS TO CONDUCT COMMUNITY-LEVEL ACTIVITIES THAT ENCOURAGE WOMEN TO ACCESS ANC SERVICES EARLY AND CONTINUE ATTENDANCE THROUGHOUT PREGNANCY, AIMING TO IMPROVE ACCESS TO INTERMITTENT PREVENTIVE TREATMENT OF MALARIA IN PREGNANCY AND INSECTICIDE-TREATED NETS (ITNS). PAMO PLUS SOCIAL AND BEHAVIOR CHANGE (SBC) ACTIVITIES AIM TO IMPROVE THE UPTAKE AND USE OF PROVEN MALARIA INTERVENTIONS AT THE COMMUNITY LEVEL TO PREVENT MALARIA AND REDUCE INCIDENCE AND DEATHS. PAMO PLUS'S STRATEGIC APPROACH IS TO ADDRESS BARRIERS THAT HINDER PEOPLE FROM ADOPTING BEHAVIORS THAT PROTECT THEM FROM MALARIA THROUGH FOUR PLATFORMS: (1) INTERPERSONAL COMMUNICATIONS, (2) COMMUNITY ENGAGEMENT, (3) MASS AND SOCIAL MEDIA, AND (4) SBC MANAGEMENT AND COORDINATION. BY THE END OF 2023, OVER 6,000 CCAS HAD BEEN TRAINED TO PROVIDE SBC ACTIVITIES THROUGH HOUSEHOLD VISITS, COMMUNITY DIALOGUES, AND HEALTH TALKS. PAMO PLUS PROVIDES SUBGRANTS TO 16 CIVIL SOCIETY ORGANIZATIONS (CSOS) THAT CONDUCT SBC ACTIVITIES IN 37 DISTRICTS IN ZAMBIA. PAMO PLUS SUPPORTS THE NATIONAL MALARIA PROGRAM IN SURVEILLANCE, MONITORING, EVALUATION, AND OPERATIONAL RESEARCH FOR MALARIA DATA. THE PROJECT PROVIDES TECHNICAL SUPPORT TO STRENGTHEN SKILLS AMONG STAFF THAT GENERATE, AGGREGATE, AND REPORT DATA AT THE DISTRICT, FACILITY, AND COMMUNITY LEVELS AND TO IMPROVE SYSTEMS FOR SUSTAINABLE, HIGH-QUALITY DATA MANAGEMENT. IN SINDA DISTRICT OF ZAMBIA, PAMO PLUS IS IMPLEMENTING TWO ACTIVITIES TO ELIMINATE MALARIA. MALARIA CASE INVESTIGATION (MCI) IS BEING PILOTED IN TEN HEALTH FACILITY CATCHMENT AREAS (HFCAS). MCI USES THE 1-3-7 APPROACH, WHERE MALARIA CASES ARE NOTIFIED WITHIN ONE DAY, INVESTIGATED THROUGH REACTIVE CASE DETECTION WITHIN THREE DAYS, AND ENTOMOLOGICAL SURVEILLANCE AND RESPONSE WITHIN SEVEN DAYS. BY DAY SEVEN, AN APPROPRIATE LOCAL RESPONSE MIGHT INCLUDE LARVAL SOURCE MANAGEMENT, RESPONSIVE INDOOR RESIDUAL SPRAYING, NET DISTRIBUTION, AND HEALTH PROMOTION. IN 12 HFCAS, PAMO PLUS IS ALSO PILOTING SINGLE LOW-DOSE PRIMAQUINE (SLDPQ) AS AN ADDITIONAL TREATMENT TO THE STANDARD ARTEMISININ-BASED COMBINATION THERAPY REGIMEN, TARGETING MALARIA PARASITE GAMETOCYTES, WHICH ARE RESPONSIBLE FOR THE CONTINUED PARASITE CYCLE IN THE MOSQUITO AND ONWARD MALARIA TRANSMISSION. THE SLDPQ PILOT (WITH ACTIVE PHARMACOVIGILANCE FOR THE UNLIKELY SIDE EFFECT OF PRIMAQUINE-INDUCED HEMOLYTIC ANEMIA) WILL INFORM A NATIONWIDE ROLLOUT OF SLDPQ IN HFCAS WITH A MALARIA INCIDENCE OF FEWER THAN 125 CASES PER 1,000 POPULATION. PAMO PLUS ALSO SUPPORTS NATIONAL-LEVEL MALARIA PROGRAM MANAGEMENT. IN 2023, IT BEGAN DISCUSSIONS WITH THE EPI, ZAMBIA IMMUNIZATION TECHNICAL ADVISORY GROUP, AND THE NATIONAL MALARIA ELIMINATION CENTER (NMEC) TO EXPLORE THE POSSIBILITY OF INTRODUCING THE MALARIA VACCINE AT THE NATIONAL LEVEL. MACEPA COLLABORATED WITH THE PMI VECTORLINK TEAM TO CREATE THE ENTOMOLOGICAL SURVEILLANCE DHIS INSTANCE, WHICH MIRRORS DATA FROM THE VECTORLINK COLLECT TOOLSET. THIS ALLOWS THE NMEC TO ENTER RESISTANCE DATASETS BEYOND THOSE MAINTAINED BY PMI. THESE TWO INSTANCES WERE MERGED IN 2023 AND BEGAN COLLECTING DATA FROM PARTNERS ENGAGED IN ENTOMOLOGICAL SURVEILLANCE ACTIVITIES. ONGOING DISCUSSIONS WITH THE NMEC AND HMIS DEPARTMENTS ARE UNDERWAY TO FURTHER INTEGRATE SEPARATE DATA STORAGE INSTANCES SUCH AS THE MALARIA RAPID REPORTING (MRR) SYSTEM AND MRR MOBILE TOP-UP PLATFORM; INTEGRATE THE CHW REGISTRY INTO THE DHIS2 NMEC INSTANCE, EITHER THROUGH DATABASE LINKAGES OR MIGRATION OF DATABASES INTO A SINGLE INSTANCE; AND MANAGE MOBILE CLIENT UPDATES. IN MID-2023, MACEPA, WORKING CLOSELY WITH A TASK TEAM SET UP AND LED BY THE NMEC, ENGAGED KEY PERSONNEL WITHIN MOH/NMEC ON THE FULL TRANSFER OF THE PLATFORMS AND TASKS TO THE MOH/NMEC. THIS TRANSFER AND HANDOVER PROCESS TO THE MOH/NMEC IS ANTICIPATED TO BE COMPLETED BY MID-2025. MACEPA IS WORKING WITH THE NMEC AND PARTNERS TO CONDUCT A MALARIA TRENDS ANALYSIS IN ORDER TO UNDERSTAND THE UNDERLYING CAUSES OF THE INCREASED MALARIA CASES NOTED IN EARLY 2023. MACEPA PROVIDED SOME INSIGHT TOWARD THIS EFFORT BY USING MODELING AND OTHER DATA ANALYTICS METHODS, WHICH INCLUDED EXAMINING CLIMATIC, PROGRAMMATIC, AND CASE DATA, AMONG OTHER ASPECTS THAT COULD GUIDE DECISION-MAKING. IN ADDITION, MACEPA WAS PART OF THE DATA ANALYTICS TEAM THAT ASSISTED IN SETTING UP THE DIGITAL HOUSEHOLD TRACKING PLATFORM USED DURING THE 2023 MASS ITN DISTRIBUTION CAMPAIGN, WHICH DISTRIBUTED 11.6 MILLION ITNS ACROSS ALL TEN PROVINCES IN ZAMBIA. |
| FORM 990, PART III, LINE 4D, DESCRIPTION OF PROGRAM SERVICE: | THE ZAMBIA MOH LAUNCHED THE NATIONAL MEDICAL OXYGEN STRATEGIC PLAN 20222026, WHICH WAS DEVELOPED WITH SUPPORT FROM PATH. THE PLAN WAS COMPLETED IN NOVEMBER 2022 AND LAUNCHED IN MAY 2023. THE STRENGTHENING OXYGEN UTILIZATION AND RESPIRATORY CARE ECOSYSTEM (SOURCE) ACTIVITY SUPPORTED THE LAUNCH AND SUBSEQUENT DISSEMINATION OF THE PLAN. ADDITIONALLY, THE SOURCE PROJECT CONDUCTED A COMPREHENSIVE NATIONAL BIOMEDICAL EQUIPMENT SURVEY OF 90 HEALTH CARE FACILITIES, COVERING ALL TEN PROVINCES IN THE COUNTRY. THE SURVEY ASSESSED THE AVAILABILITY, FUNCTIONALITY, AND MAINTENANCE STATUS OF RESPIRATORY CARE EQUIPMENT, SUCH AS OXYGEN CONCENTRATORS, PULSE OXIMETERS, VENTILATORS, AND PSA PLANTS, AS WELL AS OTHER RELATED BIOMEDICAL EQUIPMENT. THIS DATA COLLECTION EXERCISE PROVIDED A DETAILED BASELINE OF THE MEDICAL OXYGEN LANDSCAPE ACROSS THE COUNTRY, IDENTIFYING KEY GAPS AND CHALLENGES IN OXYGEN INFRASTRUCTURE AND EQUIPMENT. FURTHER, THE SOURCE PROJECT IS SUPPORTING THE MINISTRY OF HEALTH TO DEVELOP A SKILLS AWARD CURRICULUM. THE SKILLS AWARD CURRICULUM IS BEING DEVELOPED IN COLLABORATION WITH OTHER STAKEHOLDERS AND COOPERATING PARTNERS, INCLUDING CHAI, THE OXYGEN ALLIANCE, THE COPPERBELT PROVINCIAL HEALTH OFFICE, THE LUAPULA PROVINCIAL HEALTH OFFICE, EVELYN HONE COLLEGE, THE NORTHERN TECHNICAL COLLEGE, TEVETA, AND BUILD HEALTH INTERNATIONAL. THIS WILL BUILD THE CAPACITY OF PERSONNEL IN OXYGEN PRODUCTION, SUPPLY, STORAGE, AND ADMINISTRATION IN A STRUCTURED, STANDARDIZED, AND SUSTAINABLE MANNER. THE TECHNICAL EDUCATION, VOCATIONAL, AND ENTREPRENEURSHIP TRAINING AUTHORITY (TEVETA) HAS OFFERED TECHNICAL SUPPORT TO ENSURE THE CURRICULUM DEVELOPMENT AND IMPLEMENTATION ARE ALIGNED WITH NATIONAL STANDARDS AND GUIDELINES. THE SKILLS AWARD CURRICULUM IS CURRENTLY FINALIZED IN ITS DRAFT FORM AND AWAITING APPROVAL FROM TEVETA. THE SKILLS AWARD CURRICULUM WAS A RESULT OF A TRAINING NEEDS ASSESSMENT CONDUCTED BY THE SOURCE PROJECT, WHICH REVEALED GAPS IN PERSONNEL CAPABILITY TO EFFECTIVELY MANAGE MEDICAL OXYGEN SYSTEMS. THE TEAM IDENTIFIED SKILL DEFICIENCIES IN AREAS SUCH AS: - MANAGING MEDICAL OXYGEN IN HEALTH CARE FACILITIES. - MAINTAINING AND SERVICING RESPIRATORY CARE EQUIPMENT. - MAINTAINING AND SERVICING CENTRAL PIPELINE AND MANIFOLDS. - MAINTAINING AND SERVICING OXYGEN PLANTS AND LIQUID OXYGEN (LOX) TANKS. - CONDUCTING POST-SERVICE INSPECTIONS OF EQUIPMENT, PLANTS, LOX, AND ASSOCIATED INFRASTRUCTURE. THE TRAINING NEEDS ASSESSMENT REVEALED THAT THE CURRENT BIOMEDICAL ENGINEERING CURRICULUM AND JOB DESCRIPTIONS FOR MOH BIOMEDICAL ENGINEERING STAFF DO NOT ADEQUATELY ADDRESS THESE EVOLVING SKILL REQUIREMENTS. WITH FUNDING FROM THE GATES FOUNDATION, PATH HAS SUPPORTED PROVINCIAL TRAINING FOR 70 HEALTH CARE PERSONNEL IN OXYGEN ESCALATION THERAPY. THE GOAL OF THE ZAMBIA DIGITAL COMMUNITY HEALTH PROJECT IS TO DEVELOP A UNIFIED PLATFORM TO COORDINATE HEALTH SERVICE DELIVERY BY COMMUNITY HEALTH WORKERS. IN 2023, THE TEAM COMPLETED THE DEVELOPMENT AND BEGAN USER TESTING OF A MINIMUM VIABLE PRODUCT OF THE COMMUNITY HEALTH INFORMATION PLATFORM THAT ADDRESSES SERVICE DELIVERY AND DECISION SUPPORT, DATA QUALITY AND MANAGEMENT, AND A DATA CULTURE THAT CONTRIBUTES TO ADDRESSING CHALLENGES IN DATA USE. THE ACCESS COLLABORATIVE CONDUCTED A LEARNING EXCHANGE TO UGANDA IN MAY 2023, WHICH RESULTED IN A POLICY CHANGE TO ALLOW COMMUNITY-BASED DISTRIBUTORS TO TRAIN WOMEN TO SELF-INJECT DMPA-SC. THIS MILESTONE COMPLETED THE PROVISION OF SELF-INJECTION (SI) IN ALL THREE CHANNELS (PRIVATE, PUBLIC, AND COMMUNITY). FURTHERMORE, THE ACCESS COLLABORATIVE APPLIED FOR AND OBTAINED FUNDING OF $240,000 TO JUMPSTART THE PROVISION OF DMPA-SC SI IN THE COMMUNITY. THIS INCLUDED TRAINING CBDS IN SI PROVISION AND CONDUCTING SUPERVISION AND MENTORING VISITS TO THREE PROVINCES (COPPERBELT, NORTHWESTERN, AND LUAPULA). ANOTHER MAJOR ADVOCACY WIN WAS THE INCLUSION OF THE SELF-INJECTION INDICATOR IN THE HMIS. THIS WILL FOSTER DATA USE FOR DECISION-MAKING AND WILL PROVIDE DATA FOR COMMODITY SUPPLY. ADVOCACY AND PUBLIC POLICY PATH'S ADVOCACY AND PUBLIC POLICY TEAM WORKS IN THE UNITED STATES, IN COUNTRIES IN AFRICA (SUCH AS THE DRC, KENYA, SOUTH AFRICA, AND UGANDA), AND AT THE GLOBAL LEVEL WITH MULTILATERAL AGENCIES. WE PARTNER WITH POLICYMAKERS TO HELP THEM UNDERSTAND ISSUES AND MOTIVATE THEM TO COMMIT FUNDING, CRAFT POLICIES, AND SPONSOR INITIATIVES TO STRENGTHEN GLOBAL HEALTH. AS A 501(3)C ORGANIZATION, PATH DOES NOT INFLUENCE THE OUTCOMES OF ELECTIONS AND DOES NOT EMPLOY ANY REGISTERED LOBBYISTS. PATH PROVIDES BEHIND-THE-SCENES SUPPORT TO ADVOCACY PARTNERS IN THE PLACES WHERE WE WORK TO HELP STRENGTHEN THEIR CAPACITY TO ENGAGE WITH LOCAL DECISION-MAKERS TO IMPROVE HEALTH IN THEIR COMMUNITIES. WE FACILITATE PEER-TO-PEER LEARNINGS AMONG THESE PARTNERS TO EXCHANGE BEST PRACTICES AND LESSONS LEARNED ABOUT THE PRACTICE OF ADVOCACY, AND WE HELP ELEVATE LOCAL VOICES IN GLOBAL CONVERSATIONS AROUND HEALTH. IN 2023, PATH LED EFFORTS TO ENSURE SUPPORT AMONG OUR PARTNER POLICYMAKERS TO MAINTAIN AND STRENGTHEN PIVOTAL WORK IN GLOBAL HEALTH RESEARCH AND DEVELOPMENT, MATERNAL AND CHILD HEALTH, IMMUNIZATION, PRIMARY HEALTH CARE, AND PANDEMIC PREPAREDNESS AND RESPONSE. SUCCESSES INCLUDED PROTECTING KEY US GOVERNMENT FUNDING FOR PATH'S PRIORITY HEALTH AREAS AND HELPING DECISION-MAKERS IN KENYA ROLL OUT PRIMARY HEALTH CARE POLICIES TO IMPROVE HEALTH SYSTEMS. |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 WAS PREPARED BY AN OUTSIDE ACCOUNTING FIRM USING INFORMATION PROVIDED BY PATH ACCOUNTING SERVICES STAFF. PATH SENIOR MANAGEMENT REVIEWED THE DRAFT FORM. A COPY OF THE DRAFT WAS SENT TO THE BOARD OF DIRECTORS FOR COMMENT. AFTER THE COMMENT PERIOD, THE PRINCIPAL FINANCIAL OFFICER SIGNED THE FORM. |
| FORM 990, PART VI, SECTION B, LINE 12C | PATH HAS POLICIES AND PROCEDURES TO ADDRESS CONFLICTS OF INTEREST. PATH MANAGEMENT AND ALL STAFF WITHIN THE ORGANIZATION MUST COMPLETE A CONFLICT-OF-INTEREST DISCLOSURE FORM EACH YEAR. ALL FORMS ARE REVIEWED AND KEPT ON FILE. A CONFLICT MANAGEMENT PLAN IS DEVELOPED FOR ANY EMPLOYEE WITH A SIGNIFICANT ACTUAL OR PERCEIVED CONFLICT OF INTEREST. PATH ALSO HAS A WELL-DEFINED PROCEDURE FOR IDENTIFYING AND REPORTING ACTUAL AND POTENTIAL CONFLICTS OF INTEREST AMONG BOARD MEMBERS. NEW BOARD MEMBERS ARE ASKED TO COMPLETE A CONFLICT-OF-INTEREST DISCLOSURE FORM WITHIN 30 DAYS OF JOINING THE BOARD AND TO COMPLETE A NEW FORM ANNUALLY THEREAFTER. IN ADDITION, MEMBERS ARE REMINDED TO REPORT ANY NEW ISSUES THAT ARISE OUTSIDE OF THE ANNUAL DISCLOSURE PERIOD. THE DISCLOSURE FORMS ARE REVIEWED BY PATH'S GENERAL COUNSEL, AND IF ANY ACTUAL OR POTENTIAL CONFLICTS ARE IDENTIFIED, GENERAL COUNSEL MAKES A RECOMMENDATION TO THE CHAIR OF THE GOVERNANCE COMMITTEE AND THE CHAIR OF THE BOARD FOR A MANAGEMENT PLAN TO PROPERLY MANAGE ANY CONFLICTS. A FORMAL MANAGEMENT PLAN IS THEN AGREED UPON WITH THE BOARD MEMBER, AND THE ENTIRE BOARD OF DIRECTORS IS INFORMED AT THE NEXT REGULARLY SCHEDULED BOARD MEETING. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE BOARD ANNUALLY REVIEWS SALARIES AND BENEFITS FOR EXECUTIVE EMPLOYEE POSITIONS AND PROVIDES GUIDANCE TO THE PRESIDENT/CHIEF EXECUTIVE OFFICER (CEO) ON COMPENSATION DECISIONS FOR EXECUTIVE POSITIONS. THE COMPENSATION AND BENEFITS FOR PATH'S PRESIDENT/CEO ARE REVIEWED AND APPROVED BY THE ENTIRE BOARD OF DIRECTORS EACH YEAR. PATH ROUTINELY USES THE SERVICES OF EXTERNAL COMPENSATION CONSULTING FIRMS TO ASSESS AND BENCHMARK EXECUTIVE COMPENSATION (PRESIDENT/CEO AND DIVISION CHIEFS). THE MOST RECENT REVIEW WAS COMPLETED BY THE BOARD IN 2023. AT THE REQUEST OF THE BOARD, PATH ENGAGED FUTURE SENSE (A COMPENSATION, BENEFITS, AND HUMAN RESOURCES CONSULTING FIRM) TO REVIEW CURRENT AND PROPOSED BASE SALARIES OF PATH'S PRESIDENT/CEO AND DIVISION CHIEFS. FUTURE SENSE USED DATA FROM MULTIPLE SOURCES TO EVALUATE CURRENT AND PROPOSED BASE SALARIES FOR THESE POSITIONS. THE BOARD REVIEWED THE FUTURE SENSE REPORT AND APPROVED THE USE OF THE REPORT TO ESTABLISH A FRAMEWORK WITHIN WHICH THE PRESIDENT/CEO IS DELEGATED AUTHORITY TO ESTABLISH THE TOTAL COMPENSATION PACKAGES OF THE DIVISION CHIEFS. ADDITIONALLY, FUTURE SENSE REVIEWED THE PROPOSED TOTAL COMPENSATION AND BENEFITS PACKAGE FOR THE PRESIDENT/CEO POSITION AND OBTAINED A SIGNIFICANT NUMBER OF DATA POINTS TO ASCERTAIN ITS REASONABLENESS AND APPROPRIATENESS. THE BOARD APPROVED THE RECOMMENDATION FOR THE PRESIDENT/CEO'S TOTAL COMPENSATION PACKAGE. |
| FORM 990, PART VI, SECTION C, LINE 19 | PATH GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST; MOST DOCUMENTS ARE ALSO AVAILABLE ONLINE. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)
| Address Line1ForeignAddress/AddressLine1Txt | CityForeignAddress/CityNm | CountryForeignAddress/CountryCd | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile Foreign CountryLegalDomicileForeignCountryCd | Exempt Code SectionExemptCodeSectionTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd |
|---|---|---|---|---|---|---|---|
| FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND | |||||||
| 207 ROUTE DE FERNEY 1218 LE GRAND-S | GENEVA | SZ | EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH | SZ | 501(C)(3) | PATH | Yes (1) |
| PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH -KENYA | |||||||
| ACS PLAZA 4TH FL LENANA RD PO BOX | NAIROBI | KE | EDUCATIONAL AND SCIENTIFIC PROMOTION OF HEALTH | KE | 501(C)(3) | PATH | Yes (1) |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (1) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | 0 | SharingOfFacilitiesInd |
| Paid Employees Sharing | 0 | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (4 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH-KENYA | ||
| C | $2,350,595 | FMV |
| PROGRAM FOR APPROPRIATE TECHNOLOGY IN HEALTH-KENYA | ||
| B | $8,495,931 | FMV |
| FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND | ||
| C | $5,855 | FMV |
| FOUNDATION FOR APPROPRIATE TECHNOLOGIES IN HEALTH - SWITZERLAND | ||
| B | $5,869,356 | FMV |